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 RESUMO 
A etiologia das fissuras orais não-sindrômicas (FONS) é complexa e fortemente 
influenciada pelos fatores genéticos e ambientais específicos de cada população. No 
Brasil, a elevada miscigenação é considerada uma característica que pode influenciar na 
suscetibilidade das FONS. Para melhor compreender os aspectos genéticos associados 
as FONS na população brasileira, este estudo compilou resultados de 4 estudos 
específicos. O primeiro estudo foi uma revisão sistemática e meta-análise de marcadores 
genéticos avaliados na população brasileira. Este estudo revelou possíveis associações 
dos polimorfismos de nucleotídeo único (SNP) rs642961 (IRF6), rs987525 e rs1530300 
(8q24), rs1801133 (MTHFR) e rs17563 (BMP4) com a etiologia das fissuras labiais com 
ou sem fissuras palatinas não-sindrômica (FL±PNS). Contudo, frente ao pequeno número 
de estudos que analisou cada um destes marcadores, mais estudos com amostras 
robustas e que levem em consideração a elevada miscigenação da população brasileira 
são necessários. O segundo estudo optou por validar 7 SNPs (rs7552 em 2q24.2, 
rs8049367 em 16p13.3, rs1880646, rs7406226 e rs9891446 em 17p13, rs1588366 em 
17q23.2 e rs73039426 em 19q13.11), localizados em regiões associadas com FL±PNS 
em estudos de larga escala genômica, em 831 pacientes com FL±PNS e 866 controles. 
A análise de regressão logística levando em consideração as diferenças na 
ancestralidade genômica e no gênero entre os grupos revelou que o SNP rs7552 é um 
marcador de risco para o desenvolvimento das FL±PNS. Interações gene-gene (GxG) 
entre rs7552 com rs8049367, rs1880646, rs9891446, rs1588366 e rs73039426 foram 
também associadas com risco aumentado para o desenvolvimento das FL±PNS. Embora 
os SNPs rs1880646 e rs9891446 não foram individualmente associados com FL±PNS, o 
haplótipo AG (alelo A de rs1880646 e alelo G de rs9891446) foi mais frequente entre os 
pacientes com FL±PNS em comparação com os controles, exibindo um risco aumentado 
para o desenvolvimento da fissura. O terceiro estudo avaliou a influência de SNP em 
genes associados com a neutralização do estresse oxidativo (famílias de genes 
superóxido dismutase-SOD e paraoxinase-PON) no risco das FL±PNS na população 
brasileira, considerando interações GxG e gene-fatores ambientais (GxE). Os resultados 
demonstraram que o alelo C e o genótipo CT do SNP rs2237583 em PON1 evocam 
efeitos protetores para as FL±PNS, enquanto rs3917490 apresentou significância apenas 
 com amostra composta por pacientes com alta ascendência africana. Várias interações 
GxG contendo os SNP rs2237583 em PON1 e rs17166879 em PON2 atingiram 
significância após o ajuste para múltiplos testes. Por fim, o quarto estudo utilizou a 
estratégia de tag-SNP para verificar a participação de variantes (rs1169, rs7153, 
rs9968051, rs9819530 e rs6794341) em GOLGB1 na patogênese das fissuras palatinas 
isoladas não-sindrômicas (FPNS). Neste estudo contendo 270 pacientes com FPNS e 
284 controles, nenhuma associação significante foi observada entre as variantes em 
GOLGB1 e as FPNS. Em conclusão, este estudo revela alguns potenciais marcadores 
genéticos associados ao desenvolvimento das FONS na população brasileira e reforça a 
importância de considerar interações GxG na patogênese desta malformação congênita. 
 
Palavras-Chave: Fissura de lábio. Fissura de palato. Polimorfismo de nucleotídeo único. 
Genética populacional. Anormalidades congênitas. 
  
 ABSTRACT 
The nonsyndromic oral cleft (NOC) etiology is complex and strongly influenced by 
specific genetic and environmental factors within each population. In Brazil, the high 
miscegenation is considered a characteristic that may influence NOC susceptibility. To 
improve our understanding in the genetic aspects associated with NOC in the Brazilian 
population, this study compiled results from 4 specific studies. The first study was a 
systematic review and meta-analysis of genetic markers evaluated in the Brazilian 
population. This study revealed possible associations of single nucleotide polymorphisms 
(SNP) rs642961 (IRF6), rs987525 and rs1530300 (8q24), rs1801133 (MTHFR) and 
rs17563 (BMP4) with the etiology of nonsyndromic cleft lip with or without cleft palate 
(NSCL±P). However, in the view of the small number of studies that analyzed each of 
these markers, more studies with robust samples taking into account the high 
miscegenation of the Brazilian population are necessary. The second study opted to 
validate 7 SNP (rs7552 in 2q24.2, rs8049367 in 16p13.3, rs1880646, rs7406226 and 
rs9891446 in 17p13, rs1588366 in 17q23.2 and rs73039426 in 19q13.11), located in 
regions associated with NSCL±P in large-scale genomic studies, in 831 patients with 
NSCL±P and 866 controls. Logistic regression analysis adjusted to differences in the 
genomic ancestry and gender of the groups revealed that the SNP rs7552 is a marker of 
risk for the development of NSCL±P. Gene-gene (GxG) interactions between rs7552 with 
rs8049367, rs1880646, rs9891446, rs1588366 and rs73039426 were also associated with 
increased risk for the development of NSCL±P. Although rs1880646 and rs9891446 were 
not individually associated with NSCL±P, the A-G haplotype (A allele of rs1880646 and G 
allele of rs9891446) was more frequent among NSCL±P patients as compared to controls, 
exhibiting an increased risk to NSCL±P. The third study evaluated the influence of SNP 
in genes associated with neutralization of stress oxidative (superoxide dismutase-SOD 
and paraoxonase-PON gene families) in the risk of NSCL±P in the Brazilian population, 
considering GxG and gene-environment factor (GxE) interactions. The results showed 
that the C allele and the CC genotype of PON1 rs2237583 evoke significant protective 
effects against NSCL±P, while rs3917490 showed a significant association only in the 
sample composed of patients displaying high African ancestry. Some GxG interactions 
containing PON1 rs2237583 and PON2 rs17166879 reached significance after 
 adjustment for multiple tests. Finally, the fourth study used the tag-SNP strategy to verify 
the participation of variants (rs1169, rs7153, rs9968051, rs9819530 and rs6794341) in 
GOLGB1 in the pathogenesis of nonsyndromic cleft palate only (NSCPO). In this study 
containing 270 patients with NSCPO and 284 controls, no significant associations were 
observed between variants in GOLGB1 and NSCPO. In conclusion, this study reveals 
some potential genetic markers associated with the development of NOC in the Brazilian 
population, and reinforces the importance of considering GxG interactions in the 
pathogenesis of this congenital malformation. 
 
Key words: Cleft lip. Cleft palate. Single nucleotide polymorphism. Genetics, population. 
Congenital abnormalities. 
  
 SUMÁRIO 
 
 
1 INTRODUÇÃO 16 
2 ARTIGOS 23 
   2.1 Artigo: Potential genetic markers for nonsyndromic oral clefts in the 
Brazilian population: a systematic review and meta-analysis 
 
23 
   2.2 Artigo: 2p24.2 (rs7552) is a susceptibility locus for nonsyndromic cleft lip 
with or without cleft palate in the Brazilian population 
 
74 
   2.3 Artigo: Interactions between superoxide dismutase and paraoxonase 
polymorphic variants in nonsyndromic cleft lip with or without cleft palate in the 
Brazilian population 
 
 
93 
   2.4 Artigo: Association between GOLGB1 tag-polymorphisms and 
nonsyndromic cleft palate only in the Brazilian population 
132 
3 DISCUSSÃO 146 
4 CONCLUSÃO 153 
REFERÊNCIAS 154 
ANEXOS 168 
ANEXO 1 - Artigo aprovado no periódico Birth Defects Research 168 
ANEXO 2 - Artigo aprovado no periódico Clinical Genetics 169 
ANEXO 3 - Artigo submetido ao periódico Journal of Dental Research 170 
ANEXO 4 - Artigo aprovado no periódico Annals of Human Genetics 171 
 
  
16 
1 INTRODUÇÃO 
 
As fissuras orais (FO), principalmente as caracterizadas por áreas de 
descontinuidade no lábio e/ou palato, representam o defeito craniofacial congênito 
mais frequente em humanos (Dixon et al., 2011; Marazita, 2012). Aproximadamente 
70% das FO se manifestam de forma não-sindrômica (FONS), ou seja, sem 
malformações ou alterações adicionais (Jones, 1988; Marazita et al., 2002a). Os 
demais casos representam como uma característica fenotípica no espectro clínico de 
mais de 500 síndromes relatadas (Dixon et al., 2011). A classificação das FO depende 
da região anatômica envolvida e se divide basicamente em 3 grupos: fissura pré-
forame incisivo ou fissura labial (FL), fissura pós-forame incisivo ou fissura palatina 
(FP) e fissuras transforme incisivo ou fissura lábio-palatina (FLP). A FL é o resultado 
da ausência de fusão das proeminências nasais e maxilares, a FP ocorre quando os 
processos palatinos deixam de se fundir. Quando surge a falha concomitante nos dois 
processos ocorre a FLP (Shkoukani et al., 2013). Contudo, há uma tendência mundial 
em considerar a FL uma variação da FLP, colocando-as no grupo das fissuras labial 
com ou sem fissura palatina (FL±P). 
As FONS afetam aproximadamente 1 em cada 500 a 2.500 nascidos vivos, com 
grande variabilidade de acordo com a origem étnica, gênero do indivíduo e fatores 
ambientais (Marazita et al., 2002b; Dixon et al., 2011). Em geral, as populações 
asiáticas e amerińdias possuem uma alta prevalência (1:500), as populações 
européias possuem prevalência intermediária (1:1.000) e as menores taxas de 
prevalência são observadas em africanos e descendentes de africanos (1:2.500) 
(Mossey e Little, 2002; Murthy e Bhaskar, 2009; Mossey et al., 2009). No Brasil, por 
ter uma população altamente miscigenada, baseada principalmente entre 
ancestralidade europeia, afriana e ameríndia, a prevalência varia entre 1:685 a 
1:2.800 nascidos vivos (Martelli-Junior et al., 2007; Rodrigues et al., 2009). 
Além de ser uma causa importante de mortalidade, chegando até 30% em 
países subdesenvolvidos e em áreas pontuais em países desenvolvidos, as FONS 
são associadas também a uma significante morbidade (Wehby et al., 2011). Efeitos 
sobre a fala, audição e estética geram resultados adversos sobre a saúde e integração 
social (Nopoulos et al., 2007; Mossey et al., 2009). Entre as primeiras complicações 
está à dificuldade no aleitamento materno, resultando em dificuldades no ganho de 
peso e no desenvolvimento da criança (Montagnoli et al., 2005). Pesquisas com 
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pacientes fissurados em fase escolar registram alterações cognitivas, que em sua 
maioria foram associadas a micro-alterações na trajetória do crescimento e 
desenvolvimento das estruturas cerebrais (Broder et al., 1998; Weinberg et al., 2013). 
Embora a literatura tenha apontado um maior risco na incidência de alguns tipos de 
câncer nos indivíduos afetados por FONS e seus familiares (Zhu et al., 2002; Bille et 
al., 2005; Taioli et al., 2010; Jindal e Vieira, 2012; Vieira et al., 2012), alguns estudos 
realizados pelo nosso grupo não confirmaram tal achado (Gonçalves et al., 2014; 
Martelli et al., 2014; Cardoso et al., 2018). No que diz respeito às alterações no 
desenvolvimento da dentição, as anomalias dentais também têm sido cada vez mais 
investigadas e detectadas com maior frequência em indivíduos com FONS (Paranaiba 
et al., 2013; Melo-Filho et al., 2015; Sá et al., 2016a; Sá et al., 2016b; Fernandez et 
al., 2018). Além da saúde física, já se tem apontado o alto impacto das FONS na 
saúde mental dos afetados, uma vez que estes podem apresentar um maior risco em 
desenvolver distúrbios psiquiátricos que interferem na vida social (Trindade et al., 
2007; Lima et al., 2015). Todas estas complicações, vastamente estudadas, reforçam 
o impacto negativo que as FONS podem acarretar ao indivíduo, trazendo inúmeras 
consequências diretas e indiretas na sua qualidade de vida, tanto nos aspectos 
individuais quanto familiares e sociais (Wehby e Cassell, 2010). Por consequência da 
complexidade das manifestações clínicas, os indivíduos afetados por FONS 
necessitam de acompanhamento especializado e assistência integral a longo prazo 
em centros de referência de alta complexidade (Wehby e Cassell, 2010). Embora a 
reabilitação seja possível com o atendimento de boa qualidade, as FONS 
inevitavelmente constituem um ônus para o indivíduo, para a família e para a 
sociedade, com um custo substancial em termos de saúde e serviços relacionados 
(Dixon et al., 2011). 
O desenvolvimento normal da face é marcado por uma sequência de eventos 
complexos, coordenados por interações entre fatores de transcrição e sinalizadores 
moleculares, juntamente com interações célula-célula e aquisição de polarização 
celular (Stanier e Moore, 2004). Até o final da quarta semana, as células da crista 
neural, oriundas do tubo neural anterior, migram para formar o primórdio da face, 
surgindo dela os processos nasal medial e nasal lateral, que se fundem ao processo 
maxilar, para formar a parte central do lábio superior, o palato primário e o nariz 
(Marazita e Mooney, 2004). O palato primário aloja os dentes incisivos da maxila, 
dando origem à parte anterior do forame incisivo e também contribuindo para a 
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formação do lábio e a porção anterior da maxila (Rice, 2005). O palato secundário se 
desenvolve após o palato primário durante a sexta e a décima segunda semanas. Os 
processos palatinos se elevam acima da língua, fundindo medialmente na linha média, 
anteriormente com o palato primário e superiormente com o septo nasal. O forame 
incisivo marca a extensão anterior do palato secundário. A formação dos palatos 
primário e secundário completa a separação das cavidades nasal e oral, permitindo a 
respiração simultaneamente à mastigação (Dixon et al., 2011). 
A diversidade de eventos embriológicos que contribuem para a formação das 
estruturas faciais reflete nos inúmeros fatores envolvidos na formação das FONS 
(Jugessur et al., 2009; Rojas-Martinez et al., 2010). Diante da complexidade destes 
processos, pode-se perceber o significado biológico dos mecanismos de 
desenvolvimento embrionário e a sua importância, pelo fato da ocorrência de alguma 
falha neste processo poder contribuir para possíveis alterações congênitas. Nos 
últimos anos têm ocorrido uma evolução no entendimento dos fatores causais, com a 
identificação de novas variantes genéticas, de fatores de risco ambientais, a interação 
de fatores de risco ambientais e fatores genéticos, bem como a associação entre os 
genes (Dixon et al., 2011; Mangold et al., 2011; Wu et al., 2014; Machado et al., 2016; 
Wang et al., 2018). Há uma enorme variedade de agentes teratogênicos externos que 
podem influenciar o desenvolvimento do lábio e do palato, embora poucos deles 
estejam comprovados. Tem sido sugerido que a exposição materna a alguns fatores 
teratogênicos como medicamentos, álcool e tabaco e as deficiências vitamínicas, 
principalmente ácido fólico, durante o primeiro trimestre de gestação está intimamente 
associada com a ocorrência das FONS (Jianyan et al., 2010; Wehby e Murray, 2010). 
As complexidades dos mecanismos envolvidos se diferem quanto ao tipo, frequência 
e gravidade, resultando na diversidade das manifestações clínicas das fissuras 
(Economou et al., 2012). 
Após Fogh-Andersen (1942) observar em um estudo populacional a existência 
de um componente hereditário associado ao desenvolvimento das FONS, uma 
variedade de estudos tem sido utilizada para identificar vias e genes envolvidos na 
etiologia das FONS. Parte dos genes candidatos foi sugerida por meio de estudos 
com modelos experimentais em camundongos knockouts (Juriloff e Harris, 2008), 
citogenética (Brewer et al., 1999; Higgins et al., 2008), estudos de fissuras associadas 
a sińdromes mendelianas (Kondo et al., 2002; Zucchero et al., 2004) e análises da 
expressão gênica em tecidos embrionários (Mukhopadhyay et al., 2004; Gong et al., 
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2005). As abordagens mais recentes são baseadas em estudos de associação de 
larga escala genômica (GWAS), no qual polimorfismos distribuídos pelo genoma são 
analisados simultaneamente em pacientes afetados ou não pelas FONS. Seis GWAS 
(Birnbaum et al., 2009; Grant et al., 2009; Beaty et al., 2010; Mangold et al., 2010; Sun 
et al., 2015; Leslie et al., 2016a) e 1 meta-análise de 2 destes GWAS (Ludwig et al., 
2012) foram realizados com amostras de FONS, identificando 15 regiões genéticas 
de risco. No ano passado, um novo GWAS com uma ampla população chinesa e um 
grupo de validação com amostras de pacientes de populações europeias foi 
publicado, revelando 14 loci novos e confirmando outros 12 (Yu et al., 2017). Em 
adição, 3 loci foram identificados em estudos de validação dos resultados dos GWAS 
(Beaty et al., 2013; Ludwig et al., 2016) e em associação com estudos de ligação e 
análise de genes candidatos, os quais confirmaram a participação de IRF6 (interferon 
regulatory factor 6) (Zucchero et al., 2004; Rahimov et al., 2008) e o lócus 9q22 o qual 
contém o gene FOXE1 (forkhead box E1) (Marazita et al., 2009; Moreno et al., 2009). 
Então, 34 loci são atualmente associados com FONS, no entanto, diferenças de 
ancestralidade determinam a predisposição genética, onde regiões que são 
fortemente associadas com uma população podem não ser com outras. Exemplo 
disso, nota-se nos dois últimos GWAS que identificaram a região 17q23 em indivíduos 
com ascendência europeia (Leslie et al., 2016a) ou com as novas regiões identificadas 
na população chinesa 14q32.13, 17q21.32 e 9q22.32 (Yu et al., 2017). 
Como forma de delineamento experimental, as abordagens de mapeamento 
genético mais utilizadas têm sido os estudos de ligação e os estudos de associação. 
A análise de ligação genética é baseada pelo fato que duas regiões genéticas no 
mesmo cromossomo e muito próxima uma da outra, tendem a ser herdadas 
conjuntamente (ligadas). Nesse tipo de investigação, utilizam-se marcadores 
moleculares de determinadas regiões cromossômicas. Tais marcadores sinalizariam 
que na vizinhança dessas regiões existiriam genes relacionados ao transtorno, já que 
os loci dos marcadores utilizados e dos genes estariam ligados. Para essa modalidade 
de investigação, em geral, necessita-se de famiĺias grandes e com múltiplos afetados. 
Diferentemente, no estudo por associação levanta a hipótese de que um determinado 
gene pode estar envolvido na etiopatogenia do transtorno e, então, verifica se a 
frequência de uma determinada variante genética é significativamente diferente entre 
uma população de afetados e outra de não-afetados. Busca-se, portanto, determinar 
se há associação entre a condição de afetado e o polimorfismo investigado (Feitosa e 
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Krieger, 2002). Dois tipos de desenhos são frequentemente utilizados nos estudos de 
associação e são classificados como estudos caso-controle e de núcleo familiar. 
Pode-se definir o estudo caso-controle como uma forma de pesquisa na qual são 
comparados dois grupos, onde o primeiro grupo de individ́uos apresenta o fenótipo 
(caso) e o segundo grupo não apresenta tal condição (controle). Este tipo de estudo 
é muito utilizado por permitir um recrutamento de um grande número de individ́uos 
afetados, sem a necessidade de incluir seus familiares (Risch, 2000). Por outro lado, 
os estudos caso-controle apresentam a desvantagem de se basearem na diferença 
entre a frequência das variações genéticas entre os grupos, que pode ser influenciada 
pela heterogeneidade populacional. Visto que a população brasileira resulta 
principalmente da mistura de 3 populações ancestrais (Europeia, Africana e 
Amerińdia) e exibe niv́eis muito altos de diversidade genômica (Pena et al., 2011), 
para evitar resultados tendenciosos e incorretos, é recomendado que estudos com 
abordagem caso-controle envolvendo a população brasileira, e outras populações 
miscigenadas encontradas ao redor do mundo, levem em consideração a variação 
ancestral genética de cada individ́uo dos grupos. 
No estudo do núcleo familiar (pai, mãe e filho afetado), a ideia é coletar uma 
amostra de individ́uos afetados juntamente com seus pais (não afetados), ou seja; a 
base da análise é a segregação alélica em um mesmo núcleo ancestral. O genótipo 
do filho afetado é considerado como o ponto amostral do grupo “caso” e os dois alelos 
(um materno e um paterno), que não foram transmitidos para o filho afetado, são 
considerados como ponto amostral do grupo “controle”. Desta maneira, têm-se as 
amostras de uma mesma população genética (Purcell et al., 2005). A principal 
vantagem do estudo de núcleos familiares é o controle de possíveis efeitos da 
estratificação populacional (Sebro e Rogus, 2010). Para a análise utiliza-se o teste de 
desequilib́rio de transmissão (TDT), avaliando-se a transmissão dos alelos do 
polimorfismo. O TDT usa um teste x2 de Mc Nermar (1947) para verificar a hipótese 
nula em que o alelo tido como associado à caracteriśtica é transmitido em 50% das 
vezes pelo progenitor heterozigoto (Feitosa e Krieger, 2002). 
Diferentemente das fissuras orais sindrômicas, que apresentam um padrão de 
transmissão estritamente mendeliano ou ligado ao X, a análise de segregação das 
fissuras orais não-sindrômicas parte de um modelo multifatorial e complexo, com 
participação de fatores genéticos e ambientais múltiplos. Em relação ao componente 
genético é importante considerar que a distribuição populacional dos genótipos siga 
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os preceitos do teorema do equilíbrio de Hardy-Weinberg que afirma que, em uma 
população mendeliana, dentro de determinadas condições, as frequências alélicas 
permanecerão constantes ao passar das gerações. A posição da média do genótipo 
heterozigoto “Aa” em relação às médias dos homozigotos é designada por um grau 
de dominância. No caso de um dos fenótipos em estudo ser completamente 
dominante, “AA” será igual a “Aa”, no entanto, no modelo recessivo, apenas o 
homozigoto “aa” promove a variação da característica (Pierce, 2013). No modelo 
aditivo cada par de gene possui efeito próprio e independente dos outros que se 
encontram presentes no genótipo do individ́uo. Assim, a ação total do genótipo sobre 
o fenótipo será igual a soma dos efeitos de cada par de gene e a simples substituição 
de um alelo por outro em um gene impacta o resultado total dos efeitos gênicos. Sob 
essa hipótese, a relação entre o genótipo e o fenótipo é linear (Clarke et al., 2011). 
Em geral, os genes exibem distribuição independente, mas não atuam 
independentemente em sua expressão fenotiṕica, ou seja, os efeitos de um gene 
dependem da presença de outro (Pierce, 2013). Esse tipo de interação entre genes 
em regiões distintas sobre uma caracterit́ica é denominado interação gênica ou 
epistasia (Moore e Williams, 2015). No que tange à complexidade na relação genótipo-
fenótipo das FONS, uma segunda fonte de variação surge quando o efeito de um gene 
depende do ambiente é encontrado. Moore e Williams (2009) argumentam que o 
modelo de regressão linear simples ignora o contexto genômico (interação gene-gene) 
e ambiental (interação gene-ambiente) de cada SNP e a utilização do modelo de 
regressão multifatorial se faz necessário para estudo com a abordagem de co-
variantes influênciando no fenótipo. 
A correlação ou associação não aleatória entre alelos em dois ou mais 
polimorfismos de nucleotídeo único (SNP, do inglês single-nucleotide polymorpohism) 
é referida como desequilíbrio de ligação (LD, do inglês linkage desequilibrium) e a 
utilização dessa abordagem para tratar a redundância de informação dada pelo alto 
LD entre pares de SNPs se faz com a construção de blocos de SNPs. Uma possiv́el 
forma de montar tais blocos é separar os grupos de marcadores identificando regiões 
hotspots, as quais tem grande chance de sofrer recombinação. Para computar o LD 
desse bloco basta calcular a média do LD entre todos os pares que compõem o 
mesmo. Feito isso, escolhe-se um marcador representante, denominado tag-SNP, 
para esse bloco e utiliza-o juntamente com informações fenotiṕicas na tentativa de 
encontrar o subconjunto de tag-SNPs que estão associados ao fenótipo. Com esse 
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procedimento grande parte da redundância é eliminada. O entendimento e o uso do 
LD entre marcadores podem melhorar o desempenho de métodos ou técnicas usadas 
em estudos genéticos e fornecer melhor compreensão sobre a estrutura de 
associação não-aleatória entre marcadores encontrados ao final do processo de 
seleção. Como consequência, um método de seleção de SNPs deve selecionar os 
marcadores mais informativos com baixo ou nenhum LD, pois, desta forma, a 
redudância será reduzida ou até mesmo eliminada. De acordo com Foulkes (2009), 
os blocos LD variam substancialmente entre diferentes grupos étnicos. Como 
resultado, um conjunto de tag-SNPs podem capturar informações de variantes causais 
de uma doença em um grupo, mas não em outro. Logo, considerar esse fenômeno e 
a aplicação de abordagens apropriadas é crucial para estudos genéticos baseados 
em populações miscigenadas. 
Este estudo teve como objetivo compreender a participação de fatores 
genéticos na etiologia das FONS na população brasileira. Para tanto, compilou 4 
estudos específicos: 1) realizou uma revisão sistemática e meta-análise da literatura 
incluindo estudos que avaliaram marcadores polimórficos de risco para as FONS na 
população brasileira; 2) determinou o papel de variantes polimórficas recentemente 
descritas na literatura como de susceptibilidade para as fissuras orais não-
sindrômicas, incluindo os SNP rs7552 em 2q24.2, rs8049367 em 16p13.3, rs1880646, 
rs7406226 e rs9891446 em 17p13, rs1588366 em 17q23.2 e rs73039426 em 
19q13.11, na população brasileira com FL±PNS; 3) avaliou 28 SNP em genes 
relacionados ao estresse oxidativo (SOD1, SOD2, SOD3, PON1, PON2 e PON3), bem 
como as interações genes-fatores ambientais maternos, no risco das FL±PNS 
combinando uma abordagem de núcleo familiar complementada por análise caso-
controle; e 4) analisou a relação dos tag-SNP rs1169, rs7153, rs9968051, rs9819530 
e rs6794341 no gene GOLGB1 com o risco de desenvolvimento de FPNS. Nos 
estudos 2, 3 e 4, a análise caso-controle foi estruturada com as proporções de 
ancestralidade europeia, africana e ameríndia de cada individuo. 
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Abstract 
Background: Although various genes and genomic regions were described as of 
susceptibility for nonsyndromic oral clefts (NOC), recent reports have demonstrated 
significant inter-ethnic variations in the genetic predisposition, a situation that affect the 
Brazilian population, one of the most admixed populations in world. Therefore, the 
purpose of this review was to describe the available information on genetic risk markers 
for NOC in the Brazilian population. Methods: A systematic search of the literature 
was performed using LILACS, LIVIVO, PubMed, Scopus and Web of Science 
databases, and studies that investigated genetic susceptibility markers for NOC in the 
Brazilian population were retrieved. Markers with enough statistical data were 
subjected to meta-analysis using random- or fixed-effects model with odds ratio (OR) 
and 95% confidence intervals (95% CI) as effect measures. Results: Forty-nine 
studies conducted since 1999 were found, and in these 114 markers were evaluated 
throughout case-control or family-based approaches. Most of the studies were 
conducted with patients affected by nonsyndromic cleft lip with or without cleft palate 
(NSCL±P), and 79 markers (69.3%) were evaluated by a single study only. Meta-
analysis was performed with 9 markers, and the most promising results were obtained 
for IRF6 (rs642961), 8q24 (rs987525 and rs1530300) and MTHFR (rs1801133), which 
were associated with increased risk for NSCL±P, and for BMP4 (rs17563) that showed 
a protective effect for NSCL±P. Conclusion: A large number of genetic markers 
distributed in several genes/loci was associated with NOC in the Brazilian population, 
but in general the original studies included limited number of samples and 
unsatisfactory protocols. The classical risk markers located in IRF6 and 8q24 showed 
promising results as well as rs1801133 in MTHFR and rs17563 in BMP4, and they 
should be validated in larger and multicenter studies taking in consideration the 
variations in the miscegenation of Brazilian population. 
Key words: nonsyndromic oral cleft; susceptibility; genetic marker; Brazil; systematic 
review; meta-analysis.  
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Introduction 
Nonsyndromic oral cleft (NOC), a developmental defect characterized by lack of 
complete fusion of the craniofacial embryonic processes, is considered the most 
common birth defect worldwide with a prevalence of 1.43:1000 live births (Dixon et al., 
2011). The incidence varies among the different areas of world, with high incidences 
in Asia and Latin America countries, moderate in Europeans and low in African 
countries (Mossey and Modell, 2012). Among Brazilian newborns, the prevalence has 
been reported between 0.36 to 1.54:1000 live births, with approximately 4,000 new 
cases every year (Martelli-Junior et al., 2007; Rodrigues et al., 2009). As in many other 
developing/undeveloped countries, NOC is considered an important problem of public 
health to be addressed in Brazil. Taking the incisive foramen as reference, NOC are 
traditionally divided in cleft lip only (NSCLO), cleft lip and palate (NSCLP) and cleft 
palate only (NSCPO), however, as there are similarities in both epidemiologic features 
and embryologic timing for both CLO and CLP, they are considered variants of the 
same defect and grouped together to form the group cleft lip with or without cleft palate 
(NSCL±P). Very few studies have been focused on genetic risk factors for NSCPO, 
limiting the knowledge about this type of oral cleft. 
It is widely accepted that NOC is a multifactorial disease dependent of a 
complex interplay between environmental exposures, genetic and epigenetic factors 
(Machado et al., 2016a). Although the specific underlying factors remain largely 
unclear, several environmental exposures comprising maternal smoking, drinking and 
vitamin deficiency during the gestation, and some disease-susceptibility genes, 
specifically interferon regulatory factor 6 (IRF6) and 8q24 locus, have been considered 
the most reliable susceptibility factors for NOC (Dixon et al., 2011; Beaty et al., 2016). 
The genetic predisposition to NOC is ethnicity-dependent, and the genetic basis of 
susceptibility varies among different populations (Dixon et al., 2011). The population 
of Brazil is highly admixed, with each individual showing variable ancestry proportions 
of Amerindians, Europeans and sub-Saharan Africans, which has been shown to affect 
the specific genetic susceptibility of genes and loci previously associated with NOC in 
other populations (Brito et al., 2012a; Bagordakis et al., 2013; de Aquino et al., 2014a; 
do Rego Borges et al., 2015). Identifying the common and specific risk markers for the 
Brazilian population will allow preventive actions and will have important impacts on 
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genetic counseling, besides the understanding of the underlying biological 
mechanisms behind this common developmental disease. 
In order to summarize the current understanding of the potential genetic 
markers related to NOC in the Brazilian population, we carried out this systematic 
review of literature and meta-analyzed the most repeatedly reported markers. We also 
highlight the main shortcomings of the published studies to improve future research in 
the field. 
 
Materials and Methods 
PROTOCOL AND REGISTRATION 
This review adhered to the Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) checklist (Moher et al., 2010), and was registered at the 
International Prospective Register of Systematic Reviews (PROSPERO; 
https://www.crd.york.ac.uk/prospero/#myprospero) under the number 
CRD42017077272. 
STUDY DESIGN 
The study was undertaken to systematically review the susceptibility genetic markers 
for NOC in the Brazilian population, and to meta-analyze those that were more 
frequently reported. 
ELIGIBILITY CRITERIA 
Inclusion criteria: Studies that investigated the susceptibility of genetic markers for 
NOC in the Brazilian population. The search was conducted without time and language 
restrictions. The PICOS (population, intervention, comparison, outcome, study design) 
format was used to construct the research question with the following inclusion criteria: 
(i) Population: patients with NOC in the Brazilian population; (ii) Intervention: analysis 
of genetic markers; (iii) Comparison: inclusion of unaffected individuals (unrelated 
subjects for case-control studies and family members for family-based studies); (iv) 
Outcome: frequency and potential association of genetic markers; (v) Study Design: 
observational studies (case-control or family-based approaches). 
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Exclusion criteria: Studies were excluded for the following reasons: 1) patients with 
syndromic oral cleft, 2) studies that did not include Brazilian samples or mixed the 
Brazilian samples with those of other countries and was not possible the discrimination, 
3) studies that did not include genetic markers in the analysis, 4) lack of a control group, 
and 5) Reviews, letters, personal opinions, book chapters and conference abstracts. 
INFORMATION SOURCES AND SEARCH STRATEGY 
Search strategies in the LILACS, LIVIVO, PubMed, Scopus and Web of Science 
databases included the following terms: "polymorphism, genetic" OR polymorphism 
OR polymorphisms OR "single nucleotide polymorphism" OR "SNP" OR "nucleotide 
variant" OR "single nucleotide variant" OR "SNV" OR "genetic variant" OR "coding 
variant" OR "genetic marker" OR "polymorphisms, genetic" OR "genetic 
polymorphism" OR "polymorphism (genetics)" OR "genetic polymorphisms" OR 
"genetic markers" OR "genetic linkage" OR "genetic frequency" OR genes OR genetics 
OR "fine mapping" OR "gene variants" OR "gene variant" OR "genetic factors" OR 
"mutational screening" OR "rare variant" AND "cleft lip" OR "cleft palate" OR cleft OR 
"oral cleft" OR clefting OR "oral clefting" OR "cleft lip palate" OR "cleft lip only" OR 
"cleft palate only" OR "CLP" OR "CL/P" OR "CLO" OR "CPO" OR "CL±P" OR "cleft lip 
and palate" OR "cleft lip and cleft palate" OR "nonsyndromic cleft lip and cleft palate" 
OR "oral clefts" OR "cleft lip/palate" OR "cleft lip or palate" OR "orofacial clefts" OR 
"orofacial cleft" AND nonsyndromic OR non-syndromic. The full record of the searches 
performed can be found in the Supplementary Table 1. 
The search in the gray literature was conducted on August 23th, 2017 and the 
search on the 5 chosen databases was performed on September 11th, 2017. The 
partial grey literature search was performed using Google Scholar and ProQuest. The 
selected references were checked and managed by a reference manager software 
(EndNote, Thomson Reuters, Virginia, USA). In addition, the reference lists of the 
selected articles were hand screened for potential relevant studies that could have 
been missed during the electronic database searches. 
STUDY SELECTION 
The articles were selected in two phases. In phase 1, 2 authors (RAM and RDC) 
independently reviewed the titles and abstracts, and selected those that apparently 
met the inclusion criteria. In phase 2, the same authors read the full texts of the 
  
28 
selected articles at phase 1 and excluded those that did not meet the inclusion criteria. 
Any disagreements in the first or second phases were resolved by discussion and 
mutual agreement between the 2 authors. 
DATA COLLECTION PROCESS AND DATA ITEMS 
One author (RDC) collected the following information from the included articles: 
authors, year of publication, markers, study design, genotyping strategy, number of 
samples, origin of the samples by Brazilian states and results. The second author 
(RAM) crosschecked all the retrieved information. Disagreements were resolved by 
discussion and mutual agreement between authors. 
RISK OF BIAS IN INDIVIDUAL STUDIES 
Methodologically, the authors appraised all included studies according to a checklist 
based in Meta-Analysis of Statistics Assessment and Review Instrument (MAStARI) 
(The JBI, 2014). The reviewers (RAM and RDC) independently answered 9 questions 
for descriptive studies as Y for “yes”, N for “no”, U for “unclear” and NA for “not 
applicable”. After that, the risk of bias was categorized as high when the study reached 
up to 49% of a “yes” score, moderate when the study reached 50% to 69% of a “yes” 
score, and low when the study reached more than 70% of a “yes” score. 
Disagreements were solved by discussion between the 2 authors. 
RISK OF BIAS ACROSS STUDIES 
Clinical (by comparing variability among the participant’s characteristics and outcomes 
studied), methodological (by comparing the variability in study design and risk of bias) 
and statistical heterogeneities were considered. 
SYNTHESIS OF RESULTS 
Proportion meta-analysis based in the frequency of the genetic markers was performed 
using StataCorp Software version 13 (StataCorp. 2013, Stata Statistical Software: 
Release 13. College Station, TX: StataCorp LP, Texas, USA). Heterogeneity was 
calculated by inconsistency indexes (I2) and a value greater than 50% was considered 
an indicator of substantial heterogeneity between studies (Higgins and Green, 2011). 
The significance level was set at 5%. 
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CONFIDENCE IN CUMULATIVE EVIDENCE 
The Grading of Recommendation, Assessment, Development and Evaluation 
(GRADE) instrument (Balshem et al., 2011) was used to assess evidence quality and 
grading of recommendation strength in the studies included in the quantitative analysis. 
This assessment was based on the study design, risk of bias, inconsistency, 
indirectness, imprecision and other considerations. Evidence quality was 
characterized as high, moderate, low or very low. The GRADE was assessed using 
http://gradepro.org. 
 
Results 
STUDY SELECTION 
A flow-chart detailing the processes of identification, inclusion and exclusion of the 
studies is depicted in Fig. 1. In the first phase, 2500 studies were selected in the 5 
electronic databases. The duplicate studies were removed and 687 different citations 
remained. Subsequently, the comprehensive evaluation of the titles and abstracts 
resulted in the exclusion of 624 citations, thereby remaining 63 studies for 
consideration into the second phase. Moreover, 6 citations were identified in the grey 
literature (Google Scholar and ProQuest), but they were not included in the second 
phase. The experts identified 8 additional studies. In the second phase, the full-text 
review was then conducted on the 71 first-phase selected citations, which lead to the 
exclusion of 22 studies. In the end of the two phases, 49 studies fulfilled the inclusion 
criteria (Gaspar et al., 1999; Gaspar et al., 2002; Gaspar et al., 2004; Passos-Bueno 
et al., 2004; Zucchero et al., 2004; da Silva et al., 2006; Brandalize et al., 2007; Letra 
et al., 2007a; Letra et al., 2007b; Ehlers Bertoja et al., 2008; Menezes et al., 2008; 
Choi et al., 2009; Jehee et al., 2009; Letra et al., 2009; Bufalino et al., 2010; Menezes 
et al., 2010; Paranaíba et al., 2010; Letra et at., 2010; Fontoura et al., 2012; Araújo et 
al., 2012; Souza et al., 2012; Brito et al., 2012a; Brito et al., 2012b; Letra et al., 2012a; 
Letra et al., 2012b; Filézio et al., 2013; Antunes et al., 2013; Bagordakis et al., 2013; 
Paranaíba et al., 2013; Cardoso et al., 2013; Souza et al., 2013; de Aquino et al., 2013; 
de Aquino et al., 2014a; de Aquino et al., 2014b; Küchler et al., 2014; Bezerra et al., 
2015; de Aguiar et al., 2015; do Rego Borges et al., 2015; Fontoura et al., 2015; 
Falagan-Lotsch et al., 2015; Waltrick-Zambuzzi at al., 2015; Brito et al., 2015; Sabóia 
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et al., 2015; de Souza et al., 2016; de Araújo et al., 2016; Machado et al., 2016a; 
Machado et al., 2016b; Machado et al., 2017; Messetti et al., 2017), but only 11 articles 
were used in the meta-analysis (Gaspar et al., 1999; Gaspar et al., 2004; Paranaíba 
et al., 2010; Araújo et al., 2012; Brito et al., 2012a; Brito et al., 2012b; Fontoura et al., 
2012; Antunes et al., 2013; Bagordakis et al., 2013; de Aguiar et al., 2015; do Rego 
Borges et al., 2015). 
 
Figure 1. Flow diagram of literature search and selection criteria adapted from 
PRISMA. 
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STUDY CHARACTERISTICS 
The main features and findings of the studies are presented in Table 1. The selected 
studies were published between 1999 and 2017 and were all written in the English 
language. Samples from all Brazilian regions, except the Central-West region, were 
analyzed, but those from the Southeast region (São Paulo, Minas Gerais and Rio de 
Janeiro states) were the most frequent. The selected articles were observational 
studies.  
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Table 1. Overview of the selected studies (n= 49). 
Studies Markers 
(gene/locus) 
Study Design Genotyping 
strategy 
Samples Origen of 
the 
samples 
(Brazilian 
states) 
Summary of Results 
Messetti et al (2017) CRISPLD2, JARID2 Case-control Taqman assay 549 NSCL±P 
236 NSCPO 
693 Control 
BA, MG, 
PB, PR 
Marginal associations 
between CRISPLD2 
rs4783099 T allele and 
increased risk for NSCPO 
and between JARID2 
rs2237138 and decreased 
NSCL±P risk 
Machado et al (2017) AXIN2, CDH1 Case-parent trios Taqman assay 223 trios of NSCL±P BA, MG, 
PB, PR 
A allele of AXIN2 
rs7210356 and the 
haplotype containing it 
were under-transmitted to 
NSCL±P patients, and 
haplotypes of CDH1 were 
both over-transmitted and 
under-transmitted from 
parents to the children 
with NSCL±P 
Machado et al (2016) TNP1, MSX1, TCOF1, 
FGFR1, COL2A1, 
WNT3, TIMP3 
Case-parent trios 
followed by case-
control 
Taqman assay 189 trios of NSCL±P 
107 trios of NSCPO 
318 NSCL±P 
189 NSCPO 
599 Control 
BA, MG, 
PB, PR 
The significant 
associations at TDT 
analysis were not 
supported by case-control 
study 
de Araujo et al (2016) LHX8, IRF6, TCEB3, 
WNT3A, SUMO1, 
WNT5A, MSX1, SPRY1, 
WNT8A, MSX2, 
TFAP2A, PRSS35, 
HOXA2, SHH, SOX7, 
FOEX1, PTCH1, VAX1, 
TBX10, WNT1, SPRY2, 
PAX9, TGFB3, BMP4, 
JAG2, GREM1, KIF7, 
Case-control Open array 
technology 
182 NSCLP 
355 Control 
AL, CE, 
PR, RN, 
RS, SC, SP 
SNPs in TCEB3, MSX1, 
SPRY1, SHH, VAX1, 
TBX10, WNT11, PAX9, 
KIF7 and AXIN2 
increased risk for cleft, 
whereas SNPs in MSX2, 
BMP4, JAG2 and DVL2 
decreased it. SNPs in 
PRSS35 and TFAP2A 
showed both effect in 
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DVL2, RARA, ERBB2, 
WNT9B, AXIN2, FGF22, 
TGFB1, APOC2, 
CLPTM1, BCL3, TBX1, 
TBX22 
increase and decrease 
the cleft risk. 
de Souza et al (2016) IRF6, 8q24 Case-parent trios Taqman assay 186 trios of NSCLP 
32 trios of NSCLO 
41 trios of NSCPO 
AL, CE, 
PR, RS, SP 
For IRF6, the A risk allele 
of rs2235371 was under-
transmitted to NSCLP 
patients in the sample of 
European ancestry, and 
not significant 
associations with 
rs642961 were observed. 
Only a borderline 
association between 
rs987525 and patients 
with European ancestry 
was observed. 
Machado et al (2016) ADPRT, OGG1, MLH1, 
APEX1, XRCC3, 
RAD51, XRCC1, 
ERCC2 
Case-parent trios Taqman assay 223 NSCL±P BA, MG, 
PB, PR 
Maternal cigarette 
smoking interacts with 
RAD51 rs1801321 
genotypes to increase the 
risk of NSCL±P. 
Saboia et al (2015) AXIN2, BMP2, BMP4, 
BMP7, DLX1, MMP3 
Case-parent trios Taqman assay 98 NSCLP 
27 NSCLO 
23 NSCPO 
162 Control 
RJ Marginal associations 
between NSCLP and 
rs788173 in DLX1 and 
NSCPO and rs522616 in 
MMP3. 
Brito et al (2015) CDH1 Multiplex families Sequencing 189 NSCL±P 
32 NSCPO 
609 Control 
RS, SP, 
other states 
4 rare and moderately 
penetrant variants in 
CDH1 were identified. 
The frequency was 
significantly higher 
compared to controls. 
Waltrick-Zambuzzi et 
al (2015) 
TCN2, MTRR Case-control Taqman assay 270 NSCLP 
71 NSCLO 
60 NSCPO 
466 Control 
RJ No association with 
TCN2, but logistic 
regression adjusted for 
maternal smoking reveled 
that MTRR AG genotype 
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is a risk factor for 
NSCL±P. 
Falagan-Lotsch et al 
(2015) 
EGF Case-control RFLP 152 NSCLP 
39 NSCLO 
27 NSCPO 
253 Control 
RJ No significant association. 
Fontoura et al (2015) WNT9B, WNT3 Case-parent trios Taqman assay 70 trios of NSCL±P RJ WNT3 was not 
associated, but the G 
allele of WNT9B 
rs1530364 was 
overtransmitted. One 
haplotype between WNT3 
and WNT9B was also 
overtransmitted at 
significant level. 
do Rego Borges et al 
(2015) 
ABCA4, IRF6, 8q24, 
FOXE1, VAX1, 18q22, 
MAFB 
Case-control Taqman assay 293 NSCL±P 
352 Control 
BA Minor alleles of FOEX1 
(rs3758249) and VAX1 
(rs7078160) were 
significantly associated 
with risk of NSCL±P. Only 
marginal associations for 
IRF6 and 8q24. 
de Aguiar et al (2015) MTHFR Case-parent trios 
followed by case-
control 
Taqman assay 197 trios of NSCL±P 
318 NSCL±P 
598 Control 
BA, MG, 
PB, PR 
rs1801133 T allele was 
overtransmitted, and 
case-control analysis 
confirmed association 
with risk allele. 
Bezerra et al (2015) MTHFR, MTR, MTRR, 
RFC1 
Case-control 
(mother and 
offspring) 
RFLP 81 NSCLP 
25 NSCLO 
30 NSCPO 
175 Control 
RN MTHFR rs1801131 C 
allele was associated with 
risk of a mother has a 
child with NSCLP after 
adjustment for alcohol 
consumption. 
Kuchler et al (2014) AXIN2, DLX1, DLX2, 
EDAR, FGF3, FGF10, 
FGFR2, GLI2, GLI3, 
LHX6, MSX1, PAX9, 
PITX2 
Case-control Taqman assay 382 NSCLP 
90 NSCLO 
75 NSCPO 
823 Control 
RJ rs4980700 in FGF3 
showed a borderline 
association with unilateral 
clefts and tendency of 
association with NSCLP 
and bilateral clefts. 
  
35 
de Aquino et al (2014) MTHFR, MTHFD1 Case-parent trios 
followed by case-
control 
Taqman assay 147 trios of NSCL±P 
181 NSCL±P 
478 Control 
BA, MG, 
PR 
A allele of rs2274976 was 
significantly associated 
with NSCL±P risk. 
de Aquino et al (2014) PAX7, THADA, 3p11.1, 
8q21.2, 13q31.1, 
15q22.2, 17q22 
Case-control Taqman assay 343 NSCLP 
162 NSCLO 
594 Control 
BA, MG SNP in 17q22 (rs227731) 
was associated with cleft 
risk in population with 
European ancestry, and 
15q22.2 (rs1873147) was 
associated with cleft 
patients displaying high 
African ancestry. The 
association between 
PAX7 (rs742071) and 
cleft risk was only 
detected in the combined 
sample. 
de Aquino et al (2013) FGF12, VCL, CX43, 
VAX1 
Case-control Taqman assay 195 NSCLP 
105 NSCLO 
385 Control 
MG As single markers, no 
significant associations. A 
VAX1 haplotype showed 
marginal association. 
Souza et al (2013) MSX1 Case-parent trios Fragment size 
analysis 
156 trios of NSCL±P 
26 trios of NSCPO 
RS 169 bp allele was 
overtransmitted for 
NSCL±P patients. 
Cardoso et al (2013) MSX1 Case-control Taqman assay 96 NSCLP 
35 NSCLO 
27 NSCPO 
200 Control 
RN No significant association. 
Paranaiba et al (2013) TBX1, PVRL1, MID1, 
RUNX2, TP63, TGFB3, 
MSX1, MYH9, JAG2 
Case-control RFLP 198 NSCLP 
88 NSCLO 
81 NSCPO 
413 Control 
MG G allele of TBX1 
rs28649236 showed 
protective effect. 
Bagordakis et al 
(2013) 
ABCA4, IRF6, 8q24, 
FOXE1, VAX1, 18q22, 
MAFB 
Case-control Taqman assay 194 NSCLP 
105 NSCLO 
384 Control 
MG rs560426 in ABCA4 is a 
risk factor for NSCLP, 
whereas 8q24 locus is 
associated with both 
NSCLP and NSCLO. 
Antunes et al (2013) TGFB3, BMP4 Case-control Taqman assay 253 NSCLP 
71 NSCLO 
59 NSCPO 
RJ No association with 
TGFB3, but BMP4 was 
significantly associated 
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450 Control with NSCLO and oral cleft 
group. 
Filezio et al (2013) GABRG3 Case-control Taqman assay 147 NSCLP 
82 NSCLO 
314 Control 
MG No significant 
associations after 
Bonferroni correction. 
Letra et al (2012) IRF6, TGFA Case-Control Taqman 
assay, Allele-
specific PCR 
353 NSCL±P 
53 NSCPO 
285 Control 
SP rs2902345 in TGFA was 
associated with NSCL±P, 
and rs2235371 and 
rs2073487, both in IRF6, 
were associated with 
complete left NSCL±P. 
Significant gene-gene 
interaction between TGFA 
and IRF6. 
Letra et al (2012) MMP2, MMP3, MMP7, 
MMP9, MMP10, 
MMP13, MMP14, 
MMP16, MMP25, 
MMP27, TIMP1, TIMP2, 
TIMP3, TIMP4 
Case-Control Taqman assay 411 NSCLP 
10 NSCLO 
73 NSCPO 
413 Control 
RJ, SP rs522616 in MMP3 
showed a protective effect 
against NSCLP and all 
clefts, and rs8179096 in 
TIMP2 showed protective 
effect against NSCLP, 
NSCPO and all clefts. 
Significant gene-gene 
interaction between 
MMP3 and TIMP2. 
Brito et al (2012) 8q24 Case-Control Taqman assay 667 NSCL±P 
589 Control 
AL, CE, 
MG, PA, 
RJ, SP 
8q24 locus is associated 
with NSCL±P of European 
ancestry. 
Souza et al (2012) TGFA Case-parent trios RFLP 147 trios of NSCL±P 
28 trios of NSCPO 
RS No association with oral 
cleft. 
Araujo et al (2012) BMP4 Case-control RFLP 98 NSCLP 
25 NSCLO 
246 Control 
AL, PR, 
RS, SP 
C allele of BMP4 rs17563 
showed a protective 
effect. 
Fontoura et al (2012) ABCA4, MAFB Case-control Taqman assay 400 NSCL±P 
412 Control 
SP ABCA4 SNPs showed risk 
effects and no significant 
associations with MAFB 
were observed. 
Brito et al (2012) IRF6 Case-control Taqman assay 381 NSCLP 
90 NSCLO 
391 Control 
AL, CE, 
PA, RJ, SP 
A allele of rs642961 was 
significantly associated 
with NSCLO. 
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Letra et al (2010) 6q14.2-14.3 Case-control Taqman assay 324 NSCL±P 
4 NSCLO 
282 Control 
NA rs7753918 in PRSS35 
was significantly 
associated with oral cleft. 
Paranaiba et al (2010) IRF6 Case-control RFLP 177 NSCL±P 
51 NSCPO 
126 Control 
MG No significant 
associations between 
IRF6 and oral clefts. 
Menezes et al (2010) WNT3A, WNT5A, 
WNT8A, WNT11, 
WNT3, WNT9B 
Case-control Taqman assay 372 NSCL±P 
69 NSCPO 
303 Control 
RJ, SP WNT3 rs142167 is a risk 
factor for NSCL±P at 
Bonferroni level, whereas 
rs9890413 risk a nominal 
level only. Some 
haplotypes of WNT3 and 
WNT3-WNT9B were 
associated with oral clefts. 
Bufalino et al (2010) MTHFR, MTHFD1, 
MTR, SLC19A1 
Case-Control 
(mothers of cleft 
patient only) 
RFLP 50 NSCLP 
31 NSCLO 
26 NSCPO 
184 Control 
MG MTHFR rs2274976 
increased the risk of oral 
cleft. The risk was even 
increased if mothers did 
not take vitamins. 
Letra et al (2009) AXIN2, CDH1 Case-control Taqman assay 323 NSCL±P 
53 NSCPO 
252 Control 
SP Significant association 
between rs7591 in AXIN2 
and incomplete NSCPO. 
Marginal associations 
between CDH1 SNPs and 
NSCL±P. 
Jehee et al (2009) IRF6 Multiplex families Sequencing 108 families with at 
least 2 affected 
members 
100 Controls 
NA 4 mutations in IRF6 out of 
108 families with 
NSCL±P. Mutations were 
not found in 100 controls. 
Choi et al (2009) PDGF-C Case-control Taqman assay 404 NSCL±P 
66 NSCPO 
500 Control 
SP No significant 
associations. 
Menezes et al (2008) FGF3, FGF7, FGF10, 
FGF18, FGFR1, FGFR2 
Case-control Taqman assay 326 NSCLP 
53 NSCPO 
281 Control 
SP rs1448037 in FGF10 
variant allele increased 
risk for unilateral NSCLP, 
and rs4631909 in FGF3 
increased risk for 
unilateral right NSCLP 
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Ehlers Bertoja et al 
(2008) 
TGFA Case-control RFLP 133 NSCL±P 
7 NSCPO 
142 Control 
RS No significant 
associations. 
Letra et al (2007) MMP1, MMP3 Case-control RFLP, Allele-
specific PCR 
139 NSCL±P 
24 NSCP 
255 Control 
SP No significant association 
with MMP1, but protective 
effect for MMP3 SNP. 
Brandalize et al (2007) MTHFR, MTR, MTRR Case-control 
(mother and 
offspring) 
RFLP 87 NSCL±P 
27 NSCPO 
100 Control 
110 mother of cleft 
patient 
100 Control mother 
RS No significant 
associations. 
Letra et al (2007) MMP9 Case-control RFLP 96 NSCLP 
7 NSCLO 
22 NSCPO 
173 Control 
SP No significant 
associations. 
da Silva et al (2006) MTHFR, TGFB3, MSX1 Case-parent trios RFLP, 
Fragment size 
analysis 
60 without cleft 
classification 
SP No significant 
associations for TGFB3 
and MSX1, but a 
tendency of 
overtransmission of 
rs1801133 C allele to 
affected offspring. 
Zucchero et al (2004) IRF6 Multiplex families Allele-specific 
kinetic PCR, 
Taqman 
assay, 
Sequencing 
161 NSCLP 
88 NSCLO 
51 NSCPO 
3 unknown 
NA Significant 
overtransmission of the 
risk allele of rs2235371. 
Passos-Bueno et al 
(2004) 
TGFA Case-Control RFLP 398 NSCL±P 
138 NSCLO 
385 Control 
CE, SP No significant 
associations. 
Gaspar et al (2004) MTHFR Multiplex families, 
Case-control 
RFLP 102 families with 
NSCL±P 
424 NSCL±P 
644 Control 
CE, SP rs1801133 in MTHFR was 
not associated with cleft 
risk. 
Gaspar et al (2002) BCL3 Multiplex families Fragment size 
analysis 
98 families with at 
least one NSCL±P 
patient 
CE, SC, SP Marginal association with 
the allele of 135 bp, with a 
major effect in females 
and in familial cases. 
  
39 
Gaspar et al (1999) MTHFR Case-parent trios 
(offspring and 
mother only) 
followed by case-
control 
RFLP 77 NSCL±P 
59 mothers of 
NSCL±P 
113 Control 
90 Control mothers 
NA No significant 
associations. 
 
NSCL±P: nonsyndromic cleft lip with or without cleft palate; NSCLO: nonsyndromic cleft lip only; NSCPO: nonsyndromic cleft palate only; NSCLP: 
nonsyndromic cleft lip and palate; RFLP: restriction fragment length polymorphism; NA: not available. 
Brazilian states: AL: Alagoas; BA: Bahia; CE: Ceará; MG: Minas Gerais; PA: Pará; PB: Paraíba; PR: Paraná; RJ: Rio de Janeiro; RN: Rio Grande 
do Norte; RS: Rio Grande do Sul; SC: Santa Catarina; SP: São Paulo. 
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RISK OF BIAS WITHIN STUDIES 
Based on the MAStARI assessment, 20 (40.8%) articles were classified as carrying a 
low risk of bias, and 29 (59.2%) were classified as with moderate risk for bias 
(Supplementary Table 2). No study was classified as high risk. The main differences 
were due to guideline 9, which is related to statistical analysis. The main drawbacks 
included 1) the lack of baseline data, not allowing proportion analysis and calculation 
of OR and 95% CI; 2) the inclusion of several markers without adequate correction of 
p value for multiple tests; 3) the combination of cleft subtypes in a unique group, not 
respecting the differences among them; and 4) the absence of any correction in the 
case-control studies for differences on ancestry contribution of the patients. Guidelines 
7 (related to the outcome of samples that were withdraw or included in the final 
analysis) and 8 (associated with measurement of data) were classified as unclear for 
most of the studies because no information were available (Supplementary Table 2). 
SYNTHESIS OF RESULTS 
A total of 114 genes/loci was analyzed. Of these, 79 (69.3%) were reported in only one 
study. For various genes/loci, different markers (single nucleotide polymorphisms, 
SNPs) in or near, both at 5’- and 3’-UTR, were evaluated. Supplementary Table 3 
depicts the markers evaluated in only one study. Among the markers reported in more 
than 1 study (n=35, 30.7%), more than haft was described in only 2 studies 
(Supplementary Fig. 1). 
A clear majority (n=34, 69.4%) of the studies reported at least 1 associated 
marker with NOC, based on obtaining a statistically significant result for the association 
of that marker with at least 1 subtype of oral cleft or 1 considered genetic models (Table 
1). Regarding the subtype of cleft, NSCL±P was analyzed in all studies, whereas 
NSCPO was included in only 29 studies. The size of samples of NSCPO was always 
smaller than NSCL±P. Some studies have combined the subtypes of clefts in a unique 
group, termed oral cleft group, no respecting the differences on developmental 
structures, epidemiologic features and embryologic timing. 
RISK OF BIAS ACROSS STUDIES 
The included studies used quite similar methodology, which reduced the possibility of 
misinterpretation. All studies showed relative homogeneity, since all of them were 
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observational studies. Besides this particular issue, in the meta-analysis, high 
heterogeneity was found for some markers, possibly due to the sample size and the 
results that varied widely among them. 
Supplementary Figure 1. Markers evaluated in more than one study. 
 
 
RESULTS OF META-ANALYSES 
Meta-analysis for allele distribution was performed for each of the markers evaluated 
in at least 2 studies that reported necessary statistical data, as summarized in Fig. 2 
and 3. The number of eligible studies was very small ranging from 2 for 8q24 (rs987525 
and rs1530300), BMP4 (rs17563), VAX1 (rs7078160) and 18q22 (rs17085106) to 3 for 
IRF6 (rs642961), MTHFR (rs1801133), ABCA4 (rs560426) and MAFB (rs13041247). 
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A high heterogeneity in the frequencies of the alleles and ORs across the individual 
studies (I2>50%) was observed for BMP4 (rs17563), VAX1 (rs7078160) and ABCA4 
(rs560426), whereas the pertinent measures (I2 score) had low value for MTHFR 
(rs1801133) and MAFB4 (rs13041247) and very low value for IRF6 (rs642961), 8q24 
(rs987525 and rs1530300) and 18q22 (rs17085106). Thus, the fixed-effects model was 
applied in the analysis of those markers with low I2 values. 
Three studies reported data regarding the association between rs642961 in 
IRF6 and NSCL±P (Paranaíba et al., 2010; Brito et al., 2012b; do Rego Borges et al., 
2015), with 2 of them (Brito et al., 2012b; do Rego Borges et al., 2015) reporting high 
odds for the presence of the A allele in NSCL±P. The pooled OR was 1.30 (95% CI: 
1.08-1.56, p=0.006), indicating that the A allele of rs642961 in IRF6 is a susceptibility 
marker for NSCL±P in the Brazilian population (Fig. 2A). As regards 8q24, both SNPs 
(rs987525 and rs1530300) were shown to be associated with increased and significant 
odds to NSCL±P risk. For each SNP, 2 studies were included. As shown in Fig. 2B and 
2C, the pooled OR for rs987525 was 1.21 (95% CI: 1.06-1.38, p=0.005), and for 
rs1530300, the pooled OR was even higher, reaching 1.54 (95% CI: 1.30-1.82, 
p<0.0001). The SNP rs1801133 in MTHFR was evaluated in 3 studies (Gaspar et al., 
1999; Gaspar et al., 2004; de Aguiar et al., 2015), with 2 of them finding significant 
odds for the presence of the T allele in NSCL±P. The pooled OR was 1.20 (95% CI: 
1.05-1.37, p=0.007), confirming that the T is a risk allele for NSCL±P (Fig. 2D). The 
variant C allele in BMP4 rs17563 was significantly associated with a decreased risk for 
NSCL±P in the original studies (Araújo et al., 2012; Antunes et al., 2013) and in this 
meta-analysis (Fig. 2E). The pooled OR for the C allele was 0.68 (95% CI: 0.51-0.90, 
p=0.008). The meta-analyses did not find significant associations between NSCL±P 
and the variant alleles of rs7078160 in VAX1 (Fig. 3A), rs560426 in ABCA4 (Fig. 3B), 
rs17085106 in 18q22 (Fig. 3C) and rs13041247 in MAFB (Fig. 3D). 
The genetic markers with a nominal p value in the allele analysis were further 
meta-analyzed for the genotype distribution. The pooled results revealed that the 
rs987525 in 8q24 significantly increased the risk of NSCL±P in the Brazilian population 
in heterozygous (CA vs. CC, OR: 1.32, 95% CI: 1.08-1.60, p=0.006) and homozygous 
(AA vs. CC, OR: 1.51, 95% CI: 1.14-2.01, p=0.005) (Fig. 4). Evidences of association 
between NSCL±P and the genotypes of rs1530300 in 8q24 (CC vs. TT, OR: 2.58, 95% 
CI: 1.20-5.56, p=0.02), rs1801133 in MTHFR (TT vs. CC, OR: 1.43, 95% CI: 1.05-1.94, 
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p=0.02) and rs17563 in BMP4 (CC vs. TT, OR: 0.50, 95% CI: 0.39-0.66, p<0.0001) 
were provided only at the homozygote model (Fig. 4). No significant associations in 
the genotype analysis was observed for rs642961 in IRF6 (Fig. 4). 
 
Figure 2. Forest plots for the allele distribution of genetic markers with significant 
associations with NSCL±P in the pooled analysis. (A) rs642961 in IRF6, (B) rs987525 
in 8q24, (C) rs1530300 in 8q24, (D) rs1801133 in MTHFR and (E) rs17563 in BMP4.  
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Figure 3. Forest plots for the alleles of (A) rs7078160 in VAX1, (B) rs560426 in 
ABCA4, (C) rs17085106 in 18q22 and (D) rs13041247 in MAFB.  
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Figure 4. Association of genotypes of IRF6 (rs642961), 8q24 (rs987525 and 
rs1530300), MTHFR (rs1801133) and BMP4 (rs17563) with NSCL±P. ORs with 95% 
CI of NSCL±P were associated genotypes at heterozygote and homozygote model. 
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QUALITY OF EVIDENCE 
Based on GRADE analysis, the quality of the evidence for the majority of the allele 
analysis was moderate, but 2 analysis showed low quality of evidence (BMP4 and 
ABCA4), suggesting little confidence in the estimated effect. The moderate risk of bias 
and the inconsistency in some studies were the main factor responsible for the limited 
quality of evidence (Supplementary Table 4). 
Discussion 
Although NOC are amongst the most common and distressing congenital defects, the 
biological mechanisms associated with this multifactorial disease are partially known. 
Therefore, genetic and microenvironmental factors are currently the subject of intense 
research because their knowledge is essential in order to create translational 
opportunities for prevention and counselling. Different genetic studies, traditionally 
based in linkage or association analysis, have been applied to identify genomic 
susceptibility regions for NOC. In the linkage analysis, which requires large families, 
the investigation searches differences in co-segregation of known and unknown 
genetic markers transmitted through generations of affected and healthy members 
within the family, whereas studies of association investigate differences in the 
distribution of markers between cohorts containing affected and unaffected subjects. 
Association studies frequently use a case-control approach, but case-parent trio 
design (one affected child and two living biologic parents) has the advantage of 
minimizing influence of unknown confounders in the results, mainly differences in the 
population stratification within and between groups. All 49 studies identified in this 
revision applied association analyses, with a clear majority using case-control 
approach (n=32, 65.3%). Three studies (de Aquino et al., 2014b; de Aguiar et al., 2015; 
Machado et al., 2016b) have applied case-parent trio as a discovery approach followed 
by validation of the significant signals in a case-control independent sample. This 
approach is based on the premise that if the same effect of a disease-marker can be 
obtained from case-parent trio and case-control study, the magnitude of information is 
strong and true. 
Dozens of genes/loci have accumulated enough data to be listed as a putative 
causal genetic factor for NOC, though only 2 (IRF6 and 8q24 region) have been 
validated across multiple populations (Beaty et al., 2016). IRF6 was initially targeted 
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for investigation in NOC after mutations were detected in patients with van der Woude 
syndrome (OMIM 119300), the most common syndrome that has oral cleft in the 
clinical spectrum (Kondo et al. 2002; Paranaíba et al, 2008), and in patients affected 
by popliteal pterygium syndrome (OMIN 119500), a rare autosomal dominant disorder 
with varied clinical expressivity including popliteal pterygia, cleft palate, lower lip pits, 
syndactyly and genital anomalies (Paranaíba et al., 2011). Zucchero and collaborators 
(2004) were the first to reveal the association of NSCL±P with genetic variations in 
IRF6, specifically the polymorphism rs2235371 (820G>A) that replaces a valine by an 
isoleucine at amino acid position 274 (V274I) of the SMIR-binding domain of IRF6. 
Later, this same group revealed that the association of rs2235371 with the disease is 
dependent of rs642961, a polymorphism that disrupts the binding site of the 
transcription factor AP-2a in the IRF6 promoter, which is in strong linkage 
disequilibrium with rs2235371 (Rahimov et al., 2008). The association of IRF6 variants 
with NOC has been replicated in various populations (Park et al., 2007; Tang et al., 
2009; Birnbaum et al., 2009a; Huang et al., 2009; Salahshourifar et al., 2011; Krasone 
et al., 2014; Mijiti et al., 2015; Tomita et al., 2017; Moreno Uribe et al., 2017) and 
supported by animal studies (Ingraham et al., 2006; Iwata et al., 2013). Nevertheless, 
this association has not been identified in studies of African cohorts (Butali et al., 2011; 
Weatherley-White et al., 2011; Butali et al., 2014; Figueiredo et al., 2014). 
Two previous meta-analysis have assessed the contribution of rs642961 for NOC 
(Wang et al., 2012; Wattanawong et al., 2016). The first meta-analysis pooled 1673 
NSCL±P and 3158 controls from 6 studies and showed that the variant A allele of 
rs642961 was positively associated with increased risk of NSCL±P, and subgroup 
analyses by ethnicity and type of cleft revealed enhanced odds among Caucasians 
and Asians and among all cleft types (Wang et al., 2012). The second also found that 
rs642961 A allele shows risk effects for NSCL±P in both Asian and Caucasian 
populations (Wattanawong et al., 2016). Notably, both meta-analysis included the 
study of Paranaíba et al. (2010) and considered the samples of the Brazilian population 
as Caucasian. In the current study, we identified 9 studies (16 different SNPs and rare 
variants) that assessed IRF6 in the Brazilian population, but only 3 of them with the 
SNP rs642961 showed enough data for meta-analysis. The combined result showed 
that the A allele is associated NSCL±P in the Brazilian population, yielding a moderate 
OR of 1.30. Even applying Bonferroni correction for multiple tests, the risk effect of the 
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A allele remained significant. Although the heterogeneity assumption tested by I2 
metric and publication bias examination suggested robustness of results, we should 
take into consideration that one study (Brito et al., 2012b) did not comply with Hardy-
Weinberg equilibrium, one study (Paranaíba et al. 2010) did not reach significant 
results in the original analysis and the third study (do Rego Borges et al., 2015) showed 
only marginal association in a Brazilian population with high African ancestry. 
Furthermore, we did not observe association between IRF6 rs642961 and the risk for 
NSCL±P in the Brazilian population under the heterozygote and homozygote genotype 
models and the studies excluded from meta-analysis reported divergent results, such 
as the lack of association of 8 SNPs spanning different regions of IRF6 with NSCLP 
(de Araújo et al., 2016), and no association between rs642961 and NSCL±P in a case-
parent trio approach but a protective effect of IRF6 rs2235371 (de Souza et al., 2016), 
which was originally described in linkage disequilibrium with rs642961 and of risk for 
the Brazilian population (Zucchero et al., 2004). Very unique associations of rs2235371 
and rs2073487 with complete left but not right NSCL±P and rs2013162 with only 
bilateral complete NSCL±P were also reported in a study with a Brazilian cohort (Letra 
et al., 2012a). Thus, further large-scale studies, taking into account the ancestry 
genomic composition of each individual, are warranted to confirm the findings of the 
current meta-analysis. 
The first evidence that 8q24 is associated with NOC originated after the 
genome-wide association study (GWAS) conducted by Birnbaum et al. (2009b). This 
locus, mainly represented by rs987525, was extensively validated as a risk marker for 
NSCL±P by subsequent studies, including other GWAS (Grant et al., 2009; Beaty et 
al., 2010; Leslie et al., 2016) and in the meta-analyses involving previous GWAS 
(Ludwig et al., 2012; Leslie et al., 2017). Since this locus is located in an intergenic 
region (devoid of gene), Uslu et al. (2014) performed a series of in vivo and in vitro 
analyses and showed that 8q24 region contains cis-acting enhancers that control Myc 
expression during the development of face. The deletion of 8q24 region resulted in 
dysmorphic facial features including cleft lip and cleft palate. In support, the multiple 
genetic variants in 8q24, which are significantly associated with an increased 
susceptibility to prostate, colorectal and breast cancer, were predicted to alter 
enhancer elements that physically interact with Myc promoter (Pomerantz et al., 2009; 
Ahmadiyeh et al., 2010; Sotelo et al., 2010). In this meta-analysis, we found a positive 
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and significant association between the variant alleles of both rs987525 and rs1530300 
and NSCL±P in the Brazilian population, with higher yields for rs1530300. Previous 
studies have revealed a linkage disequilibrium between rs987525 and rs1530300, with 
the later showing a stronger association with NSCL±P (Grant et al., 2009; Bagordakis 
et al., 2013). Interestingly, the association between rs987525 and the risk of NSCL±P 
was evidenced in both heterozygous and homozygous genotypes, and for rs1530300, 
the association was only at homozygosity (2 copies of the risk allele). The 2 previous 
meta-analysis on rs987525 (Wang et al., 2012; Wattanawong et al., 2016), involving 
studies from different populations, corroborated our findings, supporting the 
participation of 8q24 on pathogenesis of NSCL±P. However, our conclusions are 
based in only 2 studies for each marker, warranting further large-scale study of this 
locus in the Brazilian population. 
Folic acid (folate), acting as a donor and acceptor of carbon units in the 
methylation of homocysteine to methionine, synthesis of nucleic acids and amino acids 
and DNA methylation, is an essential nutrient for cell division, gene expression and 
maintenance of chromosome structure during embryogenesis (Friso et al., 2017). 
Previous study showed that the ingestion of folic acid or multivitamin complexes 
containing folic acid in the gestational period reduces the risk of oral cleft (Wehby and 
Murray et al., 2010), whereas variations on genes related to absorption, transport and 
metabolism of folate increase the predisposition of NOC (Bufalino et al., 2010; Wang 
et al., 2016). The most studied folic acid-associated gene in NOC etiology is the 
methylenetetrahydrofolate reductase (MTHFR) gene, which encoded an enzyme that 
catalyzes the reduction of 5,10-methylenetetrahydrofolate (5,10-CH2-THF) to 5-
methyltetrahydrofolate (5-CH3THF). Variations in MTHFR, particularly the rs1801133 
(also known as C677T) that results in an increased dissociation of FAD cofactor due 
to the quaternary structure loss of the enzyme and in a thermolabile protein with 
reduction of 30-70% in its catalytic activity (Frosst et al., 1995; Pejchal et al., 2006), 
are reported as exacerbating of NOC risk. In face of the high number of studies, there 
are 4 meta-analyses on rs1801133 and NOC risk. Both Verkleij-Hagoort et al. (2007) 
and Luo et al. (2012) reported no overall associations between MTHFR rs1801133 and 
NOC, whereas Pan et al. (2012) and Zhao et al. (2014) reported significant 
associations only in Asian populations. In the current meta-analysis, we identified 3 
case-control studies (Gaspar et al., 1999; Gaspar et al., 2004; de Aguiar et al., 2015) 
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that analyzed rs1801133 in MTHFR, and the pooled result indicated an association 
between this polymorphism and NSCL±P risk in the Brazilian population. Thus, the 
associated risk of rs1801133 in MTHFR seems ancestry-dependent, and the admixed 
Brazilian population is included in the risk-group. Unfortunately, the studies did not 
bring information on dietary folate intake or maternal plasma folate concentration, not 
allowing analysis of gene-environment interactions, which should be important for the 
underlying mechanisms of MTHFR variants. 
BMP4 (bone morphogenetic protein 4), a member of the transforming growth 
factor-β superfamily, plays important roles during facial development, and its loss of 
function in mice causes a series of craniofacial abnormalities, including cleft lip and 
palate (Juriloff and Harris, 2008). Corroborating with animal studies, several studies 
have focused on the effects of BMP4 genetic variants in NOC risk in humans, with the 
functional SNP rs17563 being the most frequently investigated. Indeed, 2 meta-
analysis have summarized the association of rs17563 with NOC. In the first meta-
analysis, published in 2015 by Hu et al., only 6 studies were available and they were 
all focused in populations of China and Brazil. For the Chinese population, rs17563 
increased risk for NSCL±P whereas a protective effect was found in the Brazilian 
population (Hu et al., 2015). In the second meta-analysis (Li et al., 2017), 5 more case-
control studies were included, confirming the risk effect of C variant allele in the 
Chinese population and the protective effect in Brazilians. This recent meta-analysis 
also revealed that BMP4 rs17563 was associated with a higher risk among 
Caucasians, represented in the meta-analysis by populations from India and Iran (Li et 
al., 2017). The current meta-analysis, involving 446 patients with NSCL±P and 682 
controls, suggests that rs17563 in BMP4 is a protective factor for developing NSCL±P 
in the Brazilian population, but the conclusions on BMP4 were based in only 2 studies, 
and as revealed by Tau2 and I2 values, the effects were heterogeneous, deserving 
further studies to determine the real association of this marker with the susceptibility of 
NSCL±P in the Brazilian population. Nevertheless, we have applied random-effects 
model for this marker, which is more conservative than fixed-effects model, which 
ensures the reliability of the results even though the data come from studies with 
relative heterogeneity. 
Approximately 70% (n=34) of the reviewed studies claimed to have identified at 
least one significant genetic association, though 79 (69.3%) of the genetic markers 
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have been analyzed only once, so it is not possible to reach trustworthy conclusions 
on the basis of such limited evidence. Furthermore, several positive reports were only 
marginal associations, no resisting to correction for multiple tests, or were associations 
only at a specific genetic model. Noteworthy, most articles with positive associations 
have usually evaluated previous known-signals for NOC, mainly those reported in 
GWAS. Only 20 (40.8%) studies were classified as having low risk of bias after 
MAStARI guidelines. We particularly noted that guideline 9, which is related to 
statistics, was not fulfilled in several studies. Several articles did not report the baseline 
data, limiting the determination of magnitude of effect, the correction for multiple tests 
was sometimes ignored by the authors, and another important drawback was 
regarding the composition of groups. Many studies combined the different types of oral 
clefts in a single group, not respecting the specificity of each one (NSCL±P vs. 
NSCPO). However, the most important shortcoming was related to the population 
stratification. Brazil is formed by a remarkably heterogeneous population. The intense 
miscegenation of the native Indians, Europeans and Africans over 5 centuries 
generated a high degree of genetic variability, which has been reported to directly 
affect most genetic polymorphic traits, such as those associated with NOC (de Aquino 
et al., 2014a; do Rego Borges et al., 2015). Thus, genetic studies involving Brazilian 
samples should use ancestry informative markers for controlling for population 
stratifications and to determine the real associations with specific subgroups of 
Brazilians, as those with high African ancestry or high native American origin. 
Together, the shortcomings in the susceptibility markers tested limit the possibilities to 
reach definitive conclusions. 
Other limitations also need to be recognized. Only case-control studies were 
selected for the meta-analysis, which are less powerful for genetic associations than 
transmission disequilibrium test in case-parent trio approach. Information of 
environmental interventions or maternal periconceptional behaviors were not available 
in our study, whereas these factors may influence the associations mainly in MTHFR 
rs1801133 and folic acid intake. Last, we did not consider the genetic ancestry of the 
samples (groups) in the analysis and did not separate the populations based on 
ancestry-enrichment, one strategy with interesting results (de Aquino et al., 2014a; do 
Rego Borges et al., 2015). 
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In conclusion, this study suggests evidences for an association between 
increased risk for NSCL±P and IRF6 (rs642961), 8q24 (rs987525 and rs1530300) and 
MTHFR (rs1801133), and between BMP4 (rs17563) and a reduced risk for NSCL±P. 
Additional studies using larger and well-characterized Brazilian groups are needed to 
further replicate these findings and also those involving other potential genetic markers 
identified as the susceptibility for NOC. Furthermore, future studies should consider 
the influence of diversity of the Brazilian population in susceptibility of specific genetic 
variants in the pathogenesis of NOC. 
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Supplementary Table 1. Search strategy in the databases. 
Database Search 
PubMed 
(September 11, 2017) 
#1: "Polymorphism, Genetic"[Mesh] OR Polymorphism OR 
Polymorphisms OR "single nucleotide polymorphism" OR "SNP" 
OR "nucleotide variant" OR "single nucleotide variant" OR "SNV" 
OR "genetic variant" OR "coding variant" OR "genetic marker" OR 
"Polymorphisms, Genetic" OR "Genetic Polymorphism" OR 
"Polymorphism (Genetics)" OR "Genetic Polymorphisms" OR 
"genetic markers" OR "genetic linkage" OR "genetic frequency" 
OR genes OR genetics OR "fine mapping" OR "gene variants" OR 
"gene variant" OR "genetic factors" OR "mutational screening" OR 
"rare variant" 
#2: "cleft lip"[Mesh] OR "cleft palate"[Mesh] OR cleft OR "oral 
cleft" OR clefting OR "oral clefting" OR "cleft lip palate" OR "cleft 
lip" OR "cleft palate" OR "cleft lip only" OR "cleft palate only" OR 
"CLP" OR "CL/P" OR "CLO" OR "CPO" OR "CL±P" OR "cleft lip 
and palate" OR "cleft lip and cleft palate" OR "nonsyndromic cleft 
lip and cleft palate" OR "oral clefts" OR "cleft lip/palate" OR "cleft 
lip or palate" OR "orofacial clefts" OR "orofacial cleft" 
#3: Nonsyndromic OR non-syndromic 
#4: #1 AND #2 AND #3  
LILACS 
(September 11, 2017) 
(tw:(Polymorphism OR polimorfismo OR "genetic markers" OR 
"marcadores genéticos")) AND (tw:("cleft lip" OR "fissura labial" 
OR "fisura labial" OR "cleft palate" OR "fissura palatina" OR 
"fisura palatina" OR "cleft lip and palate" OR "fissura labiopalatina" 
OR "fisura labiopalatina")) AND (tw:(nonsyndromic OR "non 
syndromic" OR "não sindrômica" OR "no sindrómico")) 
LIVIVO 
(September 11, 2017) 
TI=(Polymorphism OR Polymorphisms OR "single nucleotide 
polymorphism" OR "SNP" OR "nucleotide variant" OR "single 
nucleotide variant" OR "SNV" OR "genetic variant" OR "coding 
variant" OR "genetic marker" OR "Polymorphisms, Genetic" OR 
"Genetic Polymorphism" OR "Polymorphism Genetics" OR 
"Genetic Polymorphisms" OR "genetic markers" OR "genetic 
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linkage" OR "genetic frequency" OR genes OR genetics OR "fine 
mapping" OR "gene variants" OR "gene variant" OR "genetic 
factors" OR "mutational screening" OR "rare variant") AND 
TI=(cleft OR "oral cleft" OR clefting OR "oral clefting" OR "cleft lip 
palate" OR "cleft lip" OR "cleft palate" OR "cleft lip only" OR "cleft 
palate only" OR "CLP" OR "CL/P" OR "CLO" OR "CPO" OR 
"CL±P" OR "cleft lip and palate" OR "cleft lip and cleft palate" OR 
"nonsyndromic cleft lip and cleft palate" OR "oral clefts" OR "cleft 
lip/palate" OR "cleft lip or palate" OR "orofacial clefts" OR 
"orofacial cleft") AND TI=(Nonsyndromic OR non-syndromic)  
Scopus 
(September 11, 2017) 
 
TITLE-ABS-KEY (polymorphism OR polymorphisms OR 
"single nucleotide polymorphism" OR "SNP" OR "nucleotide 
variant" OR "single nucleotide variant" OR "SNV" OR 
"genetic variant" OR "coding variant" OR "genetic marker" 
OR "Polymorphisms, Genetic" OR "Genetic Polymorphism" 
OR "Polymorphism (Genetics)" OR "Genetic 
Polymorphisms" OR "genetic markers" OR "genetic linkage" 
OR "genetic frequency" OR genes OR genetics OR "fine 
mapping" OR "gene variants" OR "gene variant" OR "genetic 
factors" OR "mutational screening" OR "rare variant") AND 
TITLE-ABS-KEY (cleft OR "oral cleft" OR clefting OR "oral 
clefting" OR "cleft lip palate" OR "cleft lip" OR "cleft palate" 
OR "cleft lip only" OR "cleft palate only" OR "CLP" OR "CL/P" 
OR "CLO" OR "CPO" OR "CL±P" OR "cleft lip and palate" OR 
"cleft lip and cleft palate" OR "nonsyndromic cleft lip and 
cleft palate" OR "oral clefts" OR "cleft lip/palate" OR "cleft lip 
or palate" OR "orofacial clefts" OR "orofacial cleft") AND 
TITLE-ABS-KEY (nonsyndromic OR non-syndromic) AND 
(LIMIT-TO (DOCTYPE, "ar") OR LIMIT-TO (DOCTYPE, "ip")) 
Web of Science 
(September 11, 2017) 
 
#1: TS=(Polymorphism OR Polymorphisms OR "single nucleotide 
polymorphism" OR "SNP" OR "nucleotide variant" OR "single 
nucleotide variant" OR "SNV" OR "genetic variant" OR "coding 
variant" OR "genetic marker" OR "Polymorphisms, Genetic" OR 
"Genetic Polymorphism" OR "Polymorphism (Genetics)" OR 
"Genetic Polymorphisms" OR "genetic markers" OR "genetic 
linkage" OR "genetic frequency" OR genes OR genetics OR "fine 
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mapping" OR "gene variants" OR "gene variant" OR "genetic 
factors" OR "mutational screening" OR "rare variant") 
 
#2: TS=(cleft OR "oral cleft" OR clefting OR "oral clefting" OR 
"cleft lip palate" OR "cleft lip" OR "cleft palate" OR "cleft lip only" 
OR "cleft palate only" OR "CLP" OR "CL/P" OR "CLO" OR "CPO" 
OR "CL±P" OR "cleft lip and palate" OR "cleft lip and cleft palate" 
OR "nonsyndromic cleft lip and cleft palate" OR "oral clefts" OR 
"cleft lip/palate" OR "cleft lip or palate" OR "orofacial clefts" OR 
"orofacial cleft") 
 
#3: TS=(Nonsyndromic OR non-syndromic) 
#4:  #1 AND #2 AND #3  
Google Scholar 
(August 23, 2017) 
Search 1: tudonotítulo: Polymorphism cleft lip palate Brazilian 
 
Search 2: tudonotítulo: Polymorphism cleft lip palate Brazil 
ProQuest 
(August 23, 2017) 
TI,AB(Polymorphism OR Polymorphisms OR "single nucleotide 
polymorphism" OR "SNP" OR "nucleotide variant" OR "single 
nucleotide variant" OR "SNV" OR "genetic variant" OR "coding 
variant" OR "genetic marker" OR "Polymorphisms, Genetic" OR 
"Genetic Polymorphism" OR "Polymorphism (Genetics)" OR 
"Genetic Polymorphisms" OR "genetic markers" OR "genetic 
linkage" OR "genetic frequency") AND TI,AB(cleft OR "oral cleft" 
OR clefting OR "oral clefting" OR "cleft lip palate" OR "cleft lip" OR 
"cleft palate" OR "cleft lip only" OR "cleft palate only" OR "CLP" 
OR "CL/P" OR "CLO" OR "CPO" OR "CL±P" OR "cleft lip and 
palate" OR "cleft lip and cleft palate" OR "nonsyndromic cleft lip 
and cleft palate") AND TI,AB(Nonsyndromic OR non-syndromic) 
AND TI,AB(Brazil OR Brazilian OR "Brazilian population" OR 
"Brazilian people" OR "Brazilian epidemiology" OR "European 
continental ancestry group" OR "south American" OR "south 
America") 
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Supplementary Table 2. Analysis of the risk of bias. 
Studies Questions* % Yes Risk of bias# 
 Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9   
Messetti et al (2017) NA Y Y Y Y NA U U Y 71.4 Low 
Machado et al (2017) NA Y NA Y Y NA U U N 50.0 Moderate 
Machado et al (2016) NA Y Y Y Y NA U U Y 71.4 Low 
de Araujo et al (2016) NA Y Y Y Y NA U U Y 71.4 Low 
de Souza et al (2016) NA Y NA Y Y NA U U Y 66.6 Moderate 
Machado et al (2016) NA Y NA Y Y NA U U Y 66.6 Moderate 
Saboia et al (2015) NA Y NA Y Y NA U U N 50.0 Moderate 
Brito et al (2015) NA Y Y Y Y NA U U Y 71.4 Low 
Waltrick-Zambuzzi et al (2015) NA Y Y Y Y NA U U N 57.1 Moderate 
Falagan-Lotsch et al (2015) NA Y Y Y Y NA U U N 57.1 Moderate 
Fontoura et al (2015) NA Y NA Y Y NA U Y Y 83.3 Low 
do Rego Borges et al (2015) NA Y Y Y Y NA U U Y 71.4 Low 
de Aguiar et al (2015) NA Y Y Y Y NA U U Y 71.4 Low 
Bezerra et al (2015) NA Y Y Y Y NA U U N 57.1 Moderate 
Kuchler et al (2014) NA Y Y Y Y NA U U N 57.1 Moderate 
de Aquino et al (2014) NA Y Y Y Y NA U U N 57.1 Moderate 
de Aquino et al (2014) NA Y Y Y Y NA U U Y 71.4 Low 
de Aquino et al (2013) NA Y Y Y Y NA U Y Y 85.7 Low 
Souza et al (2013) NA Y NA Y Y NA U U Y 66.6 Moderate 
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Cardoso et al (2013) NA Y Y Y Y NA U U N 57.1 Moderate 
Paranaiba et al (2013) NA Y Y Y Y NA U U Y 71.4 Low 
Bagordakis et al (2013) NA Y Y Y Y NA U Y N 71.4 Low 
Antunes et al (2013) NA Y Y Y Y NA U U N 57.1 Moderate 
Filezio et al (2013) NA Y Y Y Y NA U U Y 71.4 Low 
Letra et al (2012) NA Y Y Y Y NA U U N 57.1 Moderate 
Letra et al (2012) NA Y Y Y Y NA U Y N 71.4 Low 
Brito et al (2012) NA Y Y Y Y NA Y U Y 85.7 Low 
Souza et al (2012) NA Y NA Y Y NA U U N 50.0 Moderate 
Araujo et al (2012) NA Y Y Y Y NA U U N 57.1 Moderate 
Fontoura et al (2012) NA Y Y Y Y NA U Y N 71.4 Low 
Brito et al (2012) NA Y Y Y Y NA Y U Y 85.7 Low 
Letra et al (2010) NA Y Y Y Y NA U U N 57.1 Moderate 
Paranaiba et al (2010) NA Y Y Y Y NA U U N 57.1 Moderate 
Menezes et al (2010) NA Y Y Y Y NA U U N 57.1 Moderate 
Bufalino et al (2010) NA Y Y Y Y NA U Y N 71.4 Low 
Letra et al (2009) NA Y Y Y Y NA U U N 57.1 Moderate 
Jehee et al (2009) NA Y NA Y Y NA U U Y 66.6 Moderate 
Choi et al (2009) NA Y Y Y Y NA U U N 57.1 Moderate 
Menezes et al (2008) NA Y Y Y Y NA U U N 57.1 Moderate 
Ehlers Bertoja et al (2008) NA Y Y Y Y NA Y U N 71.4 Low 
Letra et al (2007) NA Y Y Y Y NA U U N 57.1 Moderate 
Brandalize et al (2007) NA Y Y Y Y NA U U N 57.1 Moderate 
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Letra et al (2007) NA Y Y Y Y NA U U N 57.1 Moderate 
da Silva et al (2006) NA Y NA Y Y NA U U N 50.0 Moderate 
Zucchero et al (2004) NA Y NA Y Y NA U U Y 66.6 Moderate 
Passos-Bueno et al (2004) NA Y Y Y Y NA U U N 57.1 Moderate 
Gaspar et al (2004) NA Y Y Y Y NA U U N 57.1 Moderate 
Gaspar et al (2002) NA Y NA Y Y NA Y U Y 83.3 Low 
Gaspar et al (1999) NA Y Y Y Y NA Y U N 71.4 Low 
 
Q1. Is the study based on a random or pseudorandom sample? 
Q2. Are the criteria for inclusion in the sample clearly defined? 
Q3. Are confounding factors identified and strategies to deal with them stated? 
Q4. Are outcomes assessed using objective criteria? 
Q5. If comparisons are being made, was there sufficient description of the groups? 
Q6. Is follow up carried out over a sufficient time period? 
Q7. Are the outcomes of people who withdrew described and included in the analysis? 
Q8. Are outcomes measured in a reliable way? 
Q9. Is appropriate statistical analysis used? 
*Y=Yes, N=No, U=Unclear, NA=Not applicable (which was not considered on the percentage calculation). 
# Risk of bias was categorized as high when the study reaches up to 49% score “yes”, moderate when the study reached 50% to 
69% score “yes”, and low when the study reached more than 70% score “yes”. 
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Supplementary Table 3. Genes and loci analyzed in only one study. 
Gene / Locus Study 
CRISPLD2 Messetti et al (2017) 
JARID2 Messetti et al (2017) 
TNP1 Machado et al (2016) 
TCOF1 Machado et al (2016) 
COL2A1 Machado et al (2016) 
LHX8 de Araujo et al (2016) 
TCEB3 de Araujo et al (2016) 
SUMO1 de Araujo et al (2016) 
SPRY1 de Araujo et al (2016) 
MSX2 de Araujo et al (2016) 
TFAP2A de Araujo et al (2016) 
HOXA2 de Araujo et al (2016) 
SHH de Araujo et al (2016) 
SOX7 de Araujo et al (2016) 
PTCH1 de Araujo et al (2016) 
TBX10 de Araujo et al (2016) 
SPRY2 de Araujo et al (2016) 
GREM1 de Araujo et al (2016) 
KIF7 de Araujo et al (2016) 
DVL2 de Araujo et al (2016) 
RARA de Araujo et al (2016) 
ERBB2 de Araujo et al (2016) 
FGF22 de Araujo et al (2016) 
TGFB1 de Araujo et al (2016) 
APOC2 de Araujo et al (2016) 
CLPTM1 de Araujo et al (2016) 
TBX22 de Araujo et al (2016) 
ADPRT Machado et al (2016) 
OGG1 Machado et al (2016) 
MLH1 Machado et al (2016) 
APEX1 Machado et al (2016) 
XRCC3 Machado et al (2016) 
RAD51 Machado et al (2016) 
XRCC1 Machado et al (2016) 
ERCC2 Machado et al (2016) 
BMP2 Saboia et al (2015) 
BMP7 Saboia et al (2015) 
TCN2 Waltrick-Zambuzzi et al (2015) 
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EGF Falagan-Lotsch et al (2015) 
RFC1 Bezerra et al (2015) 
DLX2 Kuchler et al (2014) 
EDAR Kuchler et al (2014) 
GLI2 Kuchler et al (2014) 
GLI3 Kuchler et al (2014) 
LHX6 Kuchler et al (2014) 
PITX2 Kuchler et al (2014) 
MTHFD1 de Aquino et al (2014) 
PAX7 de Aquino et al (2014) 
THADA de Aquino et al (2014) 
3p11.1 de Aquino et al (2014) 
8q21.2 de Aquino et al (2014) 
3q31.1 de Aquino et al (2014) 
15q22.2 de Aquino et al (2014) 
17q22 de Aquino et al (2014) 
FGF12 de Aquino et al (2013) 
VCL de Aquino et al (2013) 
CX43 de Aquino et al (2013) 
PVRL1 Paranaiba et al (2013) 
MID1 Paranaiba et al (2013) 
RUNX2 Paranaiba et al (2013) 
TP63 Paranaiba et al (2013) 
MYH9 Paranaiba et al (2013) 
GABRG3 Filezio et al (2013) 
MMP2 Letra et al (2012) 
MMP7 Letra et al (2012) 
MMP10 Letra et al (2012) 
MMP13 Letra et al (2012) 
MMP14 Letra et al (2012) 
MMP16 Letra et al (2012) 
MMP25 Letra et al (2012) 
MMP27 Letra et al (2012) 
TIMP1 Letra et al (2012) 
TIMP2 Letra et al (2012) 
TIMP4 Letra et al (2012) 
6q14.2-14.3 Letra et al (2010) 
PDGF-C Choi et al (2009) 
FGF7 Menezes et al (2008) 
FGF18 Menezes et al (2008) 
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Supplementary Table 4. Quality of the studies assessed with the Grading of Recommendation, Assessment, Development, and 
Evaluation (GRADE) system. 
 Studies (n) 
Quality assessment 
Quality 
Risk of bias Inconsistency Indirectness Imprecision 
rs642961 (IRF6) 3 observational studies Seriousa Not serious Seriousc Not serious 
⨁⨁⨁◯ 
MODERATE 
rs987525 (8q24)  2 observational studies Not serious Not serious Seriousc Not serious 
⨁⨁⨁◯ 
MODERATE 
rs1530300 (8q24) 2 observational studies Not serious Not serious Seriousc Not serious 
⨁⨁⨁◯ 
MODERATE 
rs1801133 (MTHFR) 3 observational studies Seriousa Not serious Seriousc Not serious 
⨁⨁⨁◯ 
MODERATE 
rs117563 (BMP4) 2 observational studies Seriousa Seriousb Seriousc Not serious 
⨁⨁◯◯ 
LOW 
rs7078160 (VAX1) 2 observational studies Not serious Seriousb Seriousc Not serious 
⨁⨁⨁◯ 
MODERATE 
rs560426 (ABCA4) 3 observational studies Not serious Very seriousb Seriousc Not serious 
⨁⨁◯◯ 
LOW 
rs17085106 (18q22) 2 observational studies Not serious Not serious Seriousc Not serious 
⨁⨁⨁◯ 
MODERATE 
rs13041247 (MAFB) 3 observational studies Not serious Not serious Seriousc Not serious 
⨁⨁⨁◯ 
MODERATE 
GRADE Working Group grades of evidence:  
High quality: We are very confident that the true effect lies close to that of the estimate of the effect. 
Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but 
there is a possibility that it is substantially different. 
Low quality: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect. 
Very low quality: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the 
estimate of effect. 
aSome studies were considered as moderate risk of bias; bI²>50; cMost of the studies included in the sample used convenience samples.
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2.2 Artigo 
2p24.2 (rs7552) is a susceptibility locus for nonsyndromic cleft lip with or 
without cleft palate in the Brazilian population 
Artigo Artigo aceito no periódico Clinical Genetics, 2018, doi: 10.1111/cge.13246 
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ABSTRACT 
The population of Brazil is highly admixed, with each individual showing variable levels 
of Amerindian, European and African ancestry, which may interfere in the genetic 
susceptibility of known risk loci to nonsyndromic cleft lip with or without cleft palate 
(NSCL±P). Here we investigated 5 reported genome-wide loci for NSCL±P in an 
ancestry-structured case-control study containing 1,697 Brazilian participants (831 
NSCL±P and 866 healthy controls). SNPs rs7552 in 2q24.2, rs8049367 in 16p13.3, 
rs1880646, rs7406226, rs9891446 in 17p13, rs1588366 in 17q23.2 and rs73039426 
in 19q13.11 were genotyped using TaqMan allelic discrimination assays and genomic 
ancestry was estimated using a panel of 40 biallelic short insertion/deletion 
polymorphic markers informative of the Brazilian population. Logistic regression 
analysis of the single-markers revealed rs7552 in 2p24.2 is a susceptibility risk marker 
for NSCL±P, yielding an OR of 1.71 (95% CI: 1.31-2.24, p=9x10-6) in the homozygous 
state. Several SNP-SNP interactions containing rs7552 reached significance after 
adjustment for multiple tests (both Bonferroni assumption and 1000 permutation test), 
with the most significant interaction involving the 3-loci among rs7552, rs9891446 and 
rs73039426 (p=6.1x10-9 and p1000 permutation=0.001). Our study is the first to support the 
association of rs7552 in 2p24.2 with NSCL±P in the highly admixed Brazilian 
population. 
 
KEYWORDS  
nonsyndromic cleft lip with or without cleft palate, genetic loci, single nucleotide 
polymorphism, Brazilian population. 
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1 | INTRODUCTION 
Nonsyndromic oral cleft, which include cleft lip with or without cleft palate (NSCL±P) 
and cleft palate only (NSCPO), is one of the most common birth defects worldwide, 
showing a global prevalence of 1.43:1000 live births.1 In Brazil, with approximately 
4,000 new cases every year, the prevalence ranges from 1:650 to 1:2700 live births, 
with considerable geographic variation.2,3  With the involvement of multiple 
environmental and genetic risk factors, the etiology of the nonsyndromic oral clefts is 
recognized as complex and multifactorial.4 
Previous studies based on genome-wide screening (mainly genome-wide 
association studies-GWAS) have identified several NSCL±P risk genes and 
chromosomal regions, but few have shown consistent replication across different 
populations.4 Indeed, interferon regulatory factor 6 (IRF6) gene and the 8q24 region 
are the most reliable genetic risk factors for NSCL±P and have been validated in 
different populations.5,6 In previous studies we have investigated the association of 
several GWAS-susceptibility signals in the Brazilian population, confirming some 
associations, including 8q24 region, and failing to confirm others, such as IRF6, most 
likely due to differential frequencies of the risk alleles which are dependent on 
ethnicity.7-13 Two recent well-designed GWAS on NSCL±P have been conducted.14,15 
The 3-stage GWAS with more than 5,000 subjects from China identified a novel risk 
locus for NSCL±P at 16p13.3, with rs8049367 being the most significant signal.14 
Leslie et al.15 used a multi-ethnic sample from European, Asian, African and Central 
and South American countries, and revealed novel susceptibility loci for NSCL±P on 
2p24.2, 17q23.2 and 19q13.11, besides supported the involvement of 17p13 locus with 
the risk to develop NSCL±P. The first evidence of association of 17p13, which encodes 
NTN1 (netrin 1), with NSCL±P risk was described by Beaty et al.16, with later 
characterization of involvement of this locus with NSCL±P in a subsequent study by 
the same group.17 
As validation studies of susceptibility variants in different populations are 
important to support their roles in development of NSCL±P, we investigated the 
association of NSCL±P susceptibility loci described in the recent GWAS,14,15 
represented by 2p24.2 (rs7552), 16p13.3 (rs8049367), 17p13 (rs1880646, rs7406226, 
rs9891446), 17q23.2 (rs1588366) and 19q13.11 (rs73039426), in the Brazilian 
population using an ancestry-structured case-control approach. We also analyzed the 
interactions among those SNPs (SNP-SNP interaction) in this cohort. 
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2 | MATERIAL AND METHODS 
2.1 | Study population 
A total of random unrelated 1,697 subjects were included in this case-control study. 
Patients with NSCL±P (n=831) were recruited from 3 different geographic regions of 
Brazil: the northeast region (University Hospital of Lauro Wanderley-HULW, João 
Pessoa-PB and Santo Antonio Hospital, Salvador-BA), the southeast region (Center 
for Rehabilitation of Craniofacial Anomalies, University of José Rosário Vellano, 
Alfenas-MG), and the southern region (Association of Carrier of Cleft Lip and Palate-
APOFILAB, Cascavel-PR). The patients with NSCL±P were carefully examined and 
screened for the presence of associated anomalies or syndromes by the specialized 
team of the associated Centers. Among NSCL±P group, 242 were nonsyndromic cleft 
lip only (NSCLO) and 589 were nonsyndromic cleft lip and palate (NSCLP), and the 
average age of the patients was 18.49±13.84, favoring the distinction between 
syndromic and nonsyndromic forms of oral cleft. The control group consisted of healthy 
individuals, without family history of orofacial clefts and from the same geographic 
areas. The average age of this group was 25.24±11.79. The study was approved by 
the ethics review board of each of the centers/hospitals affiliated with this collaborative 
study. Written informed consent was obtained from the parents or guardians and/or 
the participants. 
 
2.2 | Genotyping and genomic ancestry assessment 
DNA was obtained from oral mucosa cells obtained by mouthwash with a 3% sucrose 
solution using a salting-out protocol.18 The SNPs rs7552, rs8049367, rs1880646, 
rs7406226, rs9891446, rs1588366 and rs73039426 were genotyped using the 
StepOne Real-Time PCR system with TaqMan 5’-exonuclease allelic discrimination 
assays (Assay-on-Demand service, Applied Biosystems). For quality control purposes, 
reactions were randomly repeated in 10% of the samples for each SNP, and the 
concordance rate was 100%. All samples were successfully genotyped, with a 
genotype call rate of >99%. 
The genomic ancestry of subjects was estimated with a validated panel 
containing 40 biallelic short insertion-deletion polymorphisms.19 The genotyping and 
bioinformatics using the Structure software20 were previously described.21 
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2.3 | Statistical analysis 
The difference between groups was analyzed using Mann-Whitney test (for age), x2 
test (for gender) and Kruskal-Wallis test (for ancestry proportions). Genotype 
distributions were assessed for derivation from Hardy-Weinberg equilibrium (HWE) in 
the control group using the x2 test with 1 degree of freedom. Multiple logistic regression 
analysis under unrestricted, dominant and recessive genetic models was performed 
with R software (SNPassoc package), considering gender and genomic ancestry as 
potential confounders. A Bonferroni-adjusted p-value threshold of ≤0.008 was 
considered statistically significant. Linkage disequilibrium (LD) and haplotype analysis 
of NTN1 SNPs were estimated using the HaploView software. SNP-SNP interactions 
were performed using the model-based multifactor dimensionality reduction (mbmdr) 
package in R, using the 1000 permutation test to eliminate the false-positive 
interactions. The mbmdr is a dimension reduction method for SNP-SNP interaction 
analysis in case-control studies, allowing the adjustment for confounders.22 This 
method merges multilocus genotypes into a one-dimensional construct, categorizing 
the genotypic interactions into high-risk and low-risk level for the phenotype. Power for 
detecting a p value ≤0.05 for each SNP was calculated using the Quanto software, 
assuming a prevalence of NSCL±P in Brazil2 of 0.00146 and using the most 
conservative ORs reported in the original studies.14-16 
 
3 | RESULTS 
As depicted in Supplementary Table 1, there was a significant difference in the gender 
between groups, but the average ancestry contributions of the groups were quite 
similar (Supplementary Table 1). The distributions of genotypes in the control group 
were consistent with predictions under the HWE (Table 1), except for rs7406226 
(p<0.0001) that demonstrated derivation regarding the frequency of the minor G allele 
(AG and GG genotypes). This SNP was excluded from further analyses. 
A significant association between rs7552 and NSCL±P was observed. The 
frequency of variant A allele was significantly higher in the NSCL±P group compared 
with the control group, yielding an OR of 1.35 (95% CI: 1.18-1.55, p=1x10-4) (Table 1). 
Logistic regression analysis adjusted for gender and ancestry showed that the AA 
genotype is associated with NSCL±P (OR: 1.71, 95% CI: 1.31-2.24) with a p=9x10-6, 
which remained significant after applying the conservative Bonferroni adjustment for 
multiple testing (Table 2). At recessive genetic model (AA vs. GG+GA), a significant 
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effect of rs7552 was also observed (Table 2). Significant associations with rs7552 (at 
homozygote and recessive models) were detected in the subgroup analysis, 
separating NSCLO (Supplementary Table 2) from NSCLP (Supplementary Table 3). 
None of the other SNPs was significantly associated with NSCL±P at Bonferroni 
threshold level (p≤0.008), however, rs1880646 and rs9891446 in NTN1 showed, 
without any adjustment, nominal p values for allele distribution (Table 1). These SNPs 
were in strong LD (D′=0.81 and r2=0.49), and carriers of the A-G haplotype (A allele of 
rs1880646 and G allele of rs9891446) were found to be more common among NSCL±P 
patients compared to controls, exhibiting a moderate increased risk to NSCL±P (OR: 
1.26, 95% CI: 1.05-1.51, p=0.002) (Supplementary Table 4). 
The model-based multifactor dimensionality reduction approach was applied for 
detecting interactions among SNPs on NSCL±P risk. Table 3 summarized the 
significant results obtained from SNP-SNP interaction analyses with p values extracted 
for 1000 permutations. We found several significant interactions at 2, 3, 4 and 5 SNPs 
model, with most of them involving rs7552, indicating the potential role of this SNP on 
NSCL±P risk. At 2-SNPs model, rs7552 interacted significantly with all investigated 
SNPs, and p values of interactions resisted to Bonferroni adjustment for multiple 
testing and to 1000 permutation test (Table 3). Several 3- and 4-SNPs and one 5-SNPs 
model showed significance after the permutation test and many of those containing 
rs7552 as top SNP (Table 3). 
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Table 1 Characteristics of the single-nucleotide polymorphisms (SNPs), allelic distributions in the control and NSCL±P groups and 
power calculations. 
SNP Locus Gene Alleles HWE MAF 
Control 
MAF 
NSCL±P 
OR (95% CI) 
P value* 
Power 
rs7552 2p24.2 FAM49A G/A 0.71 43.3% 50.8% 1.35 (1.18-1.55) 
1x10-4 
94.7% 
rs8049367 16p13.3 CRBBP T/C 0.82 36.2% 37.4% 1.05 (0.91-1.21) 
0.48 
99.9% 
rs1880646 17p13 NTN1 A/G 0.85 32.7% 29.7% 0.86 (0.74-1.00) 
0.05 
86.5% 
rs7406226 17p13 NTN1 A/G <0.0001 33.9% 28.5% - 
 
- 
rs9891446 17p13 NTN1 C/G 0.28 27.0% 31.0% 1.21 (1.04-1.41) 
0.01 
99.9% 
rs1588366 17q23.2 TANC2 A/G 0.57 23.8% 21.5% 0.87 (0.74-1.03) 
0.10 
66.8% 
rs73039426 19q13.11 RHPN2 C/T 0.97 11.7% 10.8% 0.91 (0.73-1.13) 
0.41 
60.0% 
MAF: Minor allele frequency (minor alleles in bold); NSCL±P: nonsyndromic cleft lip with or without cleft palate sample; NSCLO: nonsyndromic 
cleft lip only; NSCPO: nonsyndromic cleft palate only. 
*P values were calculated with chi-square test. 
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Table 2 Association of single nucleotide polymorphisms in patients with nonsyndromic cleft lip with or without cleft palate (NSCLP). 
P values were adjusted for covariates by logistic regression analysis. 
 Control (%) NSCL±P (%) ORHet (95% CI) 
p value 
ORHom (95% CI) 
p value 
ORDom (95% CI) 
p value 
ORRec (95% CI) 
p value 
rs7552 (GG/GA/AA) 32.4/48.5/19.1 27.3/43.7/29.0 1.03 (0.82-1.29) 
0.78 
1.71 (1.31-2.24) 
9x10-6 
1.22 (0.99-1.51) 
0.06 
1.68 (1.34-2.11) 
8x10-7 
rs8049367 (TT/TC/CC) 40.9/45.8/13.3 39.3/46.6/14.1 1.07 (0.87-1.32) 
0.51 
1.12 (0.83-1.51) 
0.38 
1.08 (0.89-1.32) 
0.43 
1.08 (0.81-1.43) 
0.60 
rs1880646 (AA/AG/GG) 45.4/43.8/10.8 50.3/40.1/9.6 0.81 (0.66-0.99) 
0.04 
0.80 (0.57-1.11) 
0.19 
0.81 (0.67-0.98) 
0.02 
0.88 (0.64-1.21) 
0.43 
rs9891446 (CC/CG/GG) 52.5/40.9/6.6 47.5/43.0/9.5 1.17 (0.96-1.43) 
0.12 
1.57 (1.08-2.27) 
0.01 
1.23 (1.01-1.49) 
0.03 
1.46 (1.02-2.09) 
0.03 
rs1588366 (AA/AG/GG) 57.7/37.0/5.3 62.9/31.2/5.9 0.78 (0.63-0.96) 
0.01 
1.01 (0.66-1.55) 
0.93 
0.81 (0.66-0.98) 
0.03 
1.11 (0.73-1.68) 
0.62 
rs73039426 (CC/CT/TT) 77.9/20.7/1.4 81.1/16.1/2.8 0.74 (0.58-0.95) 
0.01 
1.97 (0.97-4.02) 
0.05 
0.82 (0.64-1.04) 
0.10 
2.08 (1.03-4.24) 
0.03 
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Table 3 SNP-SNP interactions in patients with nonsyndromic cleft lip with or without cleft palate (NSCLP) assessed by model-based 
multifactor dimensionality reduction. 
 SNP1 SNP2 SNP3 SNP4 SNP5 NHa betaHb NLc betaLd p valuee Perm. p 
valuef 
2 loci rs7552 rs73039426    2 0.65 2 -0.27 1.4x10-7 0.001 
 rs7552 rs1588366    1 0.70 2 -0.34 7.7x10-7 0.001 
 rs7552 rs9891446    3 0.53 2 -0.42 3.5x10-6 0.001 
 rs7552 rs8049367    3 0.53 1 -0.23 3.5x10-6 0.001 
 rs7552 rs1880646    1 0.68 2 -0.42 2.1x10-5 0.001 
 rs73039426 rs9891446    3 0.37 2 -0.30 1.9x10-4 0.002 
3 loci rs7552 rs9891446 rs73039426   5 0.59 3 -0.53 6.1x10-9 0.001 
 rs7552 rs8049367 rs1588366   4 0.79 2 -0.68 3.6x10-8 0.001 
 rs7552 rs1588366 rs73039426   4 0.67 2 -0.45 4.6x10-8 0.001 
 rs7552 rs1880646 rs1588366   3 0.73 2 -0.67 2.3x10-7 0.001 
 rs7552 rs1880646 rs73039426   2 0.83 2 -0.45 4.0x10-7 0.001 
 rs7552 rs9891446 rs1588366   3 0.70 4 -0.49 7.7x10-7 0.001 
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 rs7552 rs8049367 rs73039426   3 0.60 0 NA 1.8x10-6 0.002 
 rs7552 rs8049367 rs9891446   4 0.69 2 -0.49 7.1x10-6 0.005 
 rs73039426 rs1880646 rs1588366   1 0.32 3 -0.77 7.9x10-5 0.008 
4 loci rs7552 rs8049367 rs1880646 rs1588366  5 1.02 3 -1.06 2.0x10-9 0.001 
 rs7552 rs1880646 rs1588366 rs73039426  5 0.50 7 -0.85 4.9x10-7 0.001 
 rs7552 rs9891446 rs1588366 rs73039426  2 1.00 5 -1.00 1.0x10-6 0.004 
 rs73039426 rs8049367 rs1880646 rs1588366  4 0.62 5 -0.58 1.4x10-6 0.004 
5 loci rs7552 rs8049367 rs1880646 rs1588366 rs73039426 5 1.01 6 -1.33 4.2x10-8 0.007 
aNumber of significant high-risk genotypes in the interaction. bRegression coefficient in step2 for high-risk exposition. cNumber of significant low-
risk genotypes in the interaction. dRegression coefficient in step2 for low-risk exposition. ep value for the interaction model adjusted for covariates. 
fPermutation p value for the interaction model. 
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Supplementary Table 1 Characteristics of patients included in this study. 
 Control 
(n=866) 
NSCL±P 
(n=831) 
p value 
Gender    
Male 406 (46.88%) 466 (56.07%) 0.0002a 
Female 460 (53.12%) 365 (43.93%)  
Ancestry    
European 61.4% 59.6% 0.98b 
African 31.0% 32.4%  
Amerindian 7.6% 8.0%  
NSCL±P: nonsyndromic cleft lip with or without cleft palate sample. 
ap value calculated with x2 test and bp value calculated was Kruskal-Wallis test. 
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Supplementary Table 2 Association of single nucleotide polymorphisms in patients with nonsyndromic cleft lip only (NSCLO). P 
values were adjusted for covariates by logistic regression analysis. 
 Control (%) NSCLO (%) ORHet (95% CI) 
p value 
ORHom (95% CI) 
p value 
ORDom (95% CI) 
p value 
ORRec (95% CI) 
p value 
rs7552 (GG/GA/AA) 32.4/48.5/19.1 25.2/40.9/33.9 1.07 (0.75-1.53) 
0.66 
2.20 (1.49-3.24) 
8x10-5 
1.39 (1.00-1.92) 
0.04 
2.11 (1.54-2.90) 
6x10-6 
rs8049367 (TT/TC/CC) 40.9/45.8/13.3 40.1/48.8/11.1 1.10 (0.81-1.49) 
0.56 
0.90 (0.56-1.46) 
0.84 
1.05 (0.79-1.41) 
0.72 
0.86 (0.55-1.35) 
0.50 
rs1880646 (AA/AG/GG) 45.4/43.8/10.8 52.9/38.8/8.3 0.75 (0.55-1.01) 
0.05 
0.65 (0.38-1.10) 
0.11 
0.73 (0.55-0.97) 
0.03 
0.74 (0.45-1.23) 
0.23 
rs9891446 (CC/CG/GG) 52.5/40.9/6.6 48.7/39.7/11.6 1.05 (0.77-1.42) 
0.77 
1.81 (1.10-2.98) 
0.02 
1.16 (0.87-1.54) 
0.32 
1.77 (1.09-2.86) 
0.02 
rs1588366 (AA/AG/GG) 57.7/37.0/5.3 63.6/31.4/5.0 0.78 (0.57-1.06) 
0.11 
0.82 (0.42-1.60) 
0.55 
0.79 (0.58-1.06) 
0.10 
0.90 (0.47-1.74) 
0.75 
rs73039426 (CC/CT/TT) 77.9/20.7/1.4 81.8/15.3/2.9 0.70 (0.48-1.04) 
0.06 
1.81 (0.70-4.70) 
0.23 
0.78 (0.54-1.12) 
0.17 
1.93 (0.75-5.00) 
0.18 
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Supplementary Table 3 Association of single nucleotide polymorphisms in patients with nonsyndromic cleft lip and palate (NSCLP). 
P values were adjusted for covariates by logistic regression analysis. 
 Control (%) NSCLP (%) ORHet (95% CI) 
p value 
ORHom (95% CI) 
p value 
ORDom (95% CI) 
p value 
ORRec (95% CI) 
p value 
rs7552 (GG/GA/AA) 32.4/48.5/19.1 28.2/44.8/27.0 1.01 (0.79-1.30) 
0.91 
1.54 (1.15-2.07) 
3x10-3 
1.16 (0.92-1.47) 
0.20 
1.53 (1.19-1.97) 
1x10-3 
rs8049367 (TT/TC/CC) 40.9/45.8/13.3 39.0/45.7/15.3 1.05 (0.84-1.32) 
0.64 
1.20 (0.87-1.67) 
0.22 
1.09 (0.88-1.35) 
0.45 
1.17 (0.86-1.59) 
0.30 
rs1880646 (AA/AG/GG) 45.4/43.8/10.8 49.2/40.6/10.2 0.83 (0.66-1.04) 
0.10 
0.85 (0.59-1.22) 
0.37 
0.83 (0.67-1.03) 
0.08 
0.93 (0.66-1.31) 
0.67 
rs9891446 (CC/CG/GG) 52.5/40.9/6.6 47.0/44.3/8.7 1.23 (0.98-1.53) 
0.06 
1.49 (0.98-2.25) 
0.05 
1.26 (1.02-1.56) 
0.03 
1.35 (0.91-2.02) 
0.13 
rs1588366 (AA/AG/GG) 57.7/37.0/5.3 62.6/31.1/6.3 0.78 (0.62-0.99) 
0.03 
1.09 (0.69-1.73) 
0.70 
0.82 (0.66-1.02) 
0.07 
1.19 (0.76-1.87) 
0.44 
rs73039426 (CC/CT/TT) 77.9/20.7/1.4 80.8/16.5/2.7 0.75 (0.57-0.99) 
0.04 
1.99 (0.92-4.27) 
0.07 
0.83 (0.64-1.08) 
0.15 
2.10 (0.98-4.50) 
0.05 
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Supplementary Table 4 Haplotype analysis of the single nucleotide polymorphisms 
in NTN1 in controls and patients with nonsyndromic cleft lip with or without palate 
(NSCLP). P value was adjusted for co-variants by logistic regression analysis. 
Haplotype Control NSCLP OR (95%CI) p value 
A-C 43.3% 41.5% Reference  
A-G 23.9% 28.9% 1.26 (1.05-1.51) 0.002 
G-C 29.7% 27.5% 0.96 (0.81-1.14) 0.08 
G-G 3.1% 2.1% 0.73 (0.42-1.26) 0.32 
Sequence: rs1880646 and rs9891446. 
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4 | DISCUSSION 
Studies have described association of many genes and chromosomal regions with 
NSCL±P, but a clear majority of these studies was conducted with populations of 
European and Asian origins,4 with few studies focusing in other populations such as 
the Brazilian population, one of the most admixed populations in the world. Replication 
studies of NSCL±P susceptibility in different populations are quite important to define 
common and population-specific risk alleles and to understand the underlying genetic 
architecture of this common malformation.1 In this study we investigated 7 SNPs 
previously associated with NSCL±P by recent GWAS using a large ancestry-structured 
case-control cohort from Brazil. We found a strong association of rs7552 in 2p24.2 with 
NSCL±P. Noteworthy, the association with rs7552 was detected in both NSCLO and 
NSCLP subgroups, but a stronger association with NSCLO was observed. This is the 
first report showing a more pronounced effect of rs7552 among NSCLO than in NSCLP 
patients. Considering SNP-SNP interactions, several interactions containing rs7552 as 
lead SNP were significant after Bonferroni correction, and all of them were confirmed 
in the permutation test. Indeed, rs7552 demonstrated significant interaction effects on 
risk of NSCL±P with all investigated SNPs in 2-SNPs model, supporting the association 
of this locus with NSCL±P. 
The 2p24.2 locus was initially associated with NSCL±P in a multi-ethnic GWAS, 
with rs7552 being the top marker.15 This association was detected in the combined 
discovery-sample, since the association of rs7552 did not withstand the stratification 
into continental-ancestry groups (European, Asian and Central/South American). The 
Central and South American sample was derived from several countries, but samples 
from Colombia represented more than 60% of this group. Interestingly, this study also 
validated its top associations in a replication sample (607 NSCL±P and 1,685 controls) 
of European ancestry, and a strong and significant association between rs7552 and 
NSCL±P risk was observed, yielding an OR of 1.47 (95% CI: 1.27-1.71, p=2.68x10-7), 
which is contained in the confidence interval of the current report. Two previous 
genome-wide linkage scans have suggested 2q24.2 region as harboring a 
susceptibility locus for nonsyndromic oral clefts.23,24 The first study investigated a 
Japanese family with soft palate cleft spanning 3 successive generations, yielding a 
strong linkage score at 2p24.2-24.1.23 The subsequent study investigated 2 Chinese 
multiplex families with NSCL±P, giving evidence of linkage for the phenotype at the 
2p24-p25 region.24 The associated variant rs7552 is located in the 3’-untranslated 
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region (3’-UTR) of FAM49A. Beyond its expression in many tissues,25 with higher 
levels in brain and thyroid, little is known about the encoded product of FAM49A gene. 
Variants in 3’-UTR may influence polyadenylation, translation efficiency, localization 
and stability of the mRNA, as well as binding of microRNAs, altering one of the most 
common mechanisms of translational repression.26 Furthermore, this SNP may carry 
out a regulatory function or it may be not the true etiologic variant - it is located in a 
large haplotype block. Further efforts are needed to clarify the relationship between 
2p24.2 and the development of NSCL±P, allowing the elucidation of mechanisms 
through which 2p24.2 (rs7552 or another variant in LD with it) leads to NSCL±P 
predisposition, thus translating the findings of association studies into the clinic. 
The rs7406226 SNP in 17p13 did not adhere to the HWE and was excluded, 
and the other 2 SNPs in this gene (rs1880646 and rs9891446) showed only nominally 
significant associations as single markers, which does not appear to reflect a power 
limitation. However, both rs1880646 and rs9891446 exhibited LD and carriers of the 
A-G haplotype were found to be more prevalent among NSCL±P patients as compared 
to controls, showing a significant risk for oral clefts. The first study associating this 
locus with nonsyndromic oral clefts was a GWAS performed in Europeans and 
Asians.16 In a subsequent study with a case-parent trio cohort of European ancestry, 
Beaty et al.17 confirmed the association of NTN1 in 17p13 with NSCL±P. Moreover, 
this locus showed genome-wide significance in the genome-wide meta-analysis 
performed by Ludwig et al.27 and in the GWAS of the Chinese cases and controls.14 
Together, the results point to an association between 17p13 locus containing NTN1 
and the pathogenesis of NSCL±P, but additional studies are warranted. 
The present study failed to replicate the findings of the other GWAS candidate 
loci for NSCL±P (rs8049367 in 16p13.3, rs1588366 in 17q23.2 and rs73039426 in 
19q13.11), and this may have been related to admixed ancestry of our population or 
due to the sample size of our study. Sufficient power to detect a genetic effect for 
rs8049367 should have been achieved, however the powers for rs1588366 and 
rs73039426 were limited (~60%). Of note, we have assumed the most conservative 
genetic effect sizes of previous reports, whereas the true effect size in the Brazilian 
population is unknown. Another limitation was that we did not control for environmental 
risk factors, although the major source of confounding for genetic studies is population 
stratification, and our results were adjusted for this. Some strengths of this study 
include the high geographic coverage by including samples from 3 different regions of 
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Brazil and the assessment of the ancestry contribution of each patient, correcting for 
specific effects tof population stratification. 
To our knowledge, this is the first study regarding the relationship of 2p24.2 
locus with NSCL±P in the Brazilian population. However, additional studies are still 
necessary to unveil the exact mechanism by which 2p24.2 locus contribute to NSCL±P. 
Furthermore, our findings showed that the diversity of the Brazilian population clearly 
influences the susceptibility of specific loci in the pathogenesis of NSCL±P, 
underscoring the importance of detailed genetic studies of NSCL±P in different 
populations to improve our understanding of the etiology of this complex birth defect. 
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Abstract 
Scope: During development, oxidative stress is hypothesized to mediate 
embryotoxicity, which may be intensified by exposition to environmental factors and by 
genetic variations in the enzymes involved in protecting cells from these damaging 
effects, including superoxide dismutase (SOD) and paraoxonase (PON). The aim of 
this study was to evaluate the influence of single-nucleotide polymorphisms (SNP) in 
genes associated with the neutralization of oxidative stress (SOD and PON family 
members) in the risk of nonsyndromic cleft lip with or without cleft palate (NSCL±P) in 
the Brazilian population, considering gene, gene-gene (GxG) and gene-environmental 
factor (GxE) interactions. 
Methods: This study initially evaluated the association of 28 SNP in SOD1, SOD2, 
SOD3, PON1, PON2 and PON3 among 325 NSCL±P trios. Multiple logistic regression 
analyses were used to explore gene, GxG and GxE, involving factors that induce 
oxidative stress accumulation during pregnancy such as exposure to agrotoxics, 
environmental contact with agrotoxics, cigarette smoking, consumption of alcohol and 
drugs and folic acid supplementation. Signals that resisted to both Bonferroni 
correction and permutation test were subsequently confirmed in an ancestry-structured 
case-control analysis with 722 NSCL±P and 866 controls. 
Results: In the trio sample, transmission disequilibrium test (allele and haplotype) and 
GxE analysis showed no significant associations, but multiple pairwise GxG 
interactions containing 10 SNP in PON1, PON2 and PON3 were detected and further 
examined in the case-control sample. The PON1 rs2237583 and PON2 rs17166879 
yielded significant SNP-SNP interactions after adjustment for multiple tests (both 
Bonferroni assumption and 10,000 permutation test). The C allele and the CT genotype 
of PON1 rs2237583 evoke significant protective effects against NSCL±P, while 
rs3917490 showed a significant association only in the sample composed of patients 
displaying high African ancestry. 
Conclusion: Our results reveal associations of rs2237583 and rs3917490 in PON1 and 
GxG interactions containing rs2237583 and rs17166879 with the susceptibility of 
NSCL±P in the Brazilian population. Furthermore, the study underlines the recent 
tendency of taking into account potential GxG interactions to clarify the underlying 
mechanisms associated with the etiology of this common malformation. 
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Introduction 
The facial development involves multiple interactions of several cell populations with a 
vast range of molecules associated with different signaling pathways. Disruption of 
those interactions, affecting proliferation, cell fate, apoptosis, cell-to-cell and cell-to-
extracellular matrix adhesion or migration, are thought to underlie many of the 
craniofacial malformations such as the nonsyndromic oral clefts [1, 2]. Oxidation 
reactions during those interactions are essential for normal cell function, as are 
important the antioxidants to prevent the damage related to the subproducts of those 
processes. Indeed, the reactive oxygen species (ROS)-producing oxidative stress 
have long been considered as a mechanism of teratogenesis [3]. ROS avidly interact 
with a large number of molecules, including proteins, lipids, carbohydrates and nucleic 
acids, irreversibly destroying or altering their functions. Consequently, ROS have been 
increasingly identified as major contributors to damage in biological organisms [4, 5]. 
The enzymes encoded by the superoxide dismutase gene family, which 
includes SOD1, SOD2 and SOD3, are the most important antioxidant defense system 
against ROS, particularly against the superoxide anion radicals [6]. All SOD family 
members are metal-dependents, and their loss of functions in teratogen-induced 
oxidative stress has been associated with dysmorphogenesis of whole embryos [7]. 
Paraoxonase (PON) genes, including PON1, PON2 and PON3, possess antioxidant 
properties and is endowed of capacity of hydrolyze organophosphates and agrotoxic 
[8]. Although the participation of SODs and PONs on pathogenesis of nonsyndromic 
oral clefts is uncertain, polymorphic variants in SOD1, SOD2 and PON1 were 
associated with spina bifida [9, 10, 11]. Single-nucleotide polymorphisms (SNP) in 
PON1 were also related to defects in hands and feet and cerebral cavernous 
malformations [12, 13]. Moreover, TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin)-
induced cleft palate is associated with oxidative stress, which decreases motility and 
promotes apoptosis of medial edge epithelia cells, inhibiting palatal fusion [14]. 
Therefore, controlling of the oxidative stress, which may be intensified by 
environmental factors, is a critical step for normal development. 
Due to the vast extent of the polygenic heritability, studies have applied more 
powerful strategies to unravel human complex traits, including two-stage analysis, 
which is based on a preliminary screening of several markers (first stage) followed by 
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a second (confirmatory) analysis on a subset of markers with a reduced multiple-testing 
adjustment. In the current study, based on family association tests (first stage), we 
initially evaluated the relationships of polymorphic variants in SOD and PON members 
with the risk of nonsyndromic cleft lip with or without cleft palate (NSCL±P) in the 
Brazilian population, assessing their roles as gene only, gene-gene (GxG) interactions 
and gene-environmental factor (GxE) interactions. The environmental factors included 
were maternal exposure to agrotoxics, environmental contact with agrotoxics, cigarette 
smoking, consumption of alcohol and drugs, and folic acid supplementation during the 
first trimester of gestation – all with putative participation on NSCL±P etiology [15, 16]. 
In the second stage, we analyzed the significant signals in an independent and robust 
case-control sample, which was stratified by genomic ancestry contribution. 
 
Material and methods 
Samples 
This study included samples from patients with NSCL±P and healthy controls. We 
conducted an initial screening based in transmission disequilibrium test (TDT) analysis, 
followed by validation of the positive signals in a case-control approach. There was no 
overlapping between the samples used in the TDT and in the case-control study. The 
samples were collected in 4 different geographic regions of Brazil: the northeast region 
(University Hospital of Lauro Wanderley-HULW, João Pessoa-PB and Santo Antonio 
Hospital, Salvador-BA), the northern region (Hospital of Ophir Loyola, Belém-PA), the 
southeast region (Center for Rehabilitation of Craniofacial Anomalies, University of 
José Rosário Vellano, Alfenas-MG), and the southern region (Association of Carrier of 
Cleft Lip and Palate-APOFILAB, Cascavel-PR). All patients with NSCL±P were 
carefully examined and screened for the presence of associated anomalies or 
syndromes by the specialized teams of the associated centers or hospitals, and only 
patients with nonsyndromic form of CL±P, classification taking as reference the incisive 
foramen [17], were included. The unaffected individuals were healthy subjects without 
congenital malformations or psychiatric diseases. Individuals of the control group for 
case-control analysis had also no familial history of orofacial clefts and were born in 
the same geographic areas. 
In the TDT analysis, 325 trios composed of one affected offspring and two 
healthy parents (227 with nonsyndromic cleft lip and palate [NSCLP] and 98 with 
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nonsyndromic cleft lip only [NSCLO]) were included. Information on maternal 
exposures, including exposure to agrotoxics, environmental contact with agrotoxics, 
cigarette smoking, and consumption of alcohol and drugs during the first trimester of 
gestation, were collected through direct interview of the mothers. The mothers were 
also asked whether they used folic acid supplementation before the conception and 
during the first trimester of gestation (Supplementary Table 1). The average age of 
patients with NSCL±P was 11.47 ± 8.63 years. For the case-control analysis, 722 
patients affected with NSCL±P (515 NSCLP and 207 NSCLO) and 866 healthy 
individuals were included. The average age of the patients with NSCL±P was 18.49 ± 
13.84 years, and the average age of the control group was 25.24 ± 11.79. All 
volunteers included in this research provided written informed consent, and the study 
was approved by the ethics review board of each of the centers or hospitals affiliated 
with the collaborative study. 
 
Supplementary Table 1. Characteristics of patients included in the transmission 
disequilibrium test (family-based analysis) and frequencies of maternal exposures to 
environment factors during the first trimester of gestation. 
 No. of patients % 
Gender   
Male 205 63.1 
Female 120 36.9 
Type of cleft   
Nonsyndromic cleft lip only 98 30.1 
Nonsyndromic cleft lip and palate 227 69.9 
Maternal exposure   
Agrotoxics 14 4.3 
Environment contact with agrotoxics 31 9.5 
Cigarette smoking 39 12.0 
Alcohol consumption 22 6.7 
Drug consumption 52 16.0 
Folic acid absence 127 39,1 
Definitions: 
Agrotoxics: defined as mother that had direct contact with agrotoxic by work with those 
products on day basis, regardless frequency, during the first trimester of gestation. 
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Environment contact with agrotoxics: defined as mother that did not have direct contact with 
agrotoxic, but worked with agricultural activities during the first trimester of gestation and it is 
possible some indirect contact. 
Cigarette smoking: mothers that smoked during the first trimester of gestation, regardless 
frequency. 
Alcohol consumption: defined as mother that undertook alcoholic beverages during the first 
trimester of gestation, regardless amount and type. 
Drug consumption: defined as mother that took medicines, such as corticosteroids, antibiotics 
or anticonvulsants (barbiturates or benzodiazepines), in the first trimester of gestation. 
Folic acid absence: defined as mother that not took folic acid before conception and during the 
first trimester of gestation. 
 
Genotyping and genomic ancestry assessment 
The genomic DNA was isolated from oral mucosa cells obtained by mouthwash with a 
3% sucrose solution using a salting-out protocol [18]. Twenty-eight SNP 
(Supplementary Table 2) were genotyped on the StepOne Real-Time PCR system with 
TaqMan 5’-exonuclease allelic discrimination assays (Assay-on-Demand service, 
Applied Biosystems). Genotyping analyses were randomly repeated in 10% of the 
samples for each SNP, and the concordance rate was 100%. All samples were 
successfully genotyped, with a genotype call rate of >97.7%. 
To determinate the genomic ancestry of subjects, samples were genotyped for 
a panel containing 40 biallelic short insertion-deletion polymorphisms as previously 
described [19]. 
 
Supplementary Table 2. Characteristics of the single-nucleotide polymorphisms (SNP) 
in the genes SOD1, SOD2, SOD3, PON1, PON2 and PON3. 
Gene SNP Location Position MAF Alleles 
SOD1 (21q22.11)      
 rs1041740 Intron 31,667,849 0.242 C/T 
 rs4817420 Intron 31,668,058 0.242 C/T 
SOD2 (6q25.3)      
 rs8031 3’ UTR 159,679,60
8 
0.367 A/T 
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 rs2758331 Intron 159,684,03
8 
0.334 C/A 
 rs2855116 Intron 159,685,09
3 
0.334 A/C 
 rs4880 5’ UTR 159,692,84
0 
0.410 A/G 
SOD3 (4p15.3)      
 rs699473 5’ UTR 24,795,181 0.441 C/T 
PON1 (7q21.3)      
 rs854552 3’ UTR 95,298,612 0.366 T/C 
 rs3917551 Intron 95,305,143 0.127 G/A 
 rs3917548 Intron 95,306,593 0.133 A/G 
 rs662 Exon 
(Gln192Arg) 
95,308,134 0.457 C/T 
 rs3917527 Intron 95,310,946 0.125 T/C 
 rs2301711 Intron 95,316,347 0.182 T/C 
 rs3917490 Intron 95,319,529 0.347 T/C 
 rs2299262 Intron 95,320,616 0.440 C/T 
 rs2237583 Intron 95,320,865 0.301 C/T 
 rs705379 5’ UTR 95,324,583 0.349 G/A 
PON2 (7q21.3)      
 rs7785846 3’ UTR 95,404,529 0.282 C/T 
 rs7786401 3’ UTR 95,404,689 0.271 G/T 
 rs7493 Exon 
(Ser311Cys) 
95,405,463 0.283 G/C 
 rs2286232 Intron 95,410,133 0.282 C/T 
 rs2299263 Intron 95,411,099 0.282 C/T 
 rs17166879 Intron 95,424,103 0.247 A/G 
 rs2299267 Intron 95,432,609 0.211 A/G 
PON3 (7q21.3)      
 rs10953143 Intron 95,362,932 0.469 C/T 
 rs3757708 Intron 95,367,601 0.360 G/T 
 rs1053275 Exon 
(Ala99Ala) 
95,372,243 0.339 T/C 
 rs978903 Intron 95,374,855 0.339 G/A 
Risk alleles in bold. Source: http://www.ncbi.nlm.nih.gov/pubmed/. 
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Statistical analysis 
Genotype deviation from Hardy-Weinberg equilibrium was assessed through x2 test in 
the healthy parents of the trio sample, and in the control group of the case-control 
sample. A p value ≤0.05 was indicative of derivation. The TDT analyses, including 
allele testing and GxG and GxE interactions, were performed using the TRIO Package 
in RStudio software (version 3.0.0). The additive conditional logistic models were 
previously described [20, 21]. The full models containing genotype only (G), GxG and 
GxE to a null model without containing any terms were compared by the likelihood ratio 
test (LRT). The 2 degree of freedom (df) test was for G and GxG interactions or G and 
GxE interactions togethers, and 1df test was for GxG and GxE interactions alone. The 
haplotype-based analysis was conducted using the HBAT function of the FBAT 
software [22]. 
For the case-control analysis, the multiple logistic regression analysis under 
unrestricted, dominant and recessive genetic models, considering gender and genomic 
ancestry as potential confounders, was performed with SNPassoc and Haplo.stats 
packages in RStudio software. The genomic ancestry of each individual of the case-
control study was determined with the Structure software version 2.3.4 [23], applying 
the model of K=3 for parental populations based on the tri-hybrid origin of the Brazilian 
population. GxG interactions were performed using the model-based multifactor 
dimensionality reduction (mbmdr) package in RStudio software, using the 10,000 
permutation test to eliminate the false-positive interactions. 
In TDT analysis a Bonferroni threshold level of α ≤0.001 (28 SNP) was adopted, 
but for the case-control study, the number of SNP was reduced to 10, then the 
Bonferroni threshold was adjusted to α≤0.005. 
 
Results 
The distributions of genotypes in the healthy parents (control) did not deviate from 
expectation based on the Hardy-Weinberg equilibrium, with the exception of rs8031 
(p=0.04, Table 1). Although no individual SNP were preferentially transmitted from 
healthy parents to NSCL±P offspring (Table 1) and GxE interaction analysis yielded 
only nominally significant signals, which did not remain significant after Bonferroni 
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correction (Supplementary Table 3), signals of GxG interactions were identified (Table 
2). Multiple pairwise SNP-SNP interactions were identified, but only 14 of them, which 
included SNP in PON1 (rs3917490, rs2299262 and rs2237583), PON2 (rs2286232, 
rs17166879 and rs2299267) and PON3 (rs10953143, rs3757708, rs1053275 and 
rs978903), showed p values resistant to Bonferroni adjustment for multiple testing and 
10,000 permutation tests (Table 2). Haplotype-based analyses revealed no SOD1, 
SOD2, SOD3, PON1, PON2 and PON3 haplotype-phenotype association 
(Supplementary Table 4). 
Based on these results that revealed intriguing pairwise GxG interaction signals 
in 10 SNP located in PON1, PON2 and PON3 with NSCL±P risk, we performed further 
analyses in a larger case-control sample. As the genetic basis of susceptibility to 
NSCL±P varies among different populations [15], and the population of Brazil is highly 
admixed, with each individual showing variable ancestry proportions of Amerindians, 
Europeans and sub-Saharan Africans, we determined the proportion of genomic 
ancestry of each patient of the case-control sample. The European ancestry 
contribution was the most predominant in both NSCL±P and control groups, followed 
by African and Amerindian (Supplementary Fig. 1). Regarding gender, there was a 
significant difference between NSCL±P and controls, with NSCL±P being 
overrepresented by males (Supplementary Table 5). Therefore, the OR with 95% CI 
were estimated by multiple logistic regression models after controlling for these 
confounders in each comparison. 
The distributions of genotypes in the control group were consistent with those 
predicted by the Hardy-Weinberg equilibrium (Table 3). The frequency of the 
rs2237583 C allele was significantly lower in the NSCL±P patients compared with the 
control group, yielding an OR of 0.79 (95% CI: 0.67-0.93, p=0.005). The CT genotype 
(heterozygosis) was more frequent in the control group than in the NSCL±P group 
(p=0.01), revealing a decreased risk to NSCL±P (OR: 0.77, 95% CI: 0.62-0.95). In the 
dominant genetic model, rs2237583 SNP also demonstrated a significant association, 
with an OR of 0.75 (95% CI: 0.61-0.92, p=0.005). The conventional analysis for SNP 
effect alone also revealed an association between the C allele of rs3917490 and 
NSCL±P (OR: 0.86, 95% CI: 0.75-0.99, p=0.04), but this association did not withstand 
the p value of Bonferroni correction for multiple tests. 
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Although haplotype association analysis showed an association between 
NSCL±P and T-C-C haplotype formed by rs3917490, rs2299262 and rs2237583 in 
PON1 with a nominal p value (p=0.009), only the T-T-T-A haplotype in PON3 involving 
the SNP rs10953143, rs3757708, rs1053275 and rs978903 demonstrated an 
association that remains significant after Bonferroni correction for multiple tests 
(p=0.004, Supplementary Table 6). 
As the proportion of African genomic ancestry of the Brazilian population affects 
the genetic susceptibility to NSCL±P [19, 24, 25, 26, 27, 28], and the frequency of the 
risk alleles of some of selected SNP differ according to ethnicity, specially between 
African and Caucasian populations, we performed similar analyses in the subgroups 
of samples showing high European ancestry and high African ancestry. In the 
subgroup with high European ancestry, the average of European ancestry was higher 
than 90% in both groups (Supplementary Fig. 2), and the subgroup with high African 
ancestry showed an average African ancestry of 37.2% in the control group and 38.9% 
in the NSCL±P group (Supplementary Fig. 3). In the group with high African ancestry, 
rs2237583 showed associations with p values that did not withstand Bonferroni 
correction for multiple tests, whereas significant associations, which resisted to 
multiple comparisons, involving rs3917490 were found (Table 4). The frequency of 
PON1 rs3917490 C allele was significantly higher in the control group versus the 
NSCL±P group, with the OR of 0.64 (95% CI: 0.48-0.84, p=0.001). The genotype 
frequencies of rs3917430 were also associated with a decreased risk of NSCL±P in 
the subgroup with high African ancestry, reaching the maximum effect in the 
homozygous state (OR: 0.44, 95% CI: 0.25-0.78, p=0.004). No significant associations 
in the subgroup with high European ancestry were observed (Table 5). 
The mbmdr method was applied for detecting interactions between SNP and 
disease risk in the case-control sample. This method merges multilocus genotypes into 
a one-dimensional construct, categorizing the genotypic interactions into high-risk and 
low-risk level for the phenotype. Table 6 summarized the significant results obtained 
in 2- and 3-SNP analysis. Among the 2-SNP pairs, rs2237583 (PON1) and rs17166879 
(PON2) yielded the most significant signal (p=0.001) and it was the only one that 
remains significant after permutation test. At 3-SNP, the interactions containing 
rs2237583 (PON1) and rs17166879 (PON2) [rs2237583 - rs17166879 - rs978903 
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(PON3), rs2237583 - rs17166879 - rs1053275 (PON3), and rs2237583 - rs17166879 
- rs3757708 (PON3)] were the only significant after the permutation test. 
 
Table 1. Allelic transmission disequilibrium test of the single-nucleotide polymorphisms 
(SNP) in the sample containing probands with nonsyndromic cleft lip with or without 
cleft palate (NSCL±P) and healthy parents (trios). 
SNP HWE 
(P value) 
MAF Number of 
families 
T/NT x2 OR (95% CI) P value 
rs1041740 0.81 0.270 203 120/83 2.10 0.83 (0.64-1.06) 0.14 
rs4817420 0.87 0.286 200 116/84 2.29 0.82 (0.64-1.05) 0.12 
rs8031 0.04 0.476 244 182/62 1.38 1.14 (0.91-1.42) 0.24 
rs2758331 0.24 0.462 248 175/73 0.44 1.07 (0.86-1.33) 0.50 
rs2855116 0.67 0.456 243 169/74 0.38 1.07 (0.85-1.34) 0.53 
rs4880 0.06 0.469 251 176/75 3.09 0.82 (0.66-1.02) 0.07 
rs699473 0.66 0.468 231 158/73 3.35 0.80 (0.64-1.01) 0.06 
rs854552 0.43 0.332 218 141/77 0.09 1.03 (0.81-1.31) 0.76 
rs3917551 0.69 0.111 99 44/55 3.47 0.70 (0.48-1.01) 0.06 
rs3917548 0.82 0.119 110 52/58 2.22 0.76 (0.54-1.08) 0.13 
rs662 0.25 0.405 231 158/73 1.23 0.87 (0.69-1.10) 0.26 
rs3917527 0.55 0.110 101 49/52 1.21 0.81 (0.56-1.17) 0.27 
rs2301711 0.08 0.156 132 67/65 0.64 0.87 (0.64-1.20) 0.42 
rs3917490 0.91 0.463 236 172/64 0.73 1.10 (0.88-1.38) 0.39 
rs2299262 0.11 0.356 225 151/74 0.00 1.00 (0.79-1.26) 1.00 
rs2237583 0.83 0.240 172 109/63 0.11 0.95 (0.72-1.24) 0.73 
rs705379 0.44 0.422 244 162/82 0.44 0.92 (0.74-1.15) 0.50 
rs7785846 0.85 0.209 174 99/75 0.52 0.90 (0.70-1.17) 0.46 
rs7786401 0.92 0.222 170 95/75 0.55 0.90 (0.69-1.17) 0.45 
rs7493 0.98 0.226 169 94/75 1.62 0.84 (0.64-1.09) 0.20 
rs2286232 0.73 0.232 177 98/79 0.62 0.90 (0.69-1.16) 0.43 
rs2299263 0.82 0.228 173 96/77 1.14 0.86 (0.66-1.12) 0.28 
rs17166879 0.79 0.215 169 96/73 0.29 0.92 (0.71-1.21) 0.58 
rs2299267 0.71 0.171 148 82/66 0.95 0.86 (0.64-1.16) 0.32 
rs10953143 0.83 0.433 227 160/67 0.76 0.90 (0.71-1.13) 0.38 
rs3757708 0.80 0.490 230 174/56 0.01 0.98 (0.78-1.23) 0.90 
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rs1053275 0.58 0.459 229 170/59 0.08 0.96 (0.77-1.21) 0.77 
rs978903 0.51 0.471 232 175/57 0.003 1.00 (0.80-1.25) 0.95 
HWE: Hardy-Weinberg equilibrium; MAF: minor allele frequency; T/NT: transmission/non-
transmission counts. 
 
Table 2. Gene-gene interactions between the single-nucleotide polymorphisms (SNP) 
in SOD1, SOD2, SOD3, PON1, PON2 and PON3, using epistatic interactions analysis 
implemented in TRIO software. 
SNP1 SNP2 P value Perm. P value 
rs17166879 (PON2) rs10953143 (PON3) 1.7x10-12 <1x10-11 
rs17166879 (PON2) rs3757708 (PON3) 1.1x10-7 <1x10-11 
rs3917490 (PON1) rs1053275 (PON3) 1.7x10-7 <1x10-11 
rs2286232 (PON2) rs10953143 (PON3) 1.9x10-7 <1x10-11 
rs2286232 (PON2) rs1053275 (PON3) 2.2x10-7 <1x10-11 
rs17166879 (PON2) rs978903 (PON3) 4.1x10-7 <1x10-11 
rs3917490 (PON1) rs978903 (PON3) 5.7x10-7 <1x10-11 
rs2286232 (PON2) rs3757708 (PON3) 1.2x10-6 <1x10-11 
rs3917490 (PON1) rs3757708 (PON3) 2.4x10-6 <1x10-11 
rs2237583 (PON1) rs2299267 (PON2) 3.9x10-6 <1x10-11 
rs2299262 (PON1) rs10953143 (PON3) 3x10-5 5x10-4 
rs2299262 (PON1) rs3757708 (PON3) 0.001 0.001 
rs3917490 (PON1) rs10953143 (PON3) 0.001 0.001 
rs2299262 (PON1) rs2299267 (PON2) 0.004 0.001 
Perm. P value: p value based on 10,000 permutations. 
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Table 3. Association of single nucleotide polymorphisms (SNP) in the case-control study. P values were adjusted for confounders by 
logistic regression analysis. 
 HWE 
P 
value 
Control (%) NSCL±P (%) ORallele (95% CI) 
P value 
ORHet (95% CI) 
P value 
ORHom (95% CI) 
P value 
ORDom (95% CI) 
P value 
ORRec (95% CI) 
P value 
rs3917490 (TT/TC/CC) 0.95 28.3/49.9/21.8 33.1/47.4/19.5 0.86 (0.75-0.99) 
0.04 
0.83 (0.66-1.05) 
0.10 
0.79 (0.59-1.05) 
0.09 
0.82 (0.66-1.02) 
0.06 
0.88 (0.69-1.13) 
0.32 
rs2299262 (CC/CT/TT) 0.06 40.0/48.8/11.2 42.9/46.6/10.5 0.92 (0.79-1.06) 
0.28 
0.88 (0.71-1.09) 
0.22 
0.86 (0.61-1.22) 
0.40 
0.88 (0.71-1.07) 
0.19 
0.93 (0.67-1.28) 
0.64 
rs2237583 (CC/CT/TT) 0.54 54.8/39.0/6.2 61.6/33.7/4.7 0.79 (0.67-0.93) 
0.005 
0.77 (0.62-0.95) 
0.01 
0.66 (0.42-1.04) 
0.06 
0.75 (0.61-0.92) 
0.005 
0.73 (0.47-1.15) 
0.17 
rs2286232 (CC/CT/TT) 0.15 59.9/33.9/6.2 61.8/32.8/5.4 0.92 (0.78-1.09) 
0.36 
0.96 (0.77-1.18) 
0.66 
0.87 (0.56-1.34) 
0.51 
0.94 (0.77-1.16) 
0.56 
0.88 (0.57-1.35) 
0.56 
rs17166879 (AA/AG/GG) 0.21 62.5/32.2/5.3 66.9/28.0/5.1 0.86 (0.72-1.03) 
0.10 
0.83 (0.67-1.04) 
0.10 
0.92 (0.58-1.45) 
0.70 
0.84 (0.69-1.04) 
0.11 
0.98 (0.62-1.53) 
0.91 
rs2299267 (AA/AG/GG) 0.83 70.1/27.1/2.8 69.5/27.6/2.9 1.02 (0.84-1.23) 
0.79 
1.00 (0.80-1.26) 
0.97 
1.08 (0.59-1.97) 
0.77 
1.01 (0.81-1.26) 
0.92 
1.08 (0.59-1.96) 
0.81 
rs10953143 (TT/TC/CC) 0.07 35.5/45.6/18.9 38.6/43.1/18.3 0.92 (0.80-1.06) 
0.27 
0.86 (0.69-1.07) 
0.17 
0.89 (0.67-1.18) 
0.41 
0.87 (0.71-1.07) 
0.18 
0.97 (0.75-1.25) 
0.80 
rs3757708 (GG/GT/TT) 0.05 28.5/46.6/24.9 29.1/47.2/23.7 0.96 (0.83-1.10) 
0.60 
0.99 (0.79-1.26) 
0.95 
0.94 (0.71-1.24) 
0.61 
0.98 (0.78-1.22) 
0.82 
0.94 (0.75-1.19) 
0.61 
rs1053275 (TT/TC/CC) 0.05 30.6/46.3/23.1 32.7/46.3/21.1 0.92 (0.79-1.05) 
0.24 
0.94 (0.75-1.18) 
0.59 
0.86 (0.66-1.14) 
0.28 
0.92 (0.74-1.13) 
0.41 
0.90 (0.70-1.14) 
0.37 
rs978903 (GG/GA/AA) 0.07 30.5/46.6/22.9 32.5/47.1/20.4 0.91 (0.79-1.04) 
0.19 
0.95 (0.76-1.20) 
0.65 
0.84 (0.63-1.11) 
0.20 
0.91 (0.74-1.13) 
0.41 
0.87 (0.68-1.10) 
0.24 
HWE: Hardy-Weinberg equilibrium; NSCL±P: nonsyndromic cleft lip with or without cleft palate. 
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Table 4. Association of single-nucleotide polymorphisms in the case-control sample with high African genomic ancestry. P values 
were adjusted for confounders by logistic regression analysis. 
 HWE 
P value 
Control (%) NSCL±P (%) ORallele (95% CI) 
P value 
ORHet (95% CI) 
P value 
ORHom (95% CI) 
P value 
ORDom (95% CI) 
P value 
ORRec (95% CI) 
P value 
rs3917490 (TT/TC/CC) 0.49 23.8/52.4/23.8 37.4/47.1/15.5 0.64 (0.48-0.84) 
0.001 
0.60 (0.38-0.94) 
0.02 
0.44 (0.25-0.78) 
0.004 
0.55 (0.35-0.84) 
0.005 
0.60 (0.37-0.99) 
0.04 
rs2299262 (CC/CT/TT) 0.10 38.1/51.4/10.5 39.8/49.5/10.7 0.96 (0.72-1.28) 
0.82 
0.90 (0.59-1.36) 
0.62 
0.94 (0.48-1.86) 
0.88 
0.91 (0.61-1.35) 
0.62 
1.00 (0.53-1.89) 
0.99 
rs2237583 (CC/CT/TT) 0.23 55.7/35.7/8.6 63.6/32.5/3.9 0.70 (0.50-0.97) 
0.03 
0.78 (0.51-1.18) 
0.24 
0.38 (0.16-0.92) 
0.02 
0.70 (0.47-1.05) 
0.08 
0.42 (0.18-1.00) 
0.04 
rs2286232 (CC/CT/TT) 0.06 61.4/31.0/7.6 61.2/34.4/4.4 0.91 (0.66-1.27) 
0.60 
1.17 (0.77-1.79) 
0.47 
0.55 (0.23-1.30) 
0.15 
1.04 (0.70-1.55) 
0.84 
0.52 (0.22-1.22) 
0.12 
rs17166879 (AA/AG/GG) 0.45 63.3/31.4/5.3 67.9/27.7/4.4 0.83 (0.59-1.18) 
0.31 
0.87 (0.56-1.34) 
0.55 
0.73 (0.29-1.84) 
0.47 
0.85 (0.56-1.28) 
0.42 
0.76 (0.30-1.91) 
0.56 
rs2299267 (AA/AG/GG) 0.40 69.1/29.0/1.9 70.4/28.2/1.5 0.93 (0.64-1.35) 
0.72 
0.89 (0.57-1.37) 
0.59 
0.85 (0.18-3.94) 
0.83 
0.88 (0.58-1.35) 
0.56 
0.88 (0.19-4.05) 
0.86 
rs10953143 (TT/TC/CC) 0.32 37.6/44.8/17.6 39.3/43.7/17.0 0.95 (0.72-1.25) 
0.73 
0.88 (0.57-1.35) 
0.52 
0.91 (0.52-1.60) 
0.74 
0.89 (0.59-1.32) 
0.55 
0.98 (0.58-1.64) 
0.92 
rs3757708 (GG/GT/TT) 0.17 29.5/45.2/25.2 32.0/48.1/19.9 0.85 (0.64-1.12) 
0.25 
0.94 (0.60-1.49) 
0.80 
0.74 (0.43-1.28) 
0.28 
0.87 (0.57-1.33) 
0.53 
0.77 (0.48-1.23) 
0.27 
rs1053275 (TT/TC/CC) 0.08 31.9/43.8/24.3 37.4/46.1/16.5 0.76 (0.57-1.00) 
0.05 
0.87 (0.56-1.36) 
0.55 
0.59 (0.34-1.03) 
0.06 
0.78 (0.51-1.17) 
0.22 
0.64 (0.39-1.05) 
0.07 
rs978903 (GG/GA/AA) 0.11 31.4/44.3/24.3 35.9/47.1/17.0 0.78 (0.59-1.03) 
0.08 
0.90 (0.58-1.40) 
0.64 
0.62 (0.36-1.08) 
0.09 
0.80 (0.53-1.21) 
0.29 
0.66 (0.41-1.08) 
0.09 
HWE: Hardy-Weinberg equilibrium; NSCL±P: nonsyndromic cleft lip with or without cleft palate. 
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Table 5. Association of single-nucleotide polymorphisms in the case-control sample with high European origin. P values were adjusted 
for confounders by logistic regression analysis. 
 HWE 
P value 
Control (%) NSCL±P (%) ORallele (95% CI) 
P value 
ORHet (95% CI) 
P value 
ORHom (95% CI) 
P value 
ORDom (95% CI) 
P value 
ORRec (95% CI) 
P value 
rs3917490 (TT/TC/CC) 0.77 29.7/49.1/21.2 31.4/47.5/21.1 0.96 (0.81-1.13) 
0.67 
0.92 (0.70-1.20) 
0.52 
0.94 (0.68-1.31) 
0.73 
0.93 (0.72-1.19) 
0.55 
0.99 (0.75-1.32) 
0.97 
rs2299262 (CC/CT/TT) 0.20 40.5/48.0/11.5 44.2/45.3/10.5 0.90 (0.76-1.07) 
0.24 
0.87 (0.68-1.11) 
0.27 
0.85 (0.58-1.27) 
0.43 
0.87 (0.69-1.10) 
0.23 
0.92 (0.63-1.33) 
0.65 
rs2237583 (CC/CT/TT) 0.16 54.4/40.1/5.5 60.9/34.1/5.0 0.82 (0.68-1.00) 
0.05 
0.76 (0.60-0.97) 
0.02 
0.85 (0.50-1.44) 
0.53 
0.77 (0.61-0.98) 
0.03 
0.94 (0.56-1.59) 
0.82 
rs2286232 (CC/CT/TT) 0.54 59.4/34.8/5.8 62.0/32.2/5.8 0.92 (0.74-1.13) 
0.46 
0.89 (0.70-1.15) 
0.37 
0.99 (0.60-1.64) 
0.93 
0.91 (0.72-1.15) 
0.42 
1.03 (0.63-1.69) 
0.90 
rs17166879 (AA/AG/GG) 0.30 62.2/32.5/5.3 66.5/28.1/5.4 0.87 (0.71-1.07) 
0.21 
0.82 (0.63-1.05) 
0.11 
0.97 (0.58-1.63) 
0.89 
0.84 (0.66-1.07) 
0.14 
1.03 (0.62-1.73) 
0.89 
rs2299267 (AA/AG/GG) 0.46 70.4/26.5/3.1 69.2/27.3/3.5 1.06 (0.85-1.32) 
0.58 
1.06 (0.81-1.37) 
0.68 
1.19 (0.62-2.28) 
0.61 
1.07 (0.83-1.38) 
0.60 
1.17 (0.61-2.24) 
0.63 
rs10953143 (TT/TC/CC) 0.12 34.7/45.9/19.4 38.4/42.8/18.8 0.91 (0.77-1.08) 
0.30 
0.86 (0.66-1.11) 
0.24 
0.89 (0.64-1.23) 
0.47 
0.87 (0.68-1.10) 
0.24 
0.97 (0.72-1.30) 
0.82 
rs3757708 (GG/GT/TT) 0.12 28.2/47.0/24.8 27.9/46.9/25.2 1.01 (0.86-1.19) 
0.87 
1.00 (0.76-1.32) 
0.99 
1.01 (0.73-1.39) 
0.96 
1.00 (0.77-1.30) 
0.98 
1.01 (0.77-1.32) 
0.94 
rs1053275 (TT/TC/CC) 0.17 30.2/47.1/22.7 30.8/46.3/22.9 0.99 (0.84-1.16) 
0.90 
0.95 (0.73-1.25) 
0.72 
0.97 (0.70-1.34) 
0.86 
0.96 (0.75-1.23) 
0.74 
1.00 (0.76-1.31) 
0.98 
rs978903 (GG/GA/AA) 0.23 30.2/47.4/22.4 31.2/47.1/21.7 0.96 (0.82-1.13) 
0.67 
0.95 (0.73-1.25) 
0.72 
0.92 (0.67-1.27) 
0.61 
0.94 (0.73-1.21) 
0.64 
0.95 (0.72-1.25) 
0.70 
HWE: Hardy-Weinberg equilibrium; NSCL±P: nonsyndromic cleft lip with or without cleft palate.
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Table 6. Gene-gene interactions in patients with nonsyndromic cleft lip with or without cleft palate (NSCL±P) assessed by model-
based multifactor dimensionality reduction method. 
 SNP1 SNP2 SNP3 NHa betaHb NLc betaLd P valuee Perm. P 
valuef 
2-SNP rs2237583 (PON1) rs17166879 (PON2)  1 0.33 0 NA 0.001 0.01 
 rs10953143 (PON3) rs3917490 (PON1)  1 0.36 2 -0.32 0.003 0.05 
 rs2237583 (PON1) rs2286232 (PON2)  1 0.29 1 -0.21 0.006 0.06 
 rs2286232 (PON2) rs3917490 (PON1)  0 NA 1 -0.56 0.007 0.07 
 rs17166879 (PON2) rs3917490 (PON1)  1 0.21 1 -0.58 0.008 0.10 
3-SNP rs2237583 (PON1) rs17166879 (PON2) rs978903 (PON3) 2 0.49 0 NA 1.07x10-4 0.01 
 rs2237583 (PON1) rs17166879 (PON2) rs1053275 (PON3) 2 0.49 1 -0.36 1.14x10-4 0.01 
 rs2237583 (PON1) rs17166879 (PON2) rs3757708 (PON3) 2 0.48 1 -0.45 2.63x10-4 0.02 
 rs2237583 (PON1) rs2286232 (PON2) rs978903 (PON3) 2 0.44 0 NA 9.53x10-4 0.06 
 rs2237583 (PON1) rs2286232 (PON2) rs1053275 (PON3) 2 0.43 0 NA 0.001 0.07 
 rs978903 (PON3) rs17166879 (PON2) rs2299262 (PON1) 2 0.43 0 NA 0.001 0.12 
 rs1053275 (PON3) rs17166879 (PON2) rs2299262 (PON1) 2 0.43 1 -0.30 0.001 0.12 
 rs10953143 (PON3) rs2299267 (PON2) rs2299262 (PON1) 2 0.86 0 NA 0.001 0.12 
 rs10953143 (PON3) rs2299267 (PON2) rs2237583 (PON1) 2 0.75 0 NA 0.001 0.10 
 rs3757708 (PON3) rs2286232 (PON2) rs2237583 (PON1) 2 0.43 0 NA 0.002 0.10 
 rs10953143 (PON3) rs2286232 (PON2) rs3917490 (PON1) 1 0.54 2 -0.42 0.002 0.17 
 rs1053275 (PON3) rs2286232 (PON2) rs2299262 (PON1) 1 0.86 0 NA 0.002 0.17 
 rs3757708 (PON3) rs17166879 (PON2) rs2299262 (PON1) 2 0.42 1 -0.33 0.003 0.19 
 rs978903 (PON3) rs2299267 (PON2) rs3917490 (PON1) 2 0.44 0 NA 0.003 0.20 
 rs3757708 (PON3) rs17166879 (PON2) rs3917490 (PON1) 1 0.74 1 -0.77 0.004 0.19 
 rs978903 (PON3) rs17166879 (PON2) rs3917490 (PON1) 2 0.39 1 -0.75 0.005 0.23 
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 rs1053275 (PON3) rs17166879 (PON2) rs3917490 (PON1) 2 0.42 1 -0.75 0.005 0.24 
 rs10953143 (PON3) rs2299267 (PON2) rs3917490 (PON1) 1 0.41 2 -0.39 0.007 0.33 
 rs978903 (PON3) rs2286232 (PON2) rs2299262 (PON1) 1 0.79 0 NA 0.008 0.30 
aNumber of significant high-risk genotypes in the interaction. bRegresion coeficient in step2 for high-risk exposition. cNumber of significant low-
risk genotypes in the interaction. dRegresion coeficient in step2 for low-risk exposition. eP value for the interaction model adjusted for covariates. 
fPermutation P value for the interaction model. 
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Supplementary Figure 1. Ancestry contributions of individuals of control and NSCL±P 
groups. Each column is represented by a single individual. European, African and 
Amerindian parental samples were used as learning samples to assist the Structure 
software in estimating ancestry of the admixed individuals. 
 
 
Supplementary Figure 2. Ancestry frequencies of individuals of control and NSCL±P 
groups displaying high proportion of European ancestry. 
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Supplementary Figure 3. Ancestry frequencies of individuals of control and NSCL±P 
groups displaying high proportion of African ancestry. 
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Supplementary Table 3. Gene-environmental factor interactions between single-nucleotide 
polymorphisms (SNP) in SOD1, SOD2, SOD3, PON1, PON2 and PON3 and maternal 
exposures during the first trimester of gestation. 
A. Interactions with maternal contact with agrotoxics. 
  
  Agrotoxics   
  Non-Exposure 
OR (95% CI) 
Exposure 
OR (95% CI) 
P value (1 df) P value (2 df) 
SOD1      
 rs1041740 0.82 (0.64-1.06) 1.00 (0.28-3.45) 0.76 0.33 
 rs4817420 0.81 (0.62-1.04) 1.20 (0.36-3.93) 0.52 0.25 
SOD2      
 rs8031 1.11 (0.89-1.39) 2.33 (0.60-9.02) 0.27 0.27 
 rs2758331 1.05 (0.84-1.31) 2.33 (0.60-9.02) 0.23 0.39 
 rs2855116 1.04 (0.83-1.31) 2.33 (0.60-9.02) 0.23 0.40 
 rs4880 0.84 (0.67-1.05) 0.37 (0.09-1.41) 0.21 0.09 
SOD3      
 rs699473 0.81 (0.64-1.02) 0.66 (0.18-2.36) 0.75 0.17 
PON1      
 rs854552 1.03 (0.80-1.31) 1.16 (0.39-3.47) 0.82 0.93 
 rs3917551 0.70 (0.48-1.03) 0.66 (0.11-3.99) 0.95 0.17 
 rs3917548 0.74 (0.52-1.06) 1.50 (0.25-8.97) 0.44 0.24 
 rs662 0.86 (0.68-1.08) 1.40 (0.44-4.41) 0.38 0.41 
 rs3917527 0.82 (0.56-1.19) 0.66 (0.11-3.99) 0.82 0.52 
 rs2301711 0.87 (0.63-1.20) 1.00 (0.20-4.95) 0.87 0.71 
 rs3917490 1.10 (0.87-1.38) 1.16 (0.39-3.47) 0.91 0.68 
 rs2299262 0.96 (0.76-1.22) 2.66 (0.70-10.05) 0.11 0.29 
 rs2237583 0.91 (0.69-1.20) 5.00 (0.58-42.79) 0.07 0.19 
 rs705379 0.90 (0.72-1.13) 1.50 (0.53-4.21) 0.34 0.51 
PON2      
 rs7785846 0.94 (0.72-1.23) 0.16 (0.02-1.38) 0.05 0.12 
 rs7786401 0.94 (0.72-1.23) 0.16 (0.02-1.38) 0.05 0.12 
 rs7493 0.86 (0.66-1.13) 0.20 (0.02-1.71) 0.12 0.13 
 rs2286232 0.91 (0.70-1.18) 0.50 (0.09-2.73) 0.47 0.57 
 rs2299263 0.89 (0.68-1.16) 0.20 (0.20-1.71) 0.11 0.16 
 rs17166879 0.96 (0.73-1.25) 0.20 (0.02-1.71) 0.10 0.22 
 rs2299267 0.80 (0.59-1.09) 3.50 (0.72-16.84) 0.04 0.08 
PON3      
 rs10953143 0.92 (0.73-1.16) 0.50 (0.15-1.66) 0.31 0.40 
 rs3757708 0.96 (0.76-1.20) 1.80 (0.60-5.37) 0.26 0.52 
 rs1053275 0.93 (0.74-1.17) 2.00 (0.68-5.85) 0.16 0.36 
 rs978903 0.98 (0.78-1.23) 1.80 (0.60-5.37) 0.27 0.55 
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B. Interactions with maternal environmental contact with agrotoxics. 
  
  Environmental contact with 
agrotoxics 
  
  Non-Exposure 
OR (95% CI) 
Exposure 
OR (95% CI) 
P value (1 df) P value (2 df) 
SOD1      
 rs1041740 0.84 (0.65-1.09) 0.69 (0.29-1.62) 0.65 0.31 
 rs4817420 0.83 (0.64-1.07) 0.75 (0.31-1.78) 0.82 0.30 
SOD2      
 rs8031 1.21 (0.96-1.53) 0.65 (0.32-1.30) 0.09 0.11 
 rs2758331 1.11 (0.88-1.40) 0.77 (0.38-1.56) 0.33 0.50 
 rs2855116 1.12 (0.89-1.42) 0.66 (0.32-1.38) 0.17 0.32 
 rs4880 0.80 (0.64-1.01) 1.00 (0.48-2.04) 0.57 0.18 
SOD3      
 rs699473 0.81 (0.64-1.03) 0.69 (0.29-1.62) 0.70 0.17 
PON1      
 rs854552 1.08 (0.84-1.38) 0.64 (0.27-1.48) 0.23 0.47 
 rs3917551 0.72 (0.49-1.08) 0.50 (0.15-1.66) 0.55 0.14 
 rs3917548 0.81 (0.56-1.17) 0.44 (0.13-1.44) 0.32 0.20 
 rs662 0.92 (0.72-1.17) 0.55 (0.25-1.20) 0.21 0.24 
 rs3917527 0.81 (0.55-1.19) 0.83 (0.25-2.73) 0.96 0.54 
 rs2301711 0.89 (0.64-1.24) 0.75 (0.26-2.16) 0.75 0.69 
 rs3917490 1.13 (0.89-1.43) 0.78 (0.35-1.73) 0.37 0.46 
 rs2299262 1.00 (0.78-1.28) 0.93 (0.45-1.93) 0.84 0.98 
 rs2237583 0.93 (0.70-1.24) 1.10 (0.46-2.59) 0.73 0.88 
 rs705379 0.92 (0.74-1.16) 0.92 (0.42-2.02) 0.98 0.80 
PON2      
 rs7785846 0.93 (0.71-1.22) 0.71 (0.31-1.60) 0.53 0.63 
 rs7786401 0.90 (0.68-1.19) 0.91 (0.40-2.07) 0.97 0.75 
 rs7493 0.85 (0.64-1.13) 0.71 (0.31-1.60) 0.67 0.40 
 rs2286232 0.93 (0.71-1.22) 0.68 (0.31-1.48) 0.45 0.55 
 rs2299263 0.91 (0.69-1.20) 0.56 (0.24-1.27) 0.26 0.30 
 rs17166879 0.96 (0.72-1.27) 0.71 (0.31-1.60) 0.49 0.68 
 rs2299267 0.83 (0.61-1.14) 1.12 (0.43-2.91) 0.56 0.52 
PON3      
 rs10953143 0.87 (0.68-1.11) 1.27 (0.57-2.80) 0.37 0.45 
 rs3757708 1.00 (0.79-1.27) 0.78 (0.35-1.73) 0.55 0.83 
 rs1053275 0.96 (0.76-1.21) 1.00 (0.46-2.15) 0.93 0.95 
 rs978903 1.02 (0.80-1.28) 0.86 (0.41-1.82) 0.67 0.91 
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C. Interactions with maternal cigarette smoking. 
  
  Cigarette smoking   
  Non-Exposure 
OR (95% CI) 
Exposure 
OR (95% CI) 
P value (1 df) P value (2 df) 
SOD1      
 rs1041740 0.83 (0.63-1.08) 0.83 (0.42-1.65) 0.99 0.34 
 rs4817420 0.83 (0.63-1.08) 0.78 (0.40-1.55) 0.89 0.31 
SOD2      
 rs8031 1.11 (0.88-1.40) 1.38 (0.67-2.82) 0.57 0.42 
 rs2758331 1.07 (0.85-1.34) 1.13 (0.56-2.26) 0.87 0.79 
 rs2855116 1.04 (0.82-1.31) 1.38 (0.67-2.82) 0.45 0.62 
 rs4880 0.83 (0.66-1.04) 0.73 (0.36-1.46) 0.73 0.20 
SOD3      
 rs699473 0.91 (0.71-1.16) 0.35 (0.17-0.70) 0.007 0.005 
PON1      
 rs854552 1.03 (0.80-1.32) 1.06 (0.52-2.15) 0.93 0.95 
 rs3917551 0.67 (0.45-0.99) 1.00 (0.32-3.10) 0.51 0.13 
 rs3917548 0.74 (0.51-1.07) 1.00 (0.32-3.10) 0.63 0.28 
 rs662 0.86 (0.67-1.10) 1.00 (0.48-2.04) 0.70 0.50 
 rs3917527 0.79 (0.54-1.16) 1.00 (0.32-3.10) 0.70 0.50 
 rs2301711 0.83 (0.59-1.17) 1.22 (0.50-2.94) 0.43 0.53 
 rs3917490 1.17 (0.92-1.49) 0.68 (0.35-1.31) 0.12 0.20 
 rs2299262 1.00 (0.78-1.29) 0.95 (0.51-1.75) 0.86 0.98 
 rs2237583 0.91 (0.68-1.22) 1.25 (0.58-2.67) 0.45 0.71 
 rs705379 0.89 (0.70-1.12) 1.23 (0.65-2.34) 0.35 0.51 
PON2      
 rs7785846 0.88 (0.67-1.15) 1.25 (0.49-3.16) 0.48 0.59 
 rs7786401 0.87 (0.66-1.15) 1.25 (0.49-3.16) 0.47 0.58 
 rs7493 0.81 (0.61-1.07) 1.25 (0.49-3.16) 0.38 0.30 
 rs2286232 0.87 (0.67-1.14) 1.25 (0.49-3.16) 0.47 0.56 
 rs2299263 0.83 (0.63-1.09) 1.42 (0.54-3.75) 0.28 0.32 
 rs17166879 0.90 (0.68-1.19) 1.25 (0.49-3.16) 0.51 0.69 
 rs2299267 0.80 (0.58-1.11) 1.27 (0.57-2.80) 0.29 0.35 
PON3      
 rs10953143 0.87 (0.68-1.11) 1.13 (0.56-2.26) 0.49 0.54 
 rs3757708 1.04 (0.82-1.32) 0.65 (0.34-1.24) 0.17 0.40 
 rs1053275 1.02 (0.80-1.29) 0.66 (0.35-1.25) 0.21 0.43 
 rs978903 1.05 (0.83-1.33) 0.72 (0.38-1.38) 0.28 0.56 
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D. Interactions with maternal alcohol consumption. 
  
  Alcohol consumption   
  Non-Exposure 
OR (95% CI) 
Exposure 
OR (95% CI) 
P value (1 df) P value (2 df) 
SOD1      
 rs1041740 0.80 (0.62-1.04) 1.28 (0.47-3.45) 0.36 0.23 
 rs4817420 0.78 (0.60-1.01) 1.66 (0.60-4.58) 0.15 0.11 
SOD2      
 rs8031 1.09 (0.87-1.37) 2.00 (0.80-4.95) 0.19 0.21 
 rs2758331 1.01 (0.81-1.27) 2.50 (0.97-6.44) 0.05 0.13 
 rs2855116 1.02 (0.81-1.28) 2.14 (0.87-5.25) 0.10 0.22 
 rs4880 0.85 (0.68-1.07) 0.38 (0.13-1.07) 0.11 0.06 
SOD3      
 rs699473 0.82 (0.65-1.04) 0.64 (0.27-1.48) 0.57 0.15 
PON1      
 rs854552 1.03 (0.80-1.31) 1.11 (0.45-2.73) 0.87 0.94 
 rs3917551 0.70 (0.48-1.04) 0.60 (0.14-2.51) 0.82 0.16 
 rs3917548 0.75 (0.52-1.08) 1.00 (0.25-3.99) 0.69 0.30 
 rs662 0.87 (0.69-1.11) 0.87 (0.31-2.41) 0.99 0.53 
 rs3917527 0.80 (0.55-1.17) 1.00 (0.25-3.99) 0.76 0.51 
 rs2301711 0.88 (0.63-1.22) 0.80 (0.21-2.97) 0.88 0.71 
 rs3917490 1.11 (0.88-1.40) 0.88 (0.34-2.30) 0.64 0.62 
 rs2299262 0.96 (0.75-1.22) 1.71 (0.67-4.35) 0.23 0.49 
 rs2237583 0.91 (0.69-1.20) 2.00 (0.60-6.64) 0.19 0.41 
 rs705379 0.87 (0.69-1.09) 2.14 (0.87-5.25) 0.04 0.11 
PON2      
 rs7785846 0.91 (0.69-1.19) 0.87 (0.31-2.41) 0.94 0.76 
 rs7786401 0.90 (0.68-1.19) 0.87 (0.31-2.41) 0.94 0.75 
 rs7493 0.83 (0.63-1.10) 0.87 (0.31-2.41) 0.93 0.44 
 rs2286232 0.90 (0.69-1.17) 0.87 (0.31-2.41) 0.95 0.73 
 rs2299263 0.85 (0.65-1.12) 1.00 (0.35-2.85) 0.78 0.54  
 rs17166879 0.93 (0.71-1.22) 0.87 (0.31-2.41) 0.90 0.85  
 rs2299267 0.78 (0.57-1.06) 4.50 (0.97-20.82) 0.01 0.02 
PON3      
 rs10953143 0.86 (0.68-1.09) 2.00 (0.68-5.85) 0.12 0.20  
 rs3757708 1.03 (0.82-1.30) 0.50 (0.20-1.23) 0.11 0.29  
 rs1053275 1.01 (0.80-1.27) 0.46 (0.17-1.21) 0.10 0.26 
 rs978903 1.07 (0.85-1.34) 0.35 (0.12-0.99) 0.02 0.09 
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E. Interactions with maternal drug consumption. 
  
  Drug consumption   
  Non-Exposure 
OR (95% CI) 
Exposure 
OR (95% CI) 
P value (1 df) P value (2 df) 
SOD1      
 rs1041740 0.82 (0.63-1.08) 0.85 (0.44-1.62) 0.94 0.34 
 rs4817420 0.84 (0.64-1.10) 0.72 (0.38-1.38) 0.67 0.28 
SOD2      
 rs8031 1.12 (0.88-1.42) 1.23 (0.69-2.20) 0.76 0.47 
 rs2758331 1.12 (0.88-1.42) 0.84 (0.47-1.49) 0.36 0.53 
 rs2855116 1.08 (0.85-1.38) 1.00 (0.56-1.78) 0.79 0.79 
 rs4880 0.78 (0.62-0.99) 1.04 (0.60-1.80) 0.36 0.14 
SOD3      
 rs699473 0.84 (0.65-1.07) 0.65 (0.36-1.16) 0.43 0.13 
PON1      
 rs854552 1.10 (0.84-1.42) 0.76 (0.42-1.37) 0.26 0.51 
 rs3917551 0.74 (0.49-1.11) 0.50 (0.18-1.33) 0.45 0.12 
 rs3917548 0.84 (0.57-1.23) 0.46 (0.19-1.14) 0.22 0.15 
 rs662 0.96 (0.74-1.23) 0.54 (0.30-0.99) 0.08 0.11 
 rs3917527 0.84 (0.56-1.26) 0.69 (0.29-1.61) 0.67 0.49 
 rs2301711 0.93 (0.66-1.32) 0.64 (0.30-1.38) 0.37 0.49 
 rs3917490 1.08 (0.84-1.37) 1.22 (0.69-2.15) 0.68 0.63 
 rs2299262 0.99 (0.76-1.27) 1.04 (0.58-1.87) 0.87 0.98 
 rs2237583 1.04 (0.77-1.41) 0.64 (0.34-1.19) 0.16 0.35 
 rs705379 0.93 (0.73-1.17) 0.90 (0.49-1.66) 0.94 0.79 
PON2      
 rs7785846 0.79 (0.60-1.05) 2.00 (0.96-4.12) 0.01 0.04 
 rs7786401 0.77 (0.57-1.03) 2.44 (1.12-5.30) 0.004 0.01 
 rs7493 0.71 (0.53-0.94) 2.44 (1.12-5.30) 0.002 0.004 
 rs2286232 0.77 (0.58-1.02) 2.30 (1.09-4.83) 0.005 0.01 
 rs2299263 0.72 (0.54-0.97) 2.55 (1.18-5.52) 0.001 0.003 
 rs17166879 0.82 (0.61-1.09) 1.90 (0.92-3.95) 0.03 0.08 
 rs2299267 0.90 (0.65-1.25) 0.66 (0.32-1.38) 0.44 0.46 
PON3      
 rs10953143 0.82 (0.64-1.06) 1.34 (0.78-2.31) 0.10 0.18 
 rs3757708 1.09 (0.85-1.40) 0.58 (0.33-1.02) 0.03 0.12 
 rs1053275 1.03 (0.81-1.32) 0.65 (0.36-1.16) 0.14 0.33 
 rs978903 1.10 (0.86-1.40) 0.60 (0.33-1.07) 0.05 0.15 
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F. Interactions with maternal folic acid absence. 
 
 
 
 
 
  Folic acid absence   
  Non-Exposure 
OR (95% CI) 
Exposure 
OR (95% CI) 
P value (1 df) P value (2 df) 
SOD1      
 rs1041740 0.58 (1.12-0.16) 0.85 (0.58-1.25) 0.82 0.33 
 rs4817420 0.78 (0.56-1.09) 0.87 (0.60-1.28) 0.65 0.28 
SOD2      
 rs8031 1.10 (0.83-1.46) 1.19 (0.83-1.70) 0.73 0.47 
 rs2758331 1.08 (0.82-1.42) 1.06 (0.75-1.51) 0.94 0.80 
 rs2855116 1.07 (0.81-1.42) 1.07 (0.74-1.53) 0.98 0.82 
 rs4880 0.84 (0.64-1.11) 0.78 (0.55-1.11) 0.74 0.20 
SOD3      
 rs699473 0.87 (0.65-1.16) 0.71 (0.49-1.03) 0.41 0.13 
PON1      
 rs854552 1.13 (0.83-1.54) 0.91 (0.63-1.32) 0.38 0.65 
 rs3917551 0.96 (0.58-1.59) 0.47 (0.26-0.84) 0.06 0.03 
 rs3917548 1.00 (0.63-1.57) 0.52 (0.30-0.92) 0.07 0.06 
 rs662 0.88 (0.65-1.20) 0.86 (0.60-1.23) 0.91 0.53 
 rs3917527 1.00 (0.61-1.63) 0.63 (0.36-1.09) 0.22 0.26 
 rs2301711 1.02 (0.68-1.53) 0.70 (0.42-1.16) 0.25 0.37 
 rs3917490 1.16 (0.88-1.55) 1.00 (0.69-1.44) 0.51 0.55 
 rs2299262 0.89 (0.66-1.19) 1.21 (0.82-1.79) 0.21 0.46 
 rs2237583 0.83 (0.59-1.17) 1.20 (0.76-1.90) 0.20 0.42 
 rs705379 1.01 (0.78-1.32) 0.77 (0.52-1.12) 0.23 0.39 
PON2      
 rs7785846 0.80 (0.57-1.11) 1.12 (0.73-1.73) 0.21 0.35 
 rs7786401 0.82 (0.58-1.14) 1.08 (0.69-1.69) 0.33 0.47 
 rs7493 0.77 (0.55-1.08) 0.97 (0.62-1.52) 0.42 0.32 
 rs2286232 0.78 (0.56-1.08) 1.15 (0.75-1.75) 0.15 0.26 
 rs2299263 0.77 (0.55-1.08) 1.05 (0.67-1.62) 0.28 0.31 
 rs17166879 0.80 (0.57-1.12) 1.18 (0.76-1.84) 0.16 0.32 
 rs2299267 0.82 (0.56-1.19) 0.93 (0.57-1.53) 0.67 0.56 
PON3      
 rs10953143 0.83 (0.62-1.11) 1.03 (0.71-1.50) 0.36 0.44 
 rs3757708 1.09 (0.82-1.45) 0.82 (0.56-1.19) 0.22 0.47 
 rs1053275 1.08 (0.81-1.43) 0.79 (0.54-1.15) 0.18 0.40 
 rs978903 1.10 (0.83-1.46) 0.85 (0.58-1.23) 0.26 0.54 
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Supplementary Table 4. Haplotype family-based association tests for SOD1, SOD2, 
PON1, PON2 and PON3 performed using HBAT. 
 
A. SOD1. 
Haplotype Number of families Frequency Z score P value 
C-C 178 0.706 1.55 0.12 
T-T 174 0.279 -1.37 0.16 
T-C 10 0.009 -0.56 0.57 
Sequence: rs1041740 and rs4817420. 
 
 
B. SOD2. 
Haplotype Number of families Frequency Z score P value 
A-C-A-G 211 0.461 -1.78 0.07 
T-A-C-A 196 0.415 1.29 0.19 
A-C-A-A 57 0.058 1.10 0.26 
T-C-A-A 16 0.014 0.25 0.80 
T-A-A-A 12 0.010 0.003 0.99 
T-C-A-G 10 0.008 1.62 0.10 
T-A-C-G 22 0.007 -2.15 0.03 
Sequence: rs8031, rs2758331, rs2855116 and rs4880. 
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C. PON1. 
Haplotype Number of families Frequency Z score P value 
C-C-C 217 0.422 1.11 0.26 
T-C-C 166 0.217 -0.59 0.55 
T-T-T 152 0.198 0.66 0.50 
T-T-C 101 0.114 -0.82 0.40 
C-T-C 39 0.019 0.75 0.45 
C-T-T 35 0.014 -1.03 0.30 
C-C-T 23 0.010 -0.85 0.39 
T-C-T 25 0.007 -2.18 0.02 
Sequence rs3917490, rs2299262 and rs2237583. 
 
D. PON2. 
Haplotype Number of families Frequency Z score P value 
C-G-G-C-C-A 147 0.756 0.70 0.48 
T-T-C-T-T-G 141 0.193 -0.61 0.53 
T-T-C-T-T-A 14 0.011 0.00 1.00 
Sequence: rs7785846, rs7786401, rs7493, rs2286232, rs2299263 and rs17166879. 
 
E. PON3. 
Haplotype Number of families Frequency Z score P value 
C-T-C-A 190 0.452 0.05 0.95 
T-G-T-G 187 0.416 -0.74 0.45 
C-G-T-G 72 0.080 1.25 0.20 
C-T-T-G 31 0.028 -0.64 0.51 
C-T-T-A 11 0.009 1.87 0.06 
T-T-C-A 12 0.003 -1.99 0.04 
Sequence: rs10953143, rs3757708, rs1053275 and rs978903. 
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Supplementary Table 5. Characteristics of patients included in the case-control study. 
 Control 
(n=866) 
NSCL±P 
(n=722) 
P value 
Gender    
Male 406 (46.88%) 409 (56.65%) 0.0001a 
Female 460 (53.12%) 313 (43.35%)  
Ancestry    
European 83.6% 81.4% 0.99b 
African 14.6% 16.8%  
Amerindian 1.8% 1.8%  
NSCL±P: nonsyndromic cleft lip with or without cleft palate. 
aP value calculated with x2 test and bP value calculated with Kruskal-Wallis test. 
 
 
Supplementary Table 6. Haplotype analysis of the single-nucleotide polymorphisms in 
PON1, PON2 and PON3 in the case-control sample. P values were adjusted for 
confounders by logistic regression analysis. 
A. PON1 haplotypes. 
Haplotype Control NSCL±P P value 
C-C-C 41.8% 38.8% Reference 
T-C-C 21.6% 26.5% 0.009 
T-T-T 22.5% 19.7% 0.42 
T-T-C 8.9% 10.4% 0.14 
C-T-C 1.9% 2.6% 0.29 
C-T-T 2.2% 1.0% 0.08 
Sequence: rs3917490, rs2299262 and rs2237583. 
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B. PON2 haplotypes. 
Haplotype Control NSCL±P P value 
C-A-A 61.0% 61.9% Reference 
T-G-A 19.9% 17.5% 0.17 
C-A-G 15.2% 15.5% 0.91 
T-A-A 2.3% 3.1% 0.22 
C-G-A 0.4% 0.7% 0.48 
Sequence: rs2286232, rs17166879 and rs2299267. 
 
C. PON3 haplotypes. 
Haplotype Control NSCL±P P value 
T-T-C-A 45.8% 42.8% Reference 
C-G-T-G 41.5% 38.9% 0.94 
T-G-T-G 9.9% 12.8% 0.01 
T-T-T-G 0.1% 3.3% 0.02 
T-T-T-A 0.1% 0.4% 0.004 
Sequence: rs10953143, rs3757708, rs1053275 and rs978903. 
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Discussion 
As NSCL±P are among the most common congenital malformations in humans, with 
high mortality risk in developing countries, and therapeutic options are complex and 
expensive [15], considerable efforts are invested to identify the environmental and 
genetic factors associated with NSCL±P susceptibility. The known factors are not able 
to explain all cases of NSCL±P, and behind the concept of multifactorial disease, the 
current research has been focused on interacting networks between genes and genes 
and environmental factors to characterize putative markers with predictive significance 
for the etiology of disease. In this study, considering two representative and 
complementary samples of NSCL±P, consisting of more than 1,000 patients, we 
examined whether SNP in genes encoding enzymes with specific roles in the 
neutralization of dangerous reactive compounds for DNA damage interact with 
environmental factors in risk of NSCL±P. In the discovery sample, TDT analysis based 
on alleles and haplotypes and GxE interactions did not generate any signals achieving 
the formally adopted threshold of significance, but when GxG interactions were 
incorporated, several pairwise SNP-SNP interactions between PON1, PON2 and 
PON3 attained significant associations with NSCL±P. The case-control structured 
analysis supported some findings and revealed that GxG interactions involving 
rs2237583 in PON1 and rs17166879 in PON2 are associated with NSCL±P in the 
Brazilian population. In the case-control sample, our findings also showed that 
rs2237583 is significantly associated with NSCL±P, when all sample was considered, 
and rs3917490 in PON1 reached a significant association with NSCL±P only in patients 
with a high percentage of African ancestry, suggesting that this polymorphism may 
have different associations with NSCL±P depending on specific ancestry. 
PONs are a family of calcium-dependent hydrolases that are involved in 
antioxidant defense and the metabolism of various organophosphorus compounds, 
including insecticides [29]. Indeed, the name paraoxonase is derived of the first known 
substrate of PON1, paraoxon, the active metabolite of the insecticide parathion [30]. 
PONs also breakdown endogenous ROS by hydrolyzing oxidized phospholipids and 
by inactivating lipid hydroperoxides and hydrogen peroxide [31]. Although all three 
PONs seem to be important players in the maintenance of a low oxidative state, they 
are new identified antioxidant enzymes, warranting new studies to fully elucidate their 
physiological functions [32]. PONs are expressed in nearly all human tissues, and are 
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implicated in many diseases including cardiovascular disease, Parkinson’s disease, 
Alzheimer’s disease and diabetes [8], but little is known about their associations with 
developmental disorders. However, genetic factors altering expression and activity of 
PON family members may play a key role in determining susceptibility to oxidative 
stress associated with environmental exposures during the first trimester of gestation 
and, subsequently, DNA damage. In support, PON expression has been implicated in 
pathogenesis of neural tube defects, with its activity being essential in protecting of 
oxidative stress-induced neural tube defects [9, 11]. Moreover, high levels of oxidative 
stress decrease cell differentiation, resulting in cleft palate in mice [11, 14]. Several 
PON variants are associated with alterations in paraoxonase activity, but the most 
studied is PON1 rs662, a variant located in the coding region that promotes reduction 
in the activity of enzyme [8, 33]. Of all selected SNP of present study, only PON1 rs662 
and PON2 rs4880 were previously studied in oral clefts, but no associations were found 
[34, 35]. Similarly, our study failed to identify significant associations between rs662 
and rs4880 and NSCL±P, and this does not seem to be related to power, because 
sufficient power to detect a genetic effect was achieved for these and many other SNP. 
In this study the C allele of PON1 rs2237583 induced a protective effect against 
NSCL±P. The presence of variant allele (allele T) of this SNP has been associated with 
a decrease in the enzyme activity in vascular diseases [36, 37]. A study with mothers 
and children from a region of Northern California identified 12 SNP in PON1 associated 
with a reduction in the enzyme activity, including rs2237583 [33]. Thus, the presence 
of C allele ensures the functionality of enzyme, explaining the protective effect for 
NSCL±P development found in our study. However, rs2237583 was in strong linkage 
disequilibrium with rs705379 [33], and rs705379 was considered the causal variant in 
this locus, because it disrupts the Sp1 factor-binding site in the promoter region, 
thereby affecting transcription levels [38, 39]. In the current study, rs705379 was not 
associated with NSCL±P and was not in LD with the rs2237583 (data not shown). As 
rs2237583 allele frequencies differ according to ethnicity, the contribution of this SNP 
in different ancestry background populations may also differ. 
Indeed, previous studies with PON genotypes and phenotypes in different ethnic 
populations have revealed significant variations in both allele and haplotype 
frequencies and enzyme activities [40, 41, 42]. Exceeding 200 million people, the 
Brazilian population is highly heterogeneous and admixed, a fact that has far reaching 
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implications to NSCL±P susceptibility [19, 24, 25, 26, 27, 28]. The extent of admixture 
is well documented in a wealth of population genetic studies in Brazilians, and it is 
evident that most individuals have significant degrees of European, African and 
Amerindian ancestry. As anticipated, the individual proportions of European, African 
and Amerindian ancestry varied widely in this study. Applying subgroup analysis, no 
significant associations were observed in the patients with high European ancestry, 
though the reduction in the number of samples drove a decreased statistical power. 
However, even with a small group, PON1 rs3917490 was significantly associated with 
NSCL±P in the subgroup of patients with high African ancestry. The frequency of the 
rs3917490 T allele, which was associated with the protective effect, showed a higher 
frequency in patients with African ancestry compared with patients with elevated 
European ancestry. The impact of rs3917490, an intronic SNP, on paraoxonase 
activity of PON1 has never been assessed. Although genetic association studies often 
focus on coding SNP, particularly nonsynonymous SNP resulting in amino acid 
changes because they are likely to be functional, recent studies have showed that SNP 
in other regions, including introns and 3’ UTR regions, may also have regulatory 
functional consequences. Furthermore, this SNP may be not the true etiologic variant 
- it can be in LD with some unknown gene or region (the true-associated variant). 
Further efforts are needed to determine the functionality of rs3917490, allowing the 
elucidation of mechanisms through this SNP leads to NSCL±P susceptibility in the 
Brazilian population with high African ancestry. Moreover, these results suggest that 
some of the population differences in association with NSCL±P can be explained by 
differences in frequency of alleles and haplotypes on PON family members. 
Our study has some limitations, including the lack of characterization of impact 
of SNP on function of the encoded enzymes and the limited power in the analysis of 
the subgroup-based ancestry proportions. We also do not know whether other 
environmental factors, such as nutritional deficiency, which is related to oxidative 
stress induction, could exert important roles under GxE interactions on pathogenesis 
of this common disease. However, the study has several strengths. First, we pooled 
NSCL±P samples from several regions of Brazil, giving a high geographic coverage 
and a representative sample of the Brazilian population. Second, we have applied 
case-parent trio as a discovery approach followed by validation of the significant 
signals in a case-control independent sample. This approach is based on the premise 
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that if the same effect of a disease-marker can be obtained from case-parent trio and 
case-control study, the magnitude of information is strong and true. Third, applying 
GxG and GxE interaction analyses, we were able to verify whether the genes directly 
affect NSCL±P or whether their effects might be exerted through interactions between 
them or with environmental factors. Fourth, all measurements in the case-control 
sample were controlled for confounding effects including gender and ancestry 
proportions. Fifth, by evaluating the genomic structure of each sample, we were able 
to perform stratification analysis based on proportion of European and African 
proportions, revealing differential associations for the SNP rs3917490 in PON1. 
 
Conclusion 
In summary, this study was the first to cover the relationship of SOD and PON genetic 
variants and NSCL±P in the Brazilian population. Our results revealed by combining 
family-based and case-control models that markers in PON1, PON2 and PON3 may 
influence the risk of NSCL±P through potential GxG interactions. The presence of C 
allele in rs2237583 and of T allele in rs3917490, both in PON1, were associated with 
lower odds for NSCL±P, though the effect of rs3917490 was only observed in the 
sample with high African ancestry. Future studies are needed to confirm the exact 
mechanism by which PON variants may contribute to the development of NSCL±P. 
Furthermore, our findings showed that the diversity of the Brazilian population clearly 
influences the susceptibility of specific SNP in PON1 on NSCL±P pathogenesis. 
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Summary 
Nonsyndromic oral clefts are common congenital birth defects that exhibit variable 
prevalence around the world, often influenced by population-dependent genetic 
predisposition. Few studies have been performed with nonsyndromic cleft palate only 
(NSCPO), limiting the knowledge of the genetic risk factors related to this type of oral 
cleft. Genetic variants in golgin subfamily B member 1 (GOLGB1), a gene that is 
essential for normal murine palatogenesis, were analyzed in this study to establish its 
potential association with NSCPO risk in the Brazilian population. Five tag-single 
nucleotide polymorphisms (SNPs) of GOLGB1 (rs1169, rs7153, rs9968051, 
rs9819530 and rs6794341), which capture the majority of alleles spanning within gene, 
were genotyped in a case-control study with 270 patients with NSCPO and 284 
unrelated healthy controls. The samples were also genotyped for 40 biallelic 
polymorphic markers to characterize the genetic ancestry. After adjustment for co-
variants, the GOLGB1 tag-SNPs and the haplotypes formed by those SNPs were not 
significantly associated with NSCPO in this Brazilian case-control cohort. Our results 
suggest that common polymorphisms of GOLGB1 are not associated NSCPO 
susceptibility in the Brazilian population. 
Keywords: nonsyndromic cleft palate only, single nucleotide polymorphism, risk factor, 
GOLGB1. 
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Introduction 
Nonsyndromic oral clefts are usually divided into cleft lip with or without cleft palate 
(NSCL±P) and cleft palate only (NSCPO). NSCPO represents only one third of all 
nonsyndromic oral clefts, with prevalence around 1-25 per 10,000 live births (Burg et 
al., 2016). Females are frequently more affected than males (Burg et al., 2016). The 
etiology of nonsyndromic oral clefts is dependent of genetic and environmental 
interactions, though the specific underlying factors remain largely unclear. The genetic 
predisposition is ethnicity-dependent, a situation that is clearly illustrated in the 
Brazilian population. As result of five centuries of mating between Amerindians, 
Europeans and sub-Saharan Africans, the Brazilian population displays very high 
levels of genomic diversity, which has been shown to affect the specific genetic 
susceptibility of genes and loci previously associated with nonsyndromic oral clefts in 
other populations (Paranaiba et al., 2010; Bagordakis et al., 2013). Even in specific 
subsets of the Brazilian population, such as those displaying high African ancestry, a 
variable participation of different genomic loci in the pathogenesis of nonsyndromic 
oral clefts is observed (Aquino et al., 2014; do Rego Borges et al., 2016). 
A variety of genetic approaches, including genome-wide association studies 
(GWAS), has been employed to identify genes and loci associated with NSCL±P, but 
few studies have been performed with NSCPO. Indeed, only 2 independent GWAS for 
NSCPO were performed, with GRHL3 (rs41268753) achieving genome-wide 
significance when considered alone (Leslie et al., 2016), and markers in other few 
genes approached the genome-wide significance when gene-environment interactions 
with maternal smoking or multivitamin supplementation were taken into account (Beaty 
et al., 2011). An alternative has been the traditional studies based on animal models 
of palatogenesis or specific knockout mice resulting in cleft palate. Those models have 
yielded insights of participation of specific signaling pathways in the normal 
palatogenesis, and variations on those genes have been related to NSCPO. For 
example, Wnt signaling disruption is associated with mouse palatal malformations and 
single-nucleotide polymorphisms (SNPs) in WNT3 have been linked to NSCPO in 
humans (Machado et al., 2016). 
A recent study revealed that the loss of function of golgin subfamily B member 
1 (Golgb1) gene causes cleft palate in mice due to alterations in protein glycosylation 
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patterns in the embryonic palatal mesenchymal cells (Lan et al., 2016). Furthermore, 
a 10-bp insertion in Golgb1 exon 13 in rats, resulting in a truncated protein due to a 
premature termination codon, causes osteochondrodysplasia, which is characterized 
by cleft palate, among other phenotypes (Katayama et al., 2011). Owing to the 
substantial weight of evidence indicating the participation of Golgb1 in murine 
palatogenesis and genetic variants in genes involved in palate embryonic development 
may be associated with NSCPO in humans, we conducted this case-control structured 
study with 5 tag-SNPs in GOLGB1, in which the genetic ancestry variation of each 
individual was taken into account, to verify the relationship between GOLGB1 SNPs 
and NSCPO. 
Materials and Methods 
Samples 
This case-control study included samples from 270 unrelated patients with NSCPO 
and 284 healthy control individuals. Patients with NSCPO were carefully examined and 
screened for the presence of associated anomalies or syndromes by the specialized 
team of the associated Centers for rehabilitation of craniofacial anomalies in Brazil: the 
Association of Carrier of Cleft Lip and Palate-APOFILAB, Cascavel-PR, the Center for 
Rehabilitation of Craniofacial Anomalies, University of José Rosário Vellano, Alfenas-
MG, the University Hospital of Lauro Wanderley-HULW, João Pessoa-PB and the 
Santo Antonio Hospital, Salvador-BA. The control group was composed of healthy 
individuals with no physical illness, psychiatric, birth defects or with a family history of 
orofacial clefts, living in the same geographic areas (Supplementary Table 1). The 
study was approved by the ethics review board of each of the centers or hospitals 
affiliated with the collaborative study. Written informed consent was obtained from the 
parents or guardians and/or the participants. 
Tag-SNP selection 
The genomic region containing 5 kb upstream and 2 kb downstream of GOLGB1 was 
screened for tag-SNPs using Tagger software (de Bakker et al., 2005). The capture of 
the tag-SNPs was performed with the 1000 Genomes Project data, following the 
criteria of minor allele frequency > 0.1, p value in Hardy-Weinberg equilibrium (HWE) 
> 0.05 and r2 pairwise correlation > 0.9. Applying this stringent filter, 5 SNPs were 
selected. The main features of each SNP are described in Table 1. 
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Table 1 Characteristics of the tag-single nucleotide polymorphisms (SNPs) in 
GOLGB1, located at 3q13.33, and allelic distributions in the control and nonsyndromic 
cleft palate only (NSCPO) groups. 
SNP Position Alleles 
MAF 
Control 
MAF 
NSCPO 
HWE 
(p value) 
OR (95% CI) / p 
value* 
rs1169 121,663,357 C/t 0.363 0.354 0.73 0.96 (0.75-1.23) / 0.76 
rs7153 121,664,450 G/a 0.241 0.237 0.62 0.97 (0.74-1.28) / 0.86 
rs9968051 121,665,234 C/g 0.137 0.133 0.02 0.96 (0.68-1.36) / 0.85 
rs9819530 121,668,937 T/g 0.375 0.336 0.79 0.84 (0.65-1.08) / 0.17 
rs6794341 121,741,762 G/a 0.266 0.311 0.77 1.24 (0.95-1.61) / 0.09 
MAF: minor allele frequency. Minor allele in lower case. HWE: Hardy Weinberg equilibrium. 
*Values of p were adjusted taking into account the structured ancestral distribution. 
 
Genotyping and assessment of genomic ancestry 
Genomic DNAs extracted from oral mucosa cells were genotyped by TaqMan 5’-
exonuclease allelic discrimination assays (Assay-on-Demand service, Applied 
Biosystems). For quality control purposes, reactions were randomly repeated in 10% 
of the samples for each SNP, and the concordance rate was 100%. All samples were 
successfully genotyped, with a genotype call rate of >99%. 
To estimate the genomic ancestry proportions, each sample was also 
independently genotyped for 40 biallelic short insertion-deletion polymorphisms 
(Messetti et al., 2017). 
Statistical analysis 
All genotyped SNPs were tested for the HWE in the control group using the x2 test. 
Group comparisons were tested by Student’s t-test, x2 test or Kruskal-Wallis test. 
Differences in the allele frequency conditioned on population structure were assessed 
with STRAT (Pritchard et al., 2000). Linkage disequilibrium (LD) was estimated using 
the HaploView software. Multiple logistic regression analysis was performed with R 
software, considering age, gender and genomic ancestry as potential co-variants. For 
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association analysis, the p value was adjusted by Bonferroni correction for multiple 
testing (p≤0.01). Power for detecting a p value ≤0.05 for each SNP was estimated 
using the QUANTO software assuming a prevalence of NSCL/P in Brazil of 0.00146 
(Martelli-Junior et al., 2007). 
Results 
The distributions of genotypes in the control group were consistent with those predicted 
by the HWE (Table 1), except for rs9968051 (p=0.02). LD between each pair of SNPs 
was assessed by calculating the r2 value as depicted in Supplementary Figure 1. The 
analysis revealed none of the tag-SNPs were in LD, confirming that each tag-SNP 
probably represent a distinct haplotype block. 
The average ancestry contributions in the control group were estimated at 75.1% 
of European, 20.9% of African and 4.0% of Amerindian and those in the NSCPO group 
were 67.9% of European, 27.8% of African and 4.3% of Amerindian (Supplementary 
Table 1). There were no significant differences in the ancestry proportions between 
groups. Taking into account age, gender and genomic ancestry proportions of each 
sample, none of the tag-SNPs in GOLGB1 was significantly associated with NSCPO 
in the additive, dominant or recessive genetic model (Table 2). Indeed, when AG and 
AA genotypes for rs6794341 were combined and compared against GG genotype 
(recessive genetic model), a nominal p value was observed (p=0.03). However, this 
association did not retain statistical significance after adjusting for multiple 
comparisons. Haplotype association analysis revealed a significant association 
between NSCPO and C-G-C-G-G haplotype (p=0.02), which did not withstand 
Bonferroni correction (Table 3). 
Since this is the first study analyzing GOLGB1 SNPs in NSCPO, we performed 
power analysis assuming our current sample and different effect sizes varying the OR 
from 1.0 to 2.0 (Figure 1). Assuming the MAFs found in this Brazilian population and 
the current sample size, the predictive analysis revealed a power of 80% in effects 
ranging from 1.4 to 1.6. Indeed, 4 out of 5 tag-SNPs showed an OR near 1.4 (1.41 for 
rs1169, 1.46 for rs7153, 1.41 for rs9819530, and 1.44 for rs6794341). 
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Table 2 Distribution of genotypes of the tag-single nucleotide polymorphisms (SNPs) in GOLGB1 in the control and nonsyndromic 
cleft palate only (NSCPO) groups. Values of p were adjusted for co-variants by logistic regression analysis. 
 Control (n=284) NSCPO (n=270) ORHet (95% CI) / p value ORHom (95 CI) / p value ORDom (95% CI) / p value ORRec (95% CI) / p value 
rs1169 (CC/CT/TT) 40.1%/47.2%/12.7% 45.0%/39.3%/15.7% 0.72 (0.48-1.09) / 0.28 0.93 (0.52-1.66) / 0.28 0.77 (0.52-1.13) / 0.18 1.09 (0.64-1.88) / 0.75 
rs7153 (GG/GA/AA) 57.0%/37.7%/5.3% 61.2%/30.2%/8.6% 0.72 (0.48-1.08) / 0.25 1.08 (0.51-2.28) / 0.25 0.77 (0.53-1.14) / 0.19 1.22 (0.59-2.52)  /0.59 
rs9968051 (CC/CG/GG) 76.1%/20.4%/3.5% 75.6%/22.2%/2.2% 1.25 (0.79-1.99) / 0.47 0.66 (0.19-2.24) / 0.47 1.17 (0.75-1.82) / 0.49 0.63 (0.19-2.12) / 0.45 
rs9819530 (TT/TG/GG) 39.5%/46.1%/14.4% 45.1%/42.6%/12.3% 0.78 (0.52-1.17) / 0.37 0.72 (0.40-1.30) / 0.37 0.76 (0.52-1.12) / 0.17 0.81 (0.47-1.42) / 0.46 
rs6794341 (GG/GA/AA) 54.2%/38.4%/7.4% 48.7%/40.4%/10.9% 1.42 (0.95-2.13) / 0.07 1.98 (0.98-4.00) / 0.07 1.51 (1.03-2.21) / 0.03 1.70 (0.86-3.35) / 0.12 
 
Table 3 Haplotype analysis of the tag-single nucleotide polymorphisms in GOLGB1 in controls and patients with nonsyndromic cleft 
palate only (NSCPO). P value was adjusted for co-variants by logistic regression analysis. 
Haplotype Control NSCPO p value 
C-G-C-T-A 25.7% 29.5%  
T-A-C-T-G 23.3% 21.8% 0.08 
C-G-C-G-G 23.9% 19.8% 0.02 
C-G-G-G-G 12.5% 12.7% 0.45 
T-G-C-T-G 12.4% 11.5% 0.16 
C-G-C-T-G 0.4% 1.7% 0.19 
Sequence: rs1169, rs7153, rs9968051, rs9819530 and rs6794341.
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Figure 1 Statistical power of the study. If odds of NSCPO is ≥1.4, assuming the current 
sample, the statistical power of 80% is reached for rs1169, rs7153, rs9819530 and 
rs6794341. 
 
 
Supplementary Figure 1 Linkage disequilibrium plot with the tag-single nucleotide 
polymorphisms (SNPs) within GOLGB1. The numbers in the squares indicate the r2 
values of the linkage disequilibrium between pair of SNPs. 
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Supplementary Table 1 Characteristics of controls and patients with nonsyndromic 
cleft palate only (NSCPO). 
 
 Control 
(n=284) 
NSCPO 
(n=270) 
p value 
Age (years) 24.02  12.15 13.73  11.33 0.001a 
Gender    
Male 88 (31.0%) 104 (38.5%) 0.06b 
Female 196 (69.0%) 166 (61.5%)  
Ancestry    
European 75.1% 67.9% 0.51c 
African 20.9% 27.8%  
Amerindian 4.0% 4.3%  
 
ap value calculated with Student’s t-test, bp value calculated with x2 test, and cp value calculated 
with Kruskal-Wallis test. 
 
Discussion 
We hypothesized that GOLGB1 single nucleotide variants would be associated with 
increased risk for NSCPO. To comprehensively investigate the role of genetic variants 
in GOLGB1, tag-SNP association strategy was performed. This strategy selects the 
representative SNPs in a specific gene or region, based on the linkage disequilibrium 
scores, allowing the analysis of contribution of each SNP independently to disease 
risk. This strategy is particularly suited to cover the entire candidate gene with the 
smallest number of SNPs. Our study failed to identify significant associations between 
GOLGB1 genetic variants and NSCPO susceptibility in the Brazilian population. From 
a strategic perspective, our data is very consistent since we have included samples 
from 4 different Centers in 4 Brazilian states, covering a high geographic area of Brazil, 
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and assessed the ancestry contribution of each patient, correcting for specific effects 
that the population stratification could have. 
Giantin, encoded by GOLGB1 gene, is the largest Golgi complex-associated 
protein (Munro, 2011). Giantin interacts with p115 and GM130 to tether COPI vesicles 
with Golgi membranes, but by binding Rab1 and Rab6 proteins, is suggested that 
giantin may have additional regulatory roles, including the regulation of exocytotic 
vesicle transport from the endoplasmic reticulum to the Golgi apparatus (Rosing et al., 
2007). Besides maintenance of compact Golgi morphology and regulation of vesicle 
transport, little is known on giantin. The relation between GOLGB1 variations and 
human diseases has been reported in very few studies. By using CRISPR/Cas9-
inducing Golgb1 loss-of-function, Lan et al. (2016) demonstrated recently that mouse 
embryos deficient in Golgb1 consistently exhibit cleft palate due to failure of palatal 
shelf elevation. The authors also showed an increased cell density, reduced 
hyaluronan accumulation and impaired protein glycosylation in the palatal 
mesenchymal cells. Although Golgb1 is essential for normal embryonic development 
of palate in mice, the results of this study did not confirm the presumption that genetic 
variants in GOLGB1 are associated with an increased risk of NSCPO in humans. 
We estimated that this study has 80% of power to detect a moderate genetic 
effect (allele relative risk of ~1.4 in the additive risk model) for 4 out of 5 tag-SNPs. As 
a multifactorial and complex disease, it is well established that multiple genes with 
modest individual effects (individual odds no higher than 2.0) are capable of disrupting 
normal lip and palate development under specific circumstances, which may include 
interactions to environmental risk factors (Beaty et al., 2016). The only SNP with limited 
power was rs9968051, which showed a low frequency of the minor allele. For this SNP, 
80% of power to detect a genetic effect was only obtained in OR ≥1.6 in an additive 
risk model. The rs9968051 was also the only that did not respect the HWE. Since our 
assays showed clear discrimination ability, quality control strategy revealed 
concordance rate of 100% and possible variations in the groups related to population 
stratification were ruled out by using population structure analysis based on genetic 
ancestry, rs9968051 was kept in the analyses. As we used tag-SNPs to capture the 
majority of common variants in the GOLGB1 gene, it is possible that we might have 
missed rare variants in this gene associated with the disease. Furthermore, as 
GOLGB1 risk allele frequencies differ according to ethnicity, this relationship should 
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be tested in other populations and functional studies should be performed to clarify the 
contribution of genetic background to the development of this disease. Thus, further 
large-scale studies and sequencing of the whole gene are warranted to confirm our 
findings. 
In conclusion, our findings show that GOLGB1 tag-SNPs are not likely to be 
associated with NSCPO susceptibility, at least in the ethnically-mixed Brazilian 
population. Considering the essential role of GOLGB1 in palatogenesis, further studies 
with a larger sample sizes, samples from other ancestrally different populations and 
taking into account also possible interactions with environmental factors are 
necessaries to increase our understanding and knowledge of the genetic events that 
contribute to this uncommon form of nonsyndromic oral cleft. 
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3 DISCUSSÃO 
Como a discussão foi exaustivamente abordada em cada artigo, usamos esse 
espaço para contextualizar nossos resultados e discutir as perspectivas futuras para 
novos estudos. 
Nos últimos anos têm ocorrido uma evolução no entendimento dos fatores 
genéticos relacionados à etiologia das FONS em todo o mundo. No entanto, a 
complexidade dos mecanismos biológicos envolvidos no desenvolvimento craniofacial 
e as evidências da heterogeneidade genética entre os sub-fenótipos das FONS e 
entre as diferentes populações dificultam a identificação dos exatos mecanismos 
genéticos. Neste sentido, é fundamental estudos de replicação das variantes 
genéticas identificadas como de susceptibilidade para as FONS em diferentes 
populações. Para pesquisas desta natureza junto à população brasileira que 
apresenta uma identidade genética modificada por mais de 500 anos em decorrência 
da miscigenação principalmente entre europeus, africanos e ameríndios, faz-se 
necessário inferir variáveis contínuas que estimam a ancestralidade genômica. O 
agrupamento de individ́uos pela cor de pele ou caracteriśticas fiśicas que possam 
indicar sua etnia não garante a separação dos grupos de forma homogênia (Pena et 
al., 2011; Durso et al., 2014). Dessa forma, a implicação desta miscigenação sobre os 
estudos que buscam associação de marcadores genéticos com fenótipos complexos 
como as FONS pode levar à obtenção de resultados espúrios. Apesar deste aspecto 
negativo, populações geradas pela miscigenação representam uma possibilidade 
para a identificação de genes responsáveis pela expressão de determinados 
fenótipos, quando genes se manifestam de maneira diferenciada nos grupos 
populacionais ancestrais contribuintes para a formação da população. O manuscrito 
de revisão sistemática deste estudo identificou diversos estudos com amostras 
pequenas e de diferentes regiões do país sem adequada avaliação da influência da 
ancestralidade, indicando que a união entre grupos de pesquisa, bem como a 
estratificação ancestral dos indivíduos possibilitaria o entendimento concreto da 
etiologia das FONS na população brasileira. 
O resultado da meta-análise indicou uma possível associação do SNP 
rs642961 no gene IRF6 e dos marcadores rs987525 e rs1530300 em uma região 
intergênica na região 8q24 com as FL±PNS na população brasileira, mas esses 
resultados devem ser observados com cuidado. Mundialmente têm-se observado 
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essas associações principalmente com populações de ascendência europeia 
(Birnbaum et al., 2009; Grant et al., 2009; Nikopensius et al., 2009; Beaty et al., 2010; 
Mangold et al., 2010; Ludwig et al., 2012; Moreno et al., 2017), no entanto na 
população brasileira a participação é discutida. Estudos anteriores do nosso grupo 
não demonstraram a associação do SNP rs642961 em IRF6 com populações do 
sudeste do Brasil, onde há predominância europeia (Paranaíba et al., 2010), e em um 
grupo de amostras do estado da Bahia, onde há predomínio de indivíduos com 
ancestralidade africana (do Rego-Borges et al., 2015). Similarmente, outro estudo 
baseado em trios de diferentes regiões do Brasil não confirmou a associação de 
rs642961 em IRF6 e o risco das FONS (de Souza et al., 2016). Por outro lado, Brito 
et al. (2012a) relataram uma associação significante entre rs642961 em IRF6 e FLNS. 
Importante destacar que neste último estudo, a distribuição dos genótipos no grupo 
controle não respeitaram os preceitos do equilíbrio de Hardy-Weiberg, permitindo a 
inferência que problemas na genotipagem ocorreram. A associação de 8q24 (ambos 
rs987525 e rs1530300) com FL±PNS foi encontrada anteriormente em uma população 
brasileira com ancestralidade européia alta (Brito et al., 2012b; Bagordakis et al., 
2013), mas o estudo de do Rego-Borges et al. (2015) demonstrou apenas uma 
tendência de associação entre rs987525 e rs1530300 e o risco da FL±PNS na 
população com alta ascendência africana. 
A suplementação com ácido fólico é proposta como uma maneira de prevenção 
dos defeitos associados ao tubo neural e das FONS, visto a sua participação na 
sińtese de nucleotid́eos e aminoácidos e na metilação do DNA (Wilcox et al., 2007; 
Arruda et al., 2013). No entanto, estudos com suplementação de ácido fólico não 
encontraram uma diminuição na ocorrência das FONS (Ray et al., 2003; Lopez-
Camelo et al., 2010; Wehby e Murray, 2010), o que sugere o envolvimento de 
variantes polimórficas em genes como MTHFR (methylenetetrahydrofolate 
reductase), que codifica uma proteińa relacionada ao metabolismo do ácido fólico, ao 
risco aumentado para o surgimento das FONS (Bufalino et al., 2010; Bezerra et al., 
2014; Aquino et al., 2014, de Aguiar et al., 2015; Wang et al., 2016). Embora 
marcadores polimórficos em MTHFR não tenham sido identificados como fatores de 
risco para as FONS em todos os GWAS realizados e em uma meta-análise usando 
dois dos maiores GWAS realizados até o momento (Birnbaum et al., 2009, Grant et 
al., 2009, Beaty et al., 2010, Mangold et al., 2010, Ludwig et al., 2012, Sun et al., 2015, 
Leslie et al., 2016a, Yu et al., 2017), há vários trabalhos com abordagem de 
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genotipagem direta relatando essa associação em diferentes populações (Pan et al., 
2012; Zhao et al., 2014). Vários polimorfismos foram descritos em MTHFR, mas o 
rs1801133 é o mais estudado em FONS devido a redução da atividade enzimática e 
consequente significado clínico (Schwab et al., 2008; Afzal et al., 2009; Wang et al., 
2014; Zhou et al., 2014; Hong et al., 2017; Wang et al., 2017). O rs1801133 (C>T) 
implica em uma substituição de alanina por uma valina no domínio catalítico, 
resultando em uma maior dissociação do cofator FAD devido ao deslocamento da 
estrutura quaternária da enzima (Frosst et al., 1995; Yamada et al., 2001; Pejchal et 
al., 2006) e em uma proteína termolábil com redução de 30% a 70% em sua atividade 
catalítica (Kang et al., 1991; Frosst et al., 1995). Nossa meta-análise confirmou a 
associação desse polimorfismo como fator de risco para FL±PNS na população 
brasileira. 
Adicionalmente, a meta-análise revelou que o polimorfismo rs17563 no gene 
BMP4 apresenta um efeito protetor para as FL±PNS. Esse polimorfismo foi estudado 
apenas em três estudos no Brasil (Araújo et al., 2012; Antunes et al., 2013, de Araújo 
et al., 2016), sendo que dois deles são do mesmo grupo de pesquisa (Araújo et al., 
2012; de Araújo et al., 2016) e um não foi incluído na meta-análise devido ao fato de 
não ter apresentado a frequência dos genótipos entre os grupos FL±PNS e controle 
(de Araújo et al. 2016). O estudo de Araújo e colaboradores (2012) usaram apenas 
123 amostras de FL±PNS e 246 controles de 4 regiões diferentes do país sem 
correção por ancestralidade. Após a inclusão de amostras de mais três estados do 
país, o mesmo grupo de pesquisa apresentou um estudo com 182 pacientes com 
FL±PNS e 355 controles e um efeito protetor foi confirmado (de Araújo et al., 2016). 
Antunes et al. (2013) usaram 324 amostras FL±PNS e 450 controles do estado do Rio 
de Janeiro e apenas uma associação com FLNS (71 amostras) foi evidenciada. Esse 
polimorfismo foi estudado em outras populações e na população de origem asiática, 
é considerado um fator de risco (Hu et al., 2015; Li et al., 2017), sugerindo assim que 
a confirmação do papel deste polimorfismo na população brasileira, com amostras 
maiores e com estratificação populacional, se faz necessário para o melhor 
entendimento. 
A replicação de marcadores associados as FONS na população brasileira é 
uma estratégia simples para entender os fatores genéticos associados em nossa 
população. Com esse princípio, o manuscrito 2 avaliou os SNP rs7552 em 2q24.2, 
rs8049367 em 16p13.3, rs1880646, rs7406226, rs9891446 em 17p13, rs1588366 em 
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17q23.2 e rs73039426 em 19q13.11 em 1697 indivíduos brasileiros. Os 7 SNP foram 
previamente associados com FL±PNS nos recentes GWAS com populações multi-
etnicas (Beaty et al., 2010; Sun et al., 2015; Leslie et al., 2016; Yu et al., 2017). O SNP 
rs7552 localizado na região 3’ UTR do gene FAM49A e suas interações com os outros 
SNP desse estudo foram associados em nossa população. Embora não se conheça 
a real função da proteína codificada pelo gene FAM49A, a expressão em diversos 
tecidos foi identificada (Fagerberg et al., 2014). Variantes em 3’ UTR podem 
influenciar a poliadenização, a eficiência da tradução, a localização e a estabilidade 
do mRNA (Króliczewski et al., 2018). Além disso, este SNP pode realizar uma função 
reguladora ou pode estar em desequilíbrio de ligação com outro gene ou região 
genética e não ser a verdadeira variante etiológica. Dessa forma, estudos adicionais 
são necessários para esclarecer a relação entre 2p24.2 e o desenvolvimento de 
FL±PNS, permitindo a elucidação de mecanismos pelos quais a variante rs7552 ou 
outra variante em desequilíbrio conduz a predisposição FL±PNS, traduzindo assim os 
achados de estudos de associação na clínica. 
O manuscrito 2 também revelou a associação do haplótipo A-G formado pelos 
SNP rs1880646 e rs9891446 no gene NTN1 como fator de risco para FL±PNS. NTN1 
codifica uma proteína conhecida como netrin 1, que promove a polaridade das células 
migratórias durante o desenvolvimento neural, vascular e na morfogênese das 
glândulas mamárias, pâncreas e pulmões (Ylivinkka et al., 2016; Wu et al., 2017). Por 
interagir com a proteína fosfatase 2A (PP2A) e a proteína quinase 1 associada à morte 
celular (DAPK1), sugere-se que netrin 1 pode desempenhar funções regulatórias, 
prevenindo a apoptose celular (Lahlali et al., 2016). Além disso, netrin 1 foi expressa 
em níveis elevados no mesêquima, especialmente ao longo das bordas dos processos 
palatinos, sugerindo seu envolvimento na fusão palatal (Leslie et al., 2015). Como 
estes SNP foram previamente associados apenas com FL±PNS e nenhuma 
associação com fissuras palatinas isoladas foi descrita em humanos até o momento, 
trabalhos futuros com esse fenótipo são necessários para entender essa associação. 
Obviamente genes e seus produtos não agem isoladamente, eles são 
componentes de vias nas quais existem várias etapas que precisam ocorrer de 
maneira correta para que o processo aconteça de modo esperado. Desta forma, cada 
vez mais tem se estudado como os genes podem interagir entre si e como a 
combinação de variantes de dois ou mais genes na mesma via pode resultar em um 
efeito cumulativo. Exemplo disso foi observado no manuscrito 3 que embora nenhuma 
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interação individual entre os 28 SNPs em SOD1, SOD2, SOD3, PON1, PON2 e PON3 
no núcleo familiar, múltiplas interações GxG entre os SNPs rs3917490, rs2299262 e 
rs2237583 em PON1, rs2286232, rs17166879 e rs2299267 em PON2 e rs10953143, 
rs3757708, rs1053275 e rs978903 em PON3 foram associadas na sucetibilidade para 
FL±PNS. Os genes PON1, PON2 e PON3 codificam enzimas importantes na 
manutenção dos níveis baixos de espécies reativas de oxigênio (ROS) e são 
expressos em quase todos os tecidos humanos (Précourt et al., 2011). Embora a 
expressão de PONs tem sido implicada na patogênese de defeitos do tubo neural, o 
presente estudo foi o primeiro realizado com FL±PNS. 
Em adição, observou-se no estudo 3 que o alelo C do polimorfismo rs2237583 
em PON1 induz um efeito protetor para as FL±PNS e o SNP rs3917490 apresentou 
uma associação significante apenas em amostras com alta ancestralidade africana. O 
SNP rs3917490 está no íntron do gene PON1 e não se conhece a função até o 
momento. O SNP rs2237583, que é associado com uma diminuição a atividade 
enzimática, tem sido apontado como um fator de risco para doenças vasculares 
(Yoshino et al., 2016; Yuan et al., 2017). Um estudo no norte da Califórnia identificou 
12 SNP em PON1 associados à redução da atividade enzimática, incluindo o SNP 
rs2237583. No entanto, este SNP estava em forte LD com rs705379 (Huen et al., 
2011). O SNP rs705379 está fortemente associado a redução dos níveis da enzima e 
estudos in vivo sugerem que pode interromper a sequência de reconhecimento do 
fator Sp1, afetando a transcrição (Deakin et al., 2003; Huen et al., 2015). 
Interessantemente, o alelo C de rs705370 foi associado à expressão aumentada de 
PON1 em afro-americanos, mas não em europeus (Chen et al., 2003; Holland et al., 
2006; Rojas-Garcia et al., 2005). Em nosso estudo o SNP rs705379 não estava em 
LD com o rs2237583 e não foi associado com FL±PNS na abordagem de núcleo 
familiar com amostras de 5 estados diferentes do país. A abordagem em trio é eficaz 
para reduzir os efeitos da ancestralidade, por que utiliza como controle os pais não 
afetados da própria família. No entanto, não se consegue analisar a segregação por 
porcentagem de ascendência dos indivíduos, sendo importante um estudo caso-
controle com separação dos pacientes com alta e baixa ancestralidade africana para 
para um melhor entendimento da participação do SNP rs705370 na etiologia das 
FONS. 
Na revisão de literatura observamos 49 estudos com amostras de pacientes 
com FONS na população brasileira. Desses estudos, 29 tinham amostras de FPNS, 
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mas nenhum tinha sido realizado exclusivamente com amostras de FPNS até o 
momento na população brasileira. Interessante notar que esta tendência, muito em 
decorrência da menor prevalência deste tipo de fissura oral, é mundial. O estudo 4 foi 
dedicado exclusivamente as FPNS, na tentativa de verificar a associação de tag-SNP 
no gene GOLGB1 com a etiologia das FPNS. No entanto, nossos resultados não 
detectaram tal associação. Sabendo das diferenças embrionárias e fatores etiológicos 
envolvidos na formação do palato, a identificação de novas regiões polimórficas em 
genes candidatos às FPNS é de fundamental importância para o entendimento dessa 
anomalia. A complexidade e a diversidade dos aspectos clínicos e mecanismos 
moleculares envolvidos no desenvolvimento craniofacial proporcionam inúmeras 
oportunidades para investigações futuras da etiologia da FPNS. Dois estudos de 
GWAS com amostras de pacientes FPNS foram realizados até o momento. Um deles 
apontou o marcador rs41268753 em GRHL3 (grainyhead like transcription factor 3) 
como fator de risco para as FPNS (Leslie et al., 2016b). O outro demonstrou 
associações de inúmeros SNP em MLLT3 (MLLT3, super elongation complex subunit) 
e SMC2 (structural maintenance of chromosomes 2) e mães que consumiram álcool 
no primeiro trimestre de gravidez no risco de desenvolvimento das FPNS. Também foi 
encontrado fatores de risco para FPNS nas interações de SNP em TBK1 (TANK 
binding kinase 1) e ZNF236 (zinc finger protein 236) com o tabagismo materno e com 
risco diminuído de SNPs em BAALC (BAALC, MAP3K1 and KLF4 binding) com 
suplementação multivitamínica (Beaty et al., 2011). 
De forma geral, os estudos genéticos demonstraram sucesso na caracterização 
de alguns genes e regiões genéticas com participação na etiologia das FONS, mas a 
grande maioria destes estudos concentrou-se apenas nos efeitos dos marcadores ou 
genes de forma individualizada (Birnbaum et al., 2009, Grant et al., 2009, Beaty et al., 
2010, Mangold et al., 2010, Ludwig et al., 2012, Sun et al., 2015, Leslie et al., 2016a, 
Yu et al., 2017). Dentro do conceito etiológico multifatorial da doença, estudos de 
interações gene-gene (GxG) e gene-ambiente (GxE) devem contribuir para um melhor 
entendimento da etiologia das FONS (Cordell, 2009, Beaty et al., 2011, Letra et al., 
2012, Wu et al., 2014, Li et al., 2015, Machado et al., 2016, Wang et al., 2018). 
Exemplos recentes são as interações entre os genes BHMT/BHMT2 (betaine-
homocysteine methyltransferase) e DMGDH (dimethylglycine dehydrogenase), que 
não foram apontados como etiológicos para as FONS quando analisados de maneira 
individual, mas em conjunto (interações GxG) demonstraram associações de risco 
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(Wang et al., 2018). O tabagismo materno é discutido como uma causa importante 
para as FONS, mas apenas em interação com o SNP rs1801321 no gene RAD51 foi 
apresentado como fator de risco para FL±PNS na população brasileira (Machado et 
al., 2016). Os manuscritos 2 e 3 também revelaram interações entre dos SNP em 
2p24.2, 16p13.3, 17p13, 17q23.2 e 19q13.11 e entre os SNP em PON1, PON2 e 
PON3 como possiveis fatores de risco para as FL±PNS na população brasileira. Desta 
forma, estes resultados devem servir de incentivo para novos estudos, principalmente 
com amostras maiores, para aumentar a compreensão e conhecimento dos eventos 
genéticos que contribuem para esta complexa alteração do desenvolvimento. 
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4 CONCLUSÃO 
 
1. O estudo de revisão sistemática e meta-análise evidenciou associações entre 
rs642961 (IRF6), rs987525 e rs1530300 (8q24) e rs1801133 (MTHFR) com o risco de 
FL±PNS. O polimorfismo rs17563 em BMP4 demonstrou um efeito de proteção para 
o desenvolvimento das FL±PNS. Estudos futuros com amostras maiores e com 
populações ancestralmente caracterizadas são importantes para melhor identificar as 
variantes genéticas com influência na etiologia das FONS na população brasileira. 
 
2. Os genótipos formados pelo alelo A do SNP rs7552 em 2p24.2 e suas interações 
com rs8049367 (16p13.3), rs1880646 e rs9891446 (17p13), rs1588366 (17q23.2) e 
rs73039426 (19q13.11) são fatores de risco para desenvolvimento de FL±PNS na 
população brasileira. Adicionalmente, o haplótipo A-G formado pelos polimorfismos 
rs1880646 e rs9891446 no gene NTN1 demonstrou associação significante com 
FL±PNS. 
 
3. Múltiplas interações GxG foram observadas entre os SNP nos genes PON1, PON2 
e PON3 no risco das FL±PNS, mas as interações contendo rs2237583 em PON1 e 
rs17166879 em PON2 foram as que demonstraram um valor de p resistente a 
correção para múltiplas comparações e ao teste de permutação. O alelo C do SNP 
rs2237583 foi associado com um efeito protetor para as FL±PNS, enquanto o SNP 
rs3917490 foi associado apenas nas amostras com alta ancestralidade africana na 
população brasileira. 
 
4. Os tag-SNP em GOLGB1 não foram associados ao risco das FPNS na população 
brasileira. 
  
154 
REFERÊNCIAS* 
Afzal S, Jensen SA, Vainer B, Vogel U, Matsen JP, Sorensen JB, et al. MTHFR 
polymorphismsand 5-FU-based adjuvant chemotherapy in colorectal cancer. 
AnnOncol. 2009; 20(10):1660-1666. 
Antunes LS, Küchler EC, Tannure PN, Costa MC, Gouvêa CV, Olej B, et al. BMP4 
polymorphism is associated with nonsyndromic oral cleft in a Brazilian population. Cleft 
Palate Craniofac J. 2013; 50: 633-638. 
Aquino SN, Hoshi R, Bagordakis E, Pucciarelli MG, Messetti AC, Moreira H, et al. 
MTHFR rs2274976 polymorphism is a risk marker for nonsyndromic cleft lip with or 
without cleft palate in the Brazilian population. Birth Defects Res A Clin Mol Teratol. 
2014; 100(1): 30-5. 
Araújo TK, Simioni M, Félix TM, de Souza LT, Fontes MÍ, Monlleó IL, et al. Preliminary 
analysis of the nonsynonymous polymorphism rs17563 in BMP4 gene in Brazilian 
population suggests protection for nonsyndromic cleft lip and palate. Plast Surg Int. 
2012; 2012: 247104. 
Arruda IT, Persuhn DC, de Oliveira NF. The MTHFR C677T polymorphism and global 
DNA methylation in oral epithelial cells. Genet Mol Biol. 2013; 36(4): 490-3. 
Bagordakis E, Paranaiba LM, Brito LA, de Aquino SN, Messetti AC, Martelli-Junior H, 
et al. 2013. Polymorphisms at regions 1p22.1 (rs560426) and 8q24(rs1530300) are 
risk markers for nonsyndromic cleft lip and/or palatein the Brazilian population. Am J 
Med Genet Part A. 2013; 161A: 1177-1180. 
Beaty TH, Murray JC, Marazita ML, Munger RG, Ruczinski I, Hetmanski JB, et al. A 
genome-wide association study of cleft lip with and without cleft palate identifies risk 
variants near MAFB and ABCA4. Nat Genet. 2010; 42(6): 525-9. 
                                                          
* De acordo com as normas da UNICAMP/FOP, baseadas na padronização do International 
Committee of Medical Journal Editors - Vancouver Group. Abreviatura dos periódicos em 
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